Category_Character;Category_Name;Group_Number;Group_Name;Disease;OMIM;OMIM.link;HPO.link;Gene;Function;Incidence;Artefact disclaimer;Metabolite;HMDB.code;HMDB.link;M/z;Isobaric_compounds;Isobaric_Compounds_Names;Biomarker_PathwayPosition_BodyFluid;Biomarker_PathwayPosition_BodyFluid_Weight;Change;Change_Weight;Importance;Importance_Weight;Total_Weight;Absolute_Weight;Dispensability;Zscore_Cutoff;Diagnosis_Blood
A;Disorders of nitrogen-containing compounds;1;Disorders of pyrimidine metabolism;Uridine monophosphate synthase deficiency;258900;https://omim.org/entry/258900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258900;UMPS;Enzyme;Estimated ~20 cases;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;1;Disorders of pyrimidine metabolism;Uridine monophosphate synthase deficiency;258900;https://omim.org/entry/258900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258900;UMPS;Enzyme;Estimated ~20 cases;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;1;Disorders of pyrimidine metabolism;Uridine monophosphate synthase deficiency;258900;https://omim.org/entry/258900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258900;UMPS;Enzyme;Estimated ~20 cases;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;1;Disorders of pyrimidine metabolism;Uridine monophosphate synthase deficiency;258900;https://omim.org/entry/258900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258900;UMPS;Enzyme;Estimated ~20 cases;No possible artefacts to report;Uridine monophosphate;HMDB00288;http://www.hmdb.ca/metabolites/HMDB00288;324.1813;Yes;"3'-UMP; Uridine 2'-phosphate ; Pseudouridine 5'-phosphate";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;5-Amino-4-imidazolecarboxamide ribsosiduria;608688;https://omim.org/entry/608688;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608688;ATIC;Enzyme;Estimated ~3 cases;No possible artefacts to report;AICAR;HMDB01517;http://www.hmdb.ca/metabolites/HMDB01517;338.2112;No;NA;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;5-Amino-4-imidazolecarboxamide ribsosiduria;608688;https://omim.org/entry/608688;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608688;ATIC;Enzyme;Estimated ~3 cases;No possible artefacts to report;AICAR;HMDB01517;http://www.hmdb.ca/metabolites/HMDB01517;338.2112;No;NA;CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;5-Amino-4-imidazolecarboxamide ribsosiduria;608688;https://omim.org/entry/608688;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608688;ATIC;Enzyme;Estimated ~3 cases;No possible artefacts to report;AICAR;HMDB01517;http://www.hmdb.ca/metabolites/HMDB01517;338.2112;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;5-Amino-4-imidazolecarboxamide ribsosiduria;608688;https://omim.org/entry/608688;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608688;ATIC;Enzyme;Estimated ~3 cases;No possible artefacts to report;Inosine monophosphate;HMDB11681;http://www.hmdb.ca/metabolites/HMDB11681;348.206;Yes;Inosinic acid;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenine phosphoribosyltransferase deficiency;614723;https://omim.org/entry/614723;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614723;APRT;Enzyme;Estimated 1:50,000-1:100,000;No possible artefacts to report;Adenine;HMDB00034;http://www.hmdb.ca/metabolites/HMDB00034;135.1267;No;NA;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenine phosphoribosyltransferase deficiency;614723;https://omim.org/entry/614723;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614723;APRT;Enzyme;Estimated 1:50,000-1:100,000;No possible artefacts to report;Adenosine monophosphate;HMDB00045;http://www.hmdb.ca/metabolites/HMDB00045;347.2212;Yes;"3'-AMP; Adenosine 2'-phosphate; 2'-Deoxyguanosine 5'-monophosphate; 2-hydroxy-dAMP";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenine phosphoribosyltransferase deficiency;614723;https://omim.org/entry/614723;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614723;APRT;Enzyme;Estimated 1:50,000-1:100,000;No possible artefacts to report;Adenine;HMDB00034;http://www.hmdb.ca/metabolites/HMDB00034;135.1267;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenine phosphoribosyltransferase deficiency;614723;https://omim.org/entry/614723;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614723;APRT;Enzyme;Estimated 1:50,000-1:100,000;No possible artefacts to report;2,8-Dihydroxyadenine;HMDB00401;http://www.hmdb.ca/metabolites/HMDB00401;167.1255;Yes;8-Hydroxyguanine;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenosine deaminase deficiency;102700;https://omim.org/entry/102700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:102700;"ADA; ADA2";Enzyme;Estimated 1:200,000-1:1.000,000;No possible artefacts to report;Adenosine;HMDB00050;http://www.hmdb.ca/metabolites/HMDB00050;267.2413;Yes;Deoxyguanosine;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenosine deaminase deficiency;102700;https://omim.org/entry/102700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:102700;"ADA; ADA2";Enzyme;Estimated 1:200,000-1:1.000,000;No possible artefacts to report;Inosine;HMDB00195;http://www.hmdb.ca/metabolites/HMDB00195;268.2261;Yes;"Allopurinol riboside; Arabinosylhypoxanthine";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenosine deaminase deficiency;102700;https://omim.org/entry/102700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:102700;"ADA; ADA2";Enzyme;Estimated 1:200,000-1:1.000,000;No possible artefacts to report;Adenosine;HMDB00050;http://www.hmdb.ca/metabolites/HMDB00050;267.2413;Yes;Deoxyguanosine;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenosine deaminase deficiency;102700;https://omim.org/entry/102700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:102700;"ADA; ADA2";Enzyme;Estimated 1:200,000-1:1.000,000;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenosine deaminase deficiency;102700;https://omim.org/entry/102700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:102700;"ADA; ADA2";Enzyme;Estimated 1:200,000-1:1.000,000;No possible artefacts to report;Deoxyadenosine;HMDB00101;http://www.hmdb.ca/metabolites/HMDB00101;251.2419;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenylosuccinate lyase deficiency;103050;https://omim.org/entry/103050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:103050;ADSL;Enzyme;Estimated ~80 cases;No possible artefacts to report;SAICAR;HMDB00797;http://www.hmdb.ca/metabolites/HMDB00797;454.2833;No;NA;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenylosuccinate lyase deficiency;103050;https://omim.org/entry/103050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:103050;ADSL;Enzyme;Estimated ~80 cases;No possible artefacts to report;Succinyladenosine;HMDB00912;http://www.hmdb.ca/metabolites/HMDB00912;383.3135;No;NA;CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenylosuccinate lyase deficiency;103050;https://omim.org/entry/103050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:103050;ADSL;Enzyme;Estimated ~80 cases;No possible artefacts to report;Succinyladenosine;HMDB00912;http://www.hmdb.ca/metabolites/HMDB00912;383.3135;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenylosuccinate lyase deficiency;103050;https://omim.org/entry/103050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:103050;ADSL;Enzyme;Estimated ~80 cases;No possible artefacts to report;SAICAR;HMDB00797;http://www.hmdb.ca/metabolites/HMDB00797;454.2833;No;NA;CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenylosuccinate lyase deficiency;103050;https://omim.org/entry/103050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:103050;ADSL;Enzyme;Estimated ~80 cases;No possible artefacts to report;SAICAR;HMDB00797;http://www.hmdb.ca/metabolites/HMDB00797;454.2833;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenylosuccinate lyase deficiency;103050;https://omim.org/entry/103050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:103050;ADSL;Enzyme;Estimated ~80 cases;No possible artefacts to report;AICAR;HMDB01517;http://www.hmdb.ca/metabolites/HMDB01517;338.2112;No;NA;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenylosuccinate lyase deficiency;103050;https://omim.org/entry/103050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:103050;ADSL;Enzyme;Estimated ~80 cases;No possible artefacts to report;Succinyladenosine;HMDB00912;http://www.hmdb.ca/metabolites/HMDB00912;383.3135;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Adenylosuccinate lyase deficiency;103050;https://omim.org/entry/103050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:103050;ADSL;Enzyme;Estimated ~80 cases;No possible artefacts to report;SAICAR;HMDB00797;http://www.hmdb.ca/metabolites/HMDB00797;454.2833;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Hypoxanthine guanine phosphoribosyltransferase deficiency;300322;https://omim.org/entry/300322;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300322;HPRT1;Enzyme;Estimated 1:235.000-1:380,000;No possible artefacts to report;Hypoxanthine;HMDB00157;http://www.hmdb.ca/metabolites/HMDB00157;136.1115;No;NA;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Hypoxanthine guanine phosphoribosyltransferase deficiency;300322;https://omim.org/entry/300322;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300322;HPRT1;Enzyme;Estimated 1:235.000-1:380,000;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Hypoxanthine guanine phosphoribosyltransferase deficiency;300322;https://omim.org/entry/300322;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300322;HPRT1;Enzyme;Estimated 1:235.000-1:380,000;No possible artefacts to report;Hypoxanthine;HMDB00157;http://www.hmdb.ca/metabolites/HMDB00157;136.1115;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Hypoxanthine guanine phosphoribosyltransferase deficiency;300322;https://omim.org/entry/300322;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300322;HPRT1;Enzyme;Estimated 1:235.000-1:380,000;No possible artefacts to report;Inosine monophosphate;HMDB11681;http://www.hmdb.ca/metabolites/HMDB11681;348.206;Yes;Inosinic acid;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Hypoxanthine guanine phosphoribosyltransferase deficiency;300322;https://omim.org/entry/300322;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300322;HPRT1;Enzyme;Estimated 1:235.000-1:380,000;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Hypoxanthine guanine phosphoribosyltransferase deficiency;300322;https://omim.org/entry/300322;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300322;HPRT1;Enzyme;Estimated 1:235.000-1:380,000;No possible artefacts to report;Folic acid;HMDB00121;http://www.hmdb.ca/metabolites/HMDB00121;441.3975;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Phosphoribosyl pyrophosphate synthetase superactivity;300661;https://omim.org/entry/300661;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300661;PRPS1;Enzyme;Estimated ~30 cases;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Phosphoribosyl pyrophosphate synthetase superactivity;300661;https://omim.org/entry/300661;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300661;PRPS1;Enzyme;Estimated ~30 cases;No possible artefacts to report;Ribose-5-phosphate;HMDB01548;http://www.hmdb.ca/metabolites/HMDB01548;230.1098;Yes;"Ribose-1-phosphate; Ribulose-5-phosphate; Xylulose-1-phosphate; Xylulose-5-phosphate; Beta-arabinose-1-phosphate; Arabinose-5-phosphate";Substrate;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Phosphoribosyl pyrophosphate synthetase superactivity;300661;https://omim.org/entry/300661;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300661;PRPS1;Enzyme;Estimated ~30 cases;No possible artefacts to report;Hypoxanthine;HMDB00157;http://www.hmdb.ca/metabolites/HMDB00157;136.1115;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Phosphoribosyl pyrophosphate synthetase superactivity;300661;https://omim.org/entry/300661;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300661;PRPS1;Enzyme;Estimated ~30 cases;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Phosphoribosyl pyrophosphate synthetase superactivity;300661;https://omim.org/entry/300661;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300661;PRPS1;Enzyme;Estimated ~30 cases;No possible artefacts to report;Phosphoribosyl pyrophosphate;HMDB00280;http://www.hmdb.ca/metabolites/HMDB00280;390.0696;No;NA;Product;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Inosine;HMDB00195;http://www.hmdb.ca/metabolites/HMDB00195;268.2261;Yes;"Allopurinol riboside; Arabinosylhypoxanthine";Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Guanosine;HMDB00133;http://www.hmdb.ca/metabolites/HMDB00133;283.2407;Yes;8-Hydroxy-Deoxyguanosine;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Inosine;HMDB00195;http://www.hmdb.ca/metabolites/HMDB00195;268.2261;Yes;"Allopurinol riboside; Arabinosylhypoxanthine";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Guanosine;HMDB00133;http://www.hmdb.ca/metabolites/HMDB00133;283.2407;Yes;8-Hydroxy-Deoxyguanosine;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Inosine;HMDB00195;http://www.hmdb.ca/metabolites/HMDB00195;268.2261;Yes;"Allopurinol riboside; Arabinosylhypoxanthine";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Guanosine;HMDB00133;http://www.hmdb.ca/metabolites/HMDB00133;283.2407;Yes;8-Hydroxy-Deoxyguanosine;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Hypoxanthine;HMDB00157;http://www.hmdb.ca/metabolites/HMDB00157;136.1115;No;NA;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Guanine;HMDB00132;http://www.hmdb.ca/metabolites/HMDB00132;151.1261;Yes;"2-Hydroxyadenine; 8-Hydroxyadenine";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Urine;1;Decrease;-1.5;Important influence;3;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Deoxyuridine;HMDB00012;http://www.hmdb.ca/metabolites/HMDB00012;228.202;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Purine nucleoside phosphorylase deficiency;613179;https://omim.org/entry/613179;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613179;PNP;Enzyme;Estimated ~70 cases;No possible artefacts to report;Deoxyguanosine;HMDB00085;http://www.hmdb.ca/metabolites/HMDB00085;267.2413;Yes;Adenosine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Xanthinuria type I;278300;https://omim.org/entry/278300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:278300;XDH;Enzyme;Estimated 1:6.000-1:69.000;No possible artefacts to report;Xanthine;HMDB00292;http://www.hmdb.ca/metabolites/HMDB00292;152.1109;Yes;6,8-Dihydroxypurine;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Xanthinuria type I;278300;https://omim.org/entry/278300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:278300;XDH;Enzyme;Estimated 1:6.000-1:69.000;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Product;3;Decrease;-1.5;Important influence;3;-13.5;13.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Xanthinuria type I;278300;https://omim.org/entry/278300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:278300;XDH;Enzyme;Estimated 1:6.000-1:69.000;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Xanthinuria type I;278300;https://omim.org/entry/278300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:278300;XDH;Enzyme;Estimated 1:6.000-1:69.000;No possible artefacts to report;Xanthine;HMDB00292;http://www.hmdb.ca/metabolites/HMDB00292;152.1109;Yes;6,8-Dihydroxypurine;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Xanthinuria type I;278300;https://omim.org/entry/278300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:278300;XDH;Enzyme;Estimated 1:6.000-1:69.000;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Urine;1;Decrease;-1.5;Important influence;3;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Xanthinuria type I;278300;https://omim.org/entry/278300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:278300;XDH;Enzyme;Estimated 1:6.000-1:69.000;No possible artefacts to report;Hypoxanthine;HMDB00157;http://www.hmdb.ca/metabolites/HMDB00157;136.1115;No;NA;Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Xanthinuria type I;278300;https://omim.org/entry/278300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:278300;XDH;Enzyme;Estimated 1:6.000-1:69.000;No possible artefacts to report;5-Hydroxyisourate;HMDB30097;http://www.hmdb.ca/metabolites/HMDB30097;184.1097;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Xanthinuria type I;278300;https://omim.org/entry/278300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:278300;XDH;Enzyme;Estimated 1:6.000-1:69.000;No possible artefacts to report;5-Hydroxyisourate;HMDB30097;http://www.hmdb.ca/metabolites/HMDB30097;184.1097;No;NA;Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;2;Disorders of purine metabolism;Xanthinuria type I;278300;https://omim.org/entry/278300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:278300;XDH;Enzyme;Estimated 1:6.000-1:69.000;No possible artefacts to report;Hypoxanthine;HMDB00157;http://www.hmdb.ca/metabolites/HMDB00157;136.1115;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Arginine:glycine amidinotransferase deficiency;612718;https://omim.org/entry/612718;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612718;GATM;Enzyme;Estimated ~20 cases;No possible artefacts to report;Guanidinoacetic acid;HMDB00128;http://www.hmdb.ca/metabolites/HMDB00128;117.1066;No;NA;Product;3;Decrease;-1.5;Critical;5;-22.5;22.5;Indispensable;-2.0;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Arginine:glycine amidinotransferase deficiency;612718;https://omim.org/entry/612718;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612718;GATM;Enzyme;Estimated ~20 cases;No possible artefacts to report;Guanidinoacetic acid;HMDB00128;http://www.hmdb.ca/metabolites/HMDB00128;117.1066;No;NA;Plasma;2;Decrease;-1.5;Critical;5;-15;15;Indispensable;-2.0;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Arginine:glycine amidinotransferase deficiency;612718;https://omim.org/entry/612718;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612718;GATM;Enzyme;Estimated ~20 cases;No possible artefacts to report;Creatine;HMDB00064;http://www.hmdb.ca/metabolites/HMDB00064;131.1332;Yes;Beta-Guanidinopropionic acid;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Arginine:glycine amidinotransferase deficiency;612718;https://omim.org/entry/612718;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612718;GATM;Enzyme;Estimated ~20 cases;No possible artefacts to report;Guanidinoacetic acid;HMDB00128;http://www.hmdb.ca/metabolites/HMDB00128;117.1066;No;NA;Urine;1;Decrease;-1.5;Critical;5;-7.5;7.5;Indispensable;-2.0;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Arginine:glycine amidinotransferase deficiency;612718;https://omim.org/entry/612718;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612718;GATM;Enzyme;Estimated ~20 cases;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Arginine:glycine amidinotransferase deficiency;612718;https://omim.org/entry/612718;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612718;GATM;Enzyme;Estimated ~20 cases;No possible artefacts to report;Creatine;HMDB00064;http://www.hmdb.ca/metabolites/HMDB00064;131.1332;Yes;Beta-Guanidinopropionic acid;Urine;1;Decrease;-1.5;Important influence;3;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Arginine:glycine amidinotransferase deficiency;612718;https://omim.org/entry/612718;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612718;GATM;Enzyme;Estimated ~20 cases;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Arginine:glycine amidinotransferase deficiency;612718;https://omim.org/entry/612718;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612718;GATM;Enzyme;Estimated ~20 cases;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Creatine transporter deficiency;300352;https://omim.org/entry/300352;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300352;SLC6A8;Transporter;Estimated ~150 cases;Urinary transporter, difficult diagnosis in blood;Creatinine;HMDB00562;http://www.hmdb.ca/metabolites/HMDB00562;113.1179;No;NA;Urine;1;Decrease;-1.5;Critical;5;-7.5;7.5;Indispensable;-1.0;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Creatine transporter deficiency;300352;https://omim.org/entry/300352;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300352;SLC6A8;Transporter;Estimated ~150 cases;Urinary transporter, difficult diagnosis in blood;Creatine;HMDB00064;http://www.hmdb.ca/metabolites/HMDB00064;131.1332;Yes;Beta-Guanidinopropionic acid;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Creatine transporter deficiency;300352;https://omim.org/entry/300352;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300352;SLC6A8;Transporter;Estimated ~150 cases;Urinary transporter, difficult diagnosis in blood;Creatine;HMDB00064;http://www.hmdb.ca/metabolites/HMDB00064;131.1332;Yes;Beta-Guanidinopropionic acid;CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Creatine transporter deficiency;300352;https://omim.org/entry/300352;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300352;SLC6A8;Transporter;Estimated ~150 cases;Urinary transporter, difficult diagnosis in blood;CreatineTransporter-DiagRatio-Creatine/Creatinine;HMDB0CM01;http://www.hmdb.ca/metabolites/HMDB0CM01;NA_Ratio_0CM01;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Creatine transporter deficiency;300352;https://omim.org/entry/300352;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300352;SLC6A8;Transporter;Estimated ~150 cases;Urinary transporter, difficult diagnosis in blood;Creatinine;HMDB00562;http://www.hmdb.ca/metabolites/HMDB00562;113.1179;No;NA;Plasma;2;Decrease;-1.5;Critical;5;-15;5;Indispensable;-1.0;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Creatine transporter deficiency;300352;https://omim.org/entry/300352;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300352;SLC6A8;Transporter;Estimated ~150 cases;Urinary transporter, difficult diagnosis in blood;Creatine;HMDB00064;http://www.hmdb.ca/metabolites/HMDB00064;131.1332;Yes;Beta-Guanidinopropionic acid;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Creatine transporter deficiency;300352;https://omim.org/entry/300352;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300352;SLC6A8;Transporter;Estimated ~150 cases;Urinary transporter, difficult diagnosis in blood;CreatineTransporter-DiagRatio-Creatine/Creatinine;HMDB0CM01;http://www.hmdb.ca/metabolites/HMDB0CM01;NA_Ratio_0CM01;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Guanidinoacetate methyltransferase deficiency;612736;https://omim.org/entry/612736;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612736;GAMT;Enzyme;Estimated ~100 cases;No possible artefacts to report;Guanidinoacetic acid;HMDB00128;http://www.hmdb.ca/metabolites/HMDB00128;117.1066;No;NA;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;2.5;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Guanidinoacetate methyltransferase deficiency;612736;https://omim.org/entry/612736;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612736;GAMT;Enzyme;Estimated ~100 cases;No possible artefacts to report;Creatine;HMDB00064;http://www.hmdb.ca/metabolites/HMDB00064;131.1332;Yes;Beta-Guanidinopropionic acid;Product;3;Decrease;-1.5;Important influence;3;-13.5;13.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Guanidinoacetate methyltransferase deficiency;612736;https://omim.org/entry/612736;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612736;GAMT;Enzyme;Estimated ~100 cases;No possible artefacts to report;Guanidinoacetic acid;HMDB00128;http://www.hmdb.ca/metabolites/HMDB00128;117.1066;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;2.5;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Guanidinoacetate methyltransferase deficiency;612736;https://omim.org/entry/612736;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612736;GAMT;Enzyme;Estimated ~100 cases;No possible artefacts to report;Creatine;HMDB00064;http://www.hmdb.ca/metabolites/HMDB00064;131.1332;Yes;Beta-Guanidinopropionic acid;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Guanidinoacetate methyltransferase deficiency;612736;https://omim.org/entry/612736;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612736;GAMT;Enzyme;Estimated ~100 cases;No possible artefacts to report;Guanidinoacetic acid;HMDB00128;http://www.hmdb.ca/metabolites/HMDB00128;117.1066;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;2.5;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Guanidinoacetate methyltransferase deficiency;612736;https://omim.org/entry/612736;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612736;GAMT;Enzyme;Estimated ~100 cases;No possible artefacts to report;Creatine;HMDB00064;http://www.hmdb.ca/metabolites/HMDB00064;131.1332;Yes;Beta-Guanidinopropionic acid;Urine;1;Decrease;-1.5;Important influence;3;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Guanidinoacetate methyltransferase deficiency;612736;https://omim.org/entry/612736;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612736;GAMT;Enzyme;Estimated ~100 cases;No possible artefacts to report;Creatinine;HMDB00562;http://www.hmdb.ca/metabolites/HMDB00562;113.1179;No;NA;CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Guanidinoacetate methyltransferase deficiency;612736;https://omim.org/entry/612736;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612736;GAMT;Enzyme;Estimated ~100 cases;No possible artefacts to report;Creatinine;HMDB00562;http://www.hmdb.ca/metabolites/HMDB00562;113.1179;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;4;Disorders of creatine metabolism;Guanidinoacetate methyltransferase deficiency;612736;https://omim.org/entry/612736;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612736;GAMT;Enzyme;Estimated ~100 cases;No possible artefacts to report;Creatinine;HMDB00562;http://www.hmdb.ca/metabolites/HMDB00562;113.1179;No;NA;Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;5;Disorders of choline metabolism;Dimethylglycine dehydrogenase deficiency;605850;https://omim.org/entry/605850;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605850;DMGDH;Enzyme;Estimated ~ 1 case;No possible artefacts to report;Dimethylglycine;HMDB00092;http://www.hmdb.ca/metabolites/HMDB00092;103.1198;Yes;"Aminoisobutanoic acid; Gamma-aminobutyric acid; N-Ethylglycine; 3-Aminobutanoic acid; Aminoisobutyric acid; L- and D-alpha-aminobutyric acid";Only biomarker;5;Increase;1;Critical;5;25;25;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;5;Disorders of choline metabolism;Dimethylglycine dehydrogenase deficiency;605850;https://omim.org/entry/605850;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605850;DMGDH;Enzyme;Estimated ~ 1 case;No possible artefacts to report;Dimethylglycine;HMDB00092;http://www.hmdb.ca/metabolites/HMDB00092;103.1198;Yes;"Aminoisobutanoic acid; Gamma-aminobutyric acid; N-Ethylglycine; 3-Aminobutanoic acid; Aminoisobutyric acid; L- and D-alpha-aminobutyric acid";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;5;Disorders of choline metabolism;Dimethylglycine dehydrogenase deficiency;605850;https://omim.org/entry/605850;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605850;DMGDH;Enzyme;Estimated ~ 1 case;No possible artefacts to report;Dimethylglycine;HMDB00092;http://www.hmdb.ca/metabolites/HMDB00092;103.1198;Yes;"Aminoisobutanoic acid; Gamma-aminobutyric acid; N-Ethylglycine; 3-Aminobutanoic acid; Aminoisobutyric acid; L- and D-alpha-aminobutyric acid";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;5;Disorders of choline metabolism;Trimethylaminuria;602079;https://omim.org/entry/602079;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:602079;"FMO1; FMO2; FMO3; FMO4; FMO5";Enzyme;Estimated 1:40,000;Might be an artefact caused by the use of carnitine and/or metronidazole;Trimethylamine N-oxide;HMDB00925;http://www.hmdb.ca/metabolites/HMDB00925;75.1097;No;NA;Only biomarker;5;Increase;1;Critical;5;25;25;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;5;Disorders of choline metabolism;Trimethylaminuria;602079;https://omim.org/entry/602079;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:602079;"FMO1; FMO2; FMO3; FMO4; FMO5";Enzyme;Estimated 1:40,000;Might be an artefact caused by the use of carnitine and/or metronidazole;Trimethylamine N-oxide;HMDB00925;http://www.hmdb.ca/metabolites/HMDB00925;75.1097;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;5;Disorders of choline metabolism;Trimethylaminuria;602079;https://omim.org/entry/602079;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:602079;"FMO1; FMO2; FMO3; FMO4; FMO5";Enzyme;Estimated 1:40,000;Might be an artefact caused by the use of carnitine and/or metronidazole;Trimethylamine N-oxide;HMDB00925;http://www.hmdb.ca/metabolites/HMDB00925;75.1097;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;6;Disorders of glutathione metabolism;5-Oxoprolinase deficiency;260005;https://omim.org/entry/260005;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:260005;OPLAH;Enzyme;Estimated ~8 cases;Might be an artefact caused by use of paracetamol;Pyroglutamic acid;HMDB00267;http://www.hmdb.ca/metabolites/HMDB00267;129.114;Yes;"Pyrrolidonecarboxylic acid; Pyrroline hydroxycarboxylic acid; 1-Pyrroline-4-hydroxy-2-carboxylate; N-Acryloylglycine; 5-Oxoprolinate";Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;6;Disorders of glutathione metabolism;5-Oxoprolinase deficiency;260005;https://omim.org/entry/260005;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:260005;OPLAH;Enzyme;Estimated ~8 cases;Might be an artefact caused by use of paracetamol;Pyroglutamic acid;HMDB00267;http://www.hmdb.ca/metabolites/HMDB00267;129.114;Yes;"Pyrrolidonecarboxylic acid; Pyrroline hydroxycarboxylic acid; 1-Pyrroline-4-hydroxy-2-carboxylate; N-Acryloylglycine; 5-Oxoprolinate";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;6;Disorders of glutathione metabolism;5-Oxoprolinase deficiency;260005;https://omim.org/entry/260005;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:260005;OPLAH;Enzyme;Estimated ~8 cases;Might be an artefact caused by use of paracetamol;L-Glutamic acid;HMDB00148;http://www.hmdb.ca/metabolites/HMDB00148;147.1293;Yes;"D-Glutamic acid; DL-Glutamate; N-Methyl-D-aspartic acid; N-Acetylserine; L-4-Hydroxyglutamate semialdehyde";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;6;Disorders of glutathione metabolism;Glutathione synthetase deficiency;266130;https://omim.org/entry/266130;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266130;GSS;Enzyme;Estimated ~70 cases;No possible artefacts to report;Pyroglutamic acid;HMDB00267;http://www.hmdb.ca/metabolites/HMDB00267;129.114;Yes;"Pyrrolidonecarboxylic acid; Pyrroline hydroxycarboxylic acid; 1-Pyrroline-4-hydroxy-2-carboxylate; N-Acryloylglycine; 5-Oxoprolinate";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;6;Disorders of glutathione metabolism;Glutathione synthetase deficiency;266130;https://omim.org/entry/266130;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266130;GSS;Enzyme;Estimated ~70 cases;No possible artefacts to report;Pyroglutamic acid;HMDB00267;http://www.hmdb.ca/metabolites/HMDB00267;129.114;Yes;"Pyrrolidonecarboxylic acid; Pyrroline hydroxycarboxylic acid; 1-Pyrroline-4-hydroxy-2-carboxylate; N-Acryloylglycine; 5-Oxoprolinate";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;6;Disorders of glutathione metabolism;Glutathione synthetase deficiency;266130;https://omim.org/entry/266130;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266130;GSS;Enzyme;Estimated ~70 cases;No possible artefacts to report;Glutathione;HMDB00125;http://www.hmdb.ca/metabolites/HMDB00125;307.323;No;NA;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;6;Disorders of glutathione metabolism;Glutathione synthetase deficiency;266130;https://omim.org/entry/266130;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266130;GSS;Enzyme;Estimated ~70 cases;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;6;Disorders of glutathione metabolism;Glutathione synthetase deficiency;266130;https://omim.org/entry/266130;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266130;GSS;Enzyme;Estimated ~70 cases;No possible artefacts to report;Cysteinylglycine;HMDB00078;http://www.hmdb.ca/metabolites/HMDB00078;178.21;Yes;"Cysteinyl-Glycine; Glycyl-Cysteine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;6;Disorders of glutathione metabolism;Glutathione synthetase deficiency;266130;https://omim.org/entry/266130;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266130;GSS;Enzyme;Estimated ~70 cases;No possible artefacts to report;L-Proline;HMDB00162;http://www.hmdb.ca/metabolites/HMDB00162;115.1305;Yes;"D-Proline; Acetamidopropanal";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Arginase deficiency;207800;https://omim.org/entry/207800;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207800;ARG1;Enzyme;Estimated 1:350,000-1:1000000;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Arginase deficiency;207800;https://omim.org/entry/207800;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207800;ARG1;Enzyme;Estimated 1:350,000-1:1000000;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Arginase deficiency;207800;https://omim.org/entry/207800;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207800;ARG1;Enzyme;Estimated 1:350,000-1:1000000;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Arginase deficiency;207800;https://omim.org/entry/207800;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207800;ARG1;Enzyme;Estimated 1:350,000-1:1000000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Arginase deficiency;207800;https://omim.org/entry/207800;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207800;ARG1;Enzyme;Estimated 1:350,000-1:1000000;No possible artefacts to report;Guanidinoacetic acid;HMDB00128;http://www.hmdb.ca/metabolites/HMDB00128;117.1066;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Arginase deficiency;207800;https://omim.org/entry/207800;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207800;ARG1;Enzyme;Estimated 1:350,000-1:1000000;No possible artefacts to report;Creatine;HMDB00064;http://www.hmdb.ca/metabolites/HMDB00064;131.1332;Yes;Beta-Guanidinopropionic acid;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Arginase deficiency;207800;https://omim.org/entry/207800;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207800;ARG1;Enzyme;Estimated 1:350,000-1:1000000;No possible artefacts to report;Homo-L-arginine;HMDB00670;http://www.hmdb.ca/metabolites/HMDB00670;188.2275;No;NA;CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Arginase deficiency;207800;https://omim.org/entry/207800;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207800;ARG1;Enzyme;Estimated 1:350,000-1:1000000;No possible artefacts to report;Homo-L-arginine;HMDB00670;http://www.hmdb.ca/metabolites/HMDB00670;188.2275;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Arginase deficiency;207800;https://omim.org/entry/207800;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207800;ARG1;Enzyme;Estimated 1:350,000-1:1000000;No possible artefacts to report;Uracil;HMDB00300;http://www.hmdb.ca/metabolites/HMDB00300;112.0868;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Arginase deficiency;207800;https://omim.org/entry/207800;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207800;ARG1;Enzyme;Estimated 1:350,000-1:1000000;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Arginase deficiency;207800;https://omim.org/entry/207800;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207800;ARG1;Enzyme;Estimated 1:350,000-1:1000000;No possible artefacts to report;Argininosuccinic acid;HMDB00052;http://www.hmdb.ca/metabolites/HMDB00052;290.2731;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;Argininosuccinic acid;HMDB00052;http://www.hmdb.ca/metabolites/HMDB00052;290.2731;No;NA;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;Argininosuccinic acid;HMDB00052;http://www.hmdb.ca/metabolites/HMDB00052;290.2731;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;Argininosuccinic acid;HMDB00052;http://www.hmdb.ca/metabolites/HMDB00052;290.2731;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;Fumaric acid;HMDB00134;http://www.hmdb.ca/metabolites/HMDB00134;116.0722;Yes;Maleic acid;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;Uracil;HMDB00300;http://www.hmdb.ca/metabolites/HMDB00300;112.0868;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Argininosuccinate lyase deficiency;207900;https://omim.org/entry/207900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:207900;ASL;Enzyme;Estimated 1:218.750;No possible artefacts to report;Orotidine;HMDB00788;http://www.hmdb.ca/metabolites/HMDB00788;288.2109;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbamylphosphate synthase I deficiency;237300;https://omim.org/entry/237300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237300;CPS1;Enzyme;Estimated 1:1.300,000;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Plasma;2;Decrease;-1.5;Critical;5;-15;15;Indispensable;-2.0;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbamylphosphate synthase I deficiency;237300;https://omim.org/entry/237300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237300;CPS1;Enzyme;Estimated 1:1.300,000;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbamylphosphate synthase I deficiency;237300;https://omim.org/entry/237300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237300;CPS1;Enzyme;Estimated 1:1.300,000;No possible artefacts to report;Carbamoyl phosphate;HMDB01096;http://www.hmdb.ca/metabolites/HMDB01096;141.0199;No;NA;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbamylphosphate synthase I deficiency;237300;https://omim.org/entry/237300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237300;CPS1;Enzyme;Estimated 1:1.300,000;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbamylphosphate synthase I deficiency;237300;https://omim.org/entry/237300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237300;CPS1;Enzyme;Estimated 1:1.300,000;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbamylphosphate synthase I deficiency;237300;https://omim.org/entry/237300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237300;CPS1;Enzyme;Estimated 1:1.300,000;No possible artefacts to report;Pyroglutamic acid;HMDB00267;http://www.hmdb.ca/metabolites/HMDB00267;129.114;Yes;"Pyrrolidonecarboxylic acid; Pyrroline hydroxycarboxylic acid; 1-Pyrroline-4-hydroxy-2-carboxylate; N-Acryloylglycine; 5-Oxoprolinate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbamylphosphate synthase I deficiency;237300;https://omim.org/entry/237300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237300;CPS1;Enzyme;Estimated 1:1.300,000;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbamylphosphate synthase I deficiency;237300;https://omim.org/entry/237300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237300;CPS1;Enzyme;Estimated 1:1.300,000;No possible artefacts to report;Uracil;HMDB00300;http://www.hmdb.ca/metabolites/HMDB00300;112.0868;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbamylphosphate synthase I deficiency;237300;https://omim.org/entry/237300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237300;CPS1;Enzyme;Estimated 1:1.300,000;No possible artefacts to report;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;L-Alanine;HMDB00161;http://www.hmdb.ca/metabolites/HMDB00161;89.0932;Yes;"D-Alanine; Beta-alanine; Sarcosine";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Plasma;2;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Plasma;2;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;L-Proline;HMDB00162;http://www.hmdb.ca/metabolites/HMDB00162;115.1305;Yes;"D-Proline; Acetamidopropanal";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;Fumaric acid;HMDB00134;http://www.hmdb.ca/metabolites/HMDB00134;116.0722;Yes;Maleic acid;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;Oxoglutaric acid;HMDB00208;http://www.hmdb.ca/metabolites/HMDB00208;146.0981;Yes;3-Oxoglutaric acid;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;Adipic acid;HMDB00448;http://www.hmdb.ca/metabolites/HMDB00448;146.1412;Yes;"Methylglutaric acid; 2-Methylglutaric acid; Monomethylglutaric acid; 2,2-Dimethylsuccinic acid; Solerol; 2-Aceto-2-hydroxybutanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;Suberic acid;HMDB00893;http://www.hmdb.ca/metabolites/HMDB00893;174.1944;Yes;"Ethyladipic acid; 2,4-Dimethyladipic acid; 3-Methylpimelic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;Sebacic acid;HMDB00792;http://www.hmdb.ca/metabolites/HMDB00792;202.2475;Yes;"2-Ethylsuberic acid; Heptylmalonic acid; 3-Methylazelaic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;3-Hydroxypropionic acid;HMDB00700;http://www.hmdb.ca/metabolites/HMDB00700;90.0779;Yes;"L- and D-Lactic acid; Glyceraldehyde; Dihydroxyacetone; Methoxyacetic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;Propionylglycine;HMDB00783;http://www.hmdb.ca/metabolites/HMDB00783;131.1299;Yes;"4-Hydroxyproline; 4-Hydroxy-L-Proline; 4-Hydroxy-2-pyrrolidinecarboxylic acid; Trans-3-hydroxy-L-Proline; cis-4-Hydroxy-D-Proline; N-Acetyl-L-Alanine; 5-Aminolevulinic acid; 5-Amino-2-oxopentanoic acid; L-Glutamic gamma-semialdehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;2-Methylcitric acid;HMDB00379;http://www.hmdb.ca/metabolites/HMDB00379;206.1501;Yes;"Homocitric acid; Methylisocitric acid; 3-(Carboxymethyl)-3-hydroxypentanedioic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;3-Methylcrotonylglycine;HMDB00459;http://www.hmdb.ca/metabolites/HMDB00459;157.1671;Yes;Tiglylglycine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Carbonic anhydrase Va deficiency;615751;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;CA5A;Enzyme;Estimated ~3 cases;No possible artefacts to report;3-Hydroxyisovaleric acid;HMDB00754;http://www.hmdb.ca/metabolites/HMDB00754;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type I;215700;https://omim.org/entry/215700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:215700;ASS1;Enzyme;Estimated 1:70,000-1:100,000;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type I;215700;https://omim.org/entry/215700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:215700;ASS1;Enzyme;Estimated 1:70,000-1:100,000;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type I;215700;https://omim.org/entry/215700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:215700;ASS1;Enzyme;Estimated 1:70,000-1:100,000;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type I;215700;https://omim.org/entry/215700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:215700;ASS1;Enzyme;Estimated 1:70,000-1:100,000;No possible artefacts to report;Argininosuccinic acid;HMDB00052;http://www.hmdb.ca/metabolites/HMDB00052;290.2731;No;NA;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type I;215700;https://omim.org/entry/215700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:215700;ASS1;Enzyme;Estimated 1:70,000-1:100,000;No possible artefacts to report;L-Aspartic acid;HMDB00191;http://www.hmdb.ca/metabolites/HMDB00191;133.1027;Yes;"D-Aspartic acid; Iminodiacetic acid";Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type I;215700;https://omim.org/entry/215700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:215700;ASS1;Enzyme;Estimated 1:70,000-1:100,000;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type I;215700;https://omim.org/entry/215700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:215700;ASS1;Enzyme;Estimated 1:70,000-1:100,000;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type I;215700;https://omim.org/entry/215700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:215700;ASS1;Enzyme;Estimated 1:70,000-1:100,000;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type I;215700;https://omim.org/entry/215700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:215700;ASS1;Enzyme;Estimated 1:70,000-1:100,000;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type I;215700;https://omim.org/entry/215700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:215700;ASS1;Enzyme;Estimated 1:70,000-1:100,000;No possible artefacts to report;N-a-Acetylcitrulline;HMDB00856;http://www.hmdb.ca/metabolites/HMDB00856;217.2224;Yes;"Alanyl-Glutamine; Alanyl-Gamma-glutamate; Glutaminyl-Alanine; Gamma-glutamyl-Alanine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type I;215700;https://omim.org/entry/215700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:215700;ASS1;Enzyme;Estimated 1:70,000-1:100,000;No possible artefacts to report;Orotidine;HMDB00788;http://www.hmdb.ca/metabolites/HMDB00788;288.2109;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type II;603471;https://omim.org/entry/603471;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603471;SLC25A13;Transporter;Estimated 1:100,000-1:230,000;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Citrullinaemia type II;603471;https://omim.org/entry/603471;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603471;SLC25A13;Transporter;Estimated 1:100,000-1:230,000;No possible artefacts to report;Argininosuccinic acid;HMDB00052;http://www.hmdb.ca/metabolites/HMDB00052;290.2731;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Mitochondrial ornithine transporter deficiency;238970;https://omim.org/entry/238970;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:238970;SLC25A15;Transporter;Estimated ~100 cases;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Mitochondrial ornithine transporter deficiency;238970;https://omim.org/entry/238970;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:238970;SLC25A15;Transporter;Estimated ~100 cases;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Mitochondrial ornithine transporter deficiency;238970;https://omim.org/entry/238970;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:238970;SLC25A15;Transporter;Estimated ~100 cases;No possible artefacts to report;Homocitrulline;HMDB00679;http://www.hmdb.ca/metabolites/HMDB00679;189.2123;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Mitochondrial ornithine transporter deficiency;238970;https://omim.org/entry/238970;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:238970;SLC25A15;Transporter;Estimated ~100 cases;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Mitochondrial ornithine transporter deficiency;238970;https://omim.org/entry/238970;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:238970;SLC25A15;Transporter;Estimated ~100 cases;No possible artefacts to report;3-Amino-2-piperidone;HMDB00323;http://www.hmdb.ca/metabolites/HMDB00323;114.1457;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Mitochondrial ornithine transporter deficiency;238970;https://omim.org/entry/238970;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:238970;SLC25A15;Transporter;Estimated ~100 cases;No possible artefacts to report;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Mitochondrial ornithine transporter deficiency;238970;https://omim.org/entry/238970;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:238970;SLC25A15;Transporter;Estimated ~100 cases;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Mitochondrial ornithine transporter deficiency;238970;https://omim.org/entry/238970;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:238970;SLC25A15;Transporter;Estimated ~100 cases;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;N-acetylglutamate synthase deficiency;237310;https://omim.org/entry/237310;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237310;NAGS;Enzyme;Estimated ~56 cases;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Plasma;2;Decrease;-1.5;Critical;5;-15;15;Indispensable;-1.0;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;N-acetylglutamate synthase deficiency;237310;https://omim.org/entry/237310;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237310;NAGS;Enzyme;Estimated ~56 cases;No possible artefacts to report;N-Acetylglutamic acid;HMDB01138;http://www.hmdb.ca/metabolites/HMDB01138;189.1659;Yes;Glutarylglycine;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;N-acetylglutamate synthase deficiency;237310;https://omim.org/entry/237310;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237310;NAGS;Enzyme;Estimated ~56 cases;No possible artefacts to report;L-Glutamic acid;HMDB00148;http://www.hmdb.ca/metabolites/HMDB00148;147.1293;Yes;"D-Glutamic acid; DL-Glutamate; N-Methyl-D-aspartic acid; N-Acetylserine; L-4-Hydroxyglutamate semialdehyde";Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;N-acetylglutamate synthase deficiency;237310;https://omim.org/entry/237310;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237310;NAGS;Enzyme;Estimated ~56 cases;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;N-acetylglutamate synthase deficiency;237310;https://omim.org/entry/237310;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237310;NAGS;Enzyme;Estimated ~56 cases;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;N-acetylglutamate synthase deficiency;237310;https://omim.org/entry/237310;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237310;NAGS;Enzyme;Estimated ~56 cases;No possible artefacts to report;L-Alanine;HMDB00161;http://www.hmdb.ca/metabolites/HMDB00161;89.0932;Yes;"D-Alanine; Beta-alanine; Sarcosine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;N-acetylglutamate synthase deficiency;237310;https://omim.org/entry/237310;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237310;NAGS;Enzyme;Estimated ~56 cases;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;N-acetylglutamate synthase deficiency;237310;https://omim.org/entry/237310;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:237310;NAGS;Enzyme;Estimated ~56 cases;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Product;3;Decrease;-1.5;Important influence;3;-13.5;13.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;OTC-DiagRatio-(OA+Uri+Ura)/Cit;HMDBOAA01;NA;NA_Ratio_OAA01;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Carbamoyl phosphate;HMDB01096;http://www.hmdb.ca/metabolites/HMDB01096;141.0199;No;NA;Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;L-Asparagine;HMDB00168;http://www.hmdb.ca/metabolites/HMDB00168;132.1179;Yes;"D-Asparagaine; Ureidopropionic acid; Glycyl-glycine; N-carbamoylsarcosine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Uracil;HMDB00300;http://www.hmdb.ca/metabolites/HMDB00300;112.0868;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Homocitrulline;HMDB00679;http://www.hmdb.ca/metabolites/HMDB00679;189.2123;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;7;Disorders of ammonia detoxification;Ornithine transcarbamylase deficiency;311250;https://omim.org/entry/311250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:311250;OTC;Enzyme;Estimated 1:56.500-1:77.000;No possible artefacts to report;Uridine;HMDB00296;http://www.hmdb.ca/metabolites/HMDB00296;244.2014;Yes;Pseudouridine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Cystinuria;220100;https://omim.org/entry/220100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:220100;"SLC3A1; SLC7A9";Transporter;Estimated 1:7.000;Urinary transporter, difficult diagnosis in blood;L-Cystine;HMDB00192;http://www.hmdb.ca/metabolites/HMDB00192;240.3;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Cystinuria;220100;https://omim.org/entry/220100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:220100;"SLC3A1; SLC7A9";Transporter;Estimated 1:7.000;Urinary transporter, difficult diagnosis in blood;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Cystinuria;220100;https://omim.org/entry/220100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:220100;"SLC3A1; SLC7A9";Transporter;Estimated 1:7.000;Urinary transporter, difficult diagnosis in blood;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Cystinuria;220100;https://omim.org/entry/220100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:220100;"SLC3A1; SLC7A9";Transporter;Estimated 1:7.000;Urinary transporter, difficult diagnosis in blood;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Tryptophan;HMDB00929;http://www.hmdb.ca/metabolites/HMDB00929;204.2252;Yes;"D-Tryptophan; (+)-Tryptophan; 3-Hydroxymethylantipyrine";Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Alanine;HMDB00161;http://www.hmdb.ca/metabolites/HMDB00161;89.0932;Yes;"D-Alanine; Beta-alanine; Sarcosine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Serine;HMDB00187;http://www.hmdb.ca/metabolites/HMDB00187;105.0926;Yes;D-Serine;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Valine;HMDB00883;http://www.hmdb.ca/metabolites/HMDB00883;117.1463;Yes;"Betaine; N-Methyl-aminoisobutyric acid; Aminopentanoic acid; Norvaline";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Threonine;HMDB00167;http://www.hmdb.ca/metabolites/HMDB00167;119.1192;Yes;"L-Homoserine; L-Allothreonine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Leucine;HMDB00687;http://www.hmdb.ca/metabolites/HMDB00687;131.1729;Yes;"L-Isoleucine; L-Alloisoleucine; L-Norleucine; Beta-Leucine; D-Leucine; 3-Aminocaproic acid";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Isoleucine;HMDB00172;http://www.hmdb.ca/metabolites/HMDB00172;131.1729;Yes;"L-Leucine; L-Alloisoleucine; L-Norleucine; Beta-Leucine; D-Leucine; 3-Aminocaproic acid";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Asparagine;HMDB00168;http://www.hmdb.ca/metabolites/HMDB00168;132.1179;Yes;"D-Asparagaine; Ureidopropionic acid; Glycyl-glycine; N-carbamoylsarcosine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Histidine;HMDB00177;http://www.hmdb.ca/metabolites/HMDB00177;155.1546;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Tyrosine;HMDB00158;http://www.hmdb.ca/metabolites/HMDB00158;181.1885;Yes;"Beta-Tyrosine; o-Tyrosine; L-Threo-3-Phenylserine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;Indoleacetic acid;HMDB00197;http://www.hmdb.ca/metabolites/HMDB00197;175.184;Yes;5-Hydroxyindoleacetaldehyde;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Alanine;HMDB00161;http://www.hmdb.ca/metabolites/HMDB00161;89.0932;Yes;"D-Alanine; Beta-alanine; Sarcosine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Serine;HMDB00187;http://www.hmdb.ca/metabolites/HMDB00187;105.0926;Yes;D-Serine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Valine;HMDB00883;http://www.hmdb.ca/metabolites/HMDB00883;117.1463;Yes;"Betaine; N-Methyl-aminoisobutyric acid; Aminopentanoic acid; Norvaline";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Threonine;HMDB00167;http://www.hmdb.ca/metabolites/HMDB00167;119.1192;Yes;"L-Homoserine; L-Allothreonine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Leucine;HMDB00687;http://www.hmdb.ca/metabolites/HMDB00687;131.1729;Yes;"L-Isoleucine; L-Alloisoleucine; L-Norleucine; Beta-Leucine; D-Leucine; 3-Aminocaproic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Isoleucine;HMDB00172;http://www.hmdb.ca/metabolites/HMDB00172;131.1729;Yes;"L-Leucine; L-Alloisoleucine; L-Norleucine; Beta-Leucine; D-Leucine; 3-Aminocaproic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Asparagine;HMDB00168;http://www.hmdb.ca/metabolites/HMDB00168;132.1179;Yes;"D-Asparagaine; Ureidopropionic acid; Glycyl-glycine; N-carbamoylsarcosine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Histidine;HMDB00177;http://www.hmdb.ca/metabolites/HMDB00177;155.1546;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Tyrosine;HMDB00158;http://www.hmdb.ca/metabolites/HMDB00158;181.1885;Yes;"Beta-Tyrosine; o-Tyrosine; L-Threo-3-Phenylserine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Hartnup disorder;234500;https://omim.org/entry/234500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:234500;SLC6A19;Transporter;Estimated 1:30,000;Urinary transporter, difficult diagnosis in blood;L-Tryptophan;HMDB00929;http://www.hmdb.ca/metabolites/HMDB00929;204.2252;Yes;"D-Tryptophan; (+)-Tryptophan; 3-Hydroxymethylantipyrine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;No
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Plasma;2;Decrease;-1.5;Critical;5;-15;15;Indispensable;-1.0;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;4-Hydroxyproline;HMDB00725;http://www.hmdb.ca/metabolites/HMDB00725;131.1299;Yes;"4-Hydroxy-L-Proline; 4-Hydroxy-2-pyrrolidinecarboxylic acid; Trans-3-hydroxy-L-Proline; cis-4-Hydroxy-D-Proline; N-Acetyl-L-Alanine; Propionylglycine; 5-Aminolevulinic acid; 5-Amino-2-oxopentanoic acid; L-Glutamic gamma-semialdehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;8;Disorders of amino acid transport;Lysinuric protein intolerance;222700;https://omim.org/entry/222700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222700;SLC7A7;Transporter;Estimated 1:60,000;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;9;Aminoacylase deficiencies;N-acetylaspartic aciduria;271900;https://omim.org/entry/271900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271900;ASPA;Enzyme;Estimated 1:100,000;No possible artefacts to report;N-Acetylaspartic acid;HMDB00812;http://www.hmdb.ca/metabolites/HMDB00812;175.1394;Yes;N-Formyl-L-glutamic acid;Only biomarker;5;Increase;1;Critical;5;25;25;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;9;Aminoacylase deficiencies;N-acetylaspartic aciduria;271900;https://omim.org/entry/271900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271900;ASPA;Enzyme;Estimated 1:100,000;No possible artefacts to report;N-Acetylaspartic acid;HMDB00812;http://www.hmdb.ca/metabolites/HMDB00812;175.1394;Yes;N-Formyl-L-glutamic acid;CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;9;Aminoacylase deficiencies;N-acetylaspartic aciduria;271900;https://omim.org/entry/271900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271900;ASPA;Enzyme;Estimated 1:100,000;No possible artefacts to report;N-Acetylaspartic acid;HMDB00812;http://www.hmdb.ca/metabolites/HMDB00812;175.1394;Yes;N-Formyl-L-glutamic acid;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;9;Aminoacylase deficiencies;N-acetylaspartic aciduria;271900;https://omim.org/entry/271900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271900;ASPA;Enzyme;Estimated 1:100,000;No possible artefacts to report;N-Acetylaspartic acid;HMDB00812;http://www.hmdb.ca/metabolites/HMDB00812;175.1394;Yes;N-Formyl-L-glutamic acid;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Aromatic L-amino acid decarboxylase deficiency;608643;https://omim.org/entry/608643;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608643;DDC;Enzyme;Estimated ~123 cases;Might be an artefact caused by the use of L-Dopa;3-Methoxytyrosine;HMDB01434;http://www.hmdb.ca/metabolites/HMDB01434;211.2145;Yes;Methyldopa;DBS;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Aromatic L-amino acid decarboxylase deficiency;608643;https://omim.org/entry/608643;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608643;DDC;Enzyme;Estimated ~123 cases;Might be an artefact caused by the use of L-Dopa;3-Methoxytyrosine;HMDB01434;http://www.hmdb.ca/metabolites/HMDB01434;211.2145;Yes;Methyldopa;CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Aromatic L-amino acid decarboxylase deficiency;608643;https://omim.org/entry/608643;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608643;DDC;Enzyme;Estimated ~123 cases;Might be an artefact caused by the use of L-Dopa;Homovanillic acid;HMDB00118;http://www.hmdb.ca/metabolites/HMDB00118;182.1733;Yes;"Isohomovanillic acid; Hydroxyphenyllactic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Aromatic L-amino acid decarboxylase deficiency;608643;https://omim.org/entry/608643;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608643;DDC;Enzyme;Estimated ~123 cases;Might be an artefact caused by the use of L-Dopa;Vanylglycol (MHPG);HMDB01490;http://www.hmdb.ca/metabolites/HMDB01490;184.1892;No;NA;CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Aromatic L-amino acid decarboxylase deficiency;608643;https://omim.org/entry/608643;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608643;DDC;Enzyme;Estimated ~123 cases;Might be an artefact caused by the use of L-Dopa;5-Hydroxyindoleacetic acid;HMDB00763;http://www.hmdb.ca/metabolites/HMDB00763;191.1834;No;NA;CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Aromatic L-amino acid decarboxylase deficiency;608643;https://omim.org/entry/608643;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608643;DDC;Enzyme;Estimated ~123 cases;Might be an artefact caused by the use of L-Dopa;L-Dopa;HMDB00181;http://www.hmdb.ca/metabolites/HMDB00181;197.1879;Yes;DL-Dopa;CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Aromatic L-amino acid decarboxylase deficiency;608643;https://omim.org/entry/608643;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608643;DDC;Enzyme;Estimated ~123 cases;Might be an artefact caused by the use of L-Dopa;Vanillactic acid;HMDB00913;http://www.hmdb.ca/metabolites/HMDB00913;212.1993;No;NA;CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Aromatic L-amino acid decarboxylase deficiency;608643;https://omim.org/entry/608643;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608643;DDC;Enzyme;Estimated ~123 cases;Might be an artefact caused by the use of L-Dopa;5-Hydroxytryptophan;HMDB00472;http://www.hmdb.ca/metabolites/HMDB00472;220.2246;No;NA;CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Aromatic L-amino acid decarboxylase deficiency;608643;https://omim.org/entry/608643;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608643;DDC;Enzyme;Estimated ~123 cases;Might be an artefact caused by the use of L-Dopa;L-Dopa;HMDB00181;http://www.hmdb.ca/metabolites/HMDB00181;197.1879;Yes;DL-Dopa;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Dopamine transporter defect;613135;https://omim.org/entry/613135;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613135;SLC6A3;Transporter;Estimated ~15 cases;No possible artefacts to report;Homovanillic acid/5-hydroxyindoleacetic acid ratio;HMDBCSF01;NA;NA_Ratio_CSF01;NA;NA;CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Dopamine transporter defect;613135;https://omim.org/entry/613135;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613135;SLC6A3;Transporter;Estimated ~15 cases;No possible artefacts to report;Homovanillic acid;HMDB00118;http://www.hmdb.ca/metabolites/HMDB00118;182.1733;Yes;"Isohomovanillic acid; Hydroxyphenyllactic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Dopamine transporter defect;613135;https://omim.org/entry/613135;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613135;SLC6A3;Transporter;Estimated ~15 cases;No possible artefacts to report;Homovanillic acid;HMDB00118;http://www.hmdb.ca/metabolites/HMDB00118;182.1733;Yes;"Isohomovanillic acid; Hydroxyphenyllactic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Monoamine oxidase A deficiency;300615;https://omim.org/entry/300615;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300615;MAOA;Enzyme;Estimated ~100 cases;No possible artefacts to report;Vanylglycol (MHPG);HMDB01490;http://www.hmdb.ca/metabolites/HMDB01490;184.1892;No;NA;Urine;1;Decrease;-1.5;Important influence;3;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Monoamine oxidase A deficiency;300615;https://omim.org/entry/300615;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300615;MAOA;Enzyme;Estimated ~100 cases;No possible artefacts to report;Vanillactic acid;HMDB00913;http://www.hmdb.ca/metabolites/HMDB00913;212.1993;No;NA;Urine;1;Decrease;-1.5;Important influence;3;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Monoamine oxidase A deficiency;300615;https://omim.org/entry/300615;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300615;MAOA;Enzyme;Estimated ~100 cases;No possible artefacts to report;Tyramine;HMDB00306;http://www.hmdb.ca/metabolites/HMDB00306;137.179;Yes;m-Tyramine, Dimethylaniline-N-oxide, 2-Hydroxyphenethylamine;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Monoamine oxidase A deficiency;300615;https://omim.org/entry/300615;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300615;MAOA;Enzyme;Estimated ~100 cases;No possible artefacts to report;3-Methoxytyramine;HMDB00022;http://www.hmdb.ca/metabolites/HMDB00022;167.205;Yes;p-Synephrine;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Monoamine oxidase A deficiency;300615;https://omim.org/entry/300615;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300615;MAOA;Enzyme;Estimated ~100 cases;No possible artefacts to report;Serotonin;HMDB00259;http://www.hmdb.ca/metabolites/HMDB00259;176.2151;Yes;Cotinine;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Monoamine oxidase A deficiency;300615;https://omim.org/entry/300615;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300615;MAOA;Enzyme;Estimated ~100 cases;No possible artefacts to report;Normetanephrine;HMDB00819;http://www.hmdb.ca/metabolites/HMDB00819;183.2044;Yes;Epinephrine, methylnoradrenaline;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Tyrosine hydroxylase deficiency;605407;https://omim.org/entry/605407;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605407;TH;Enzyme;Estimated ~10 cases;No possible artefacts to report;Homovanillic acid;HMDB00118;http://www.hmdb.ca/metabolites/HMDB00118;182.1733;Yes;"Isohomovanillic acid; Hydroxyphenyllactic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Tyrosine hydroxylase deficiency;605407;https://omim.org/entry/605407;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605407;TH;Enzyme;Estimated ~10 cases;No possible artefacts to report;Vanylglycol (MHPG);HMDB01490;http://www.hmdb.ca/metabolites/HMDB01490;184.1892;No;NA;CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;10;Disorders of monoamine metabolism;Tyrosine hydroxylase deficiency;605407;https://omim.org/entry/605407;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605407;TH;Enzyme;Estimated ~10 cases;No possible artefacts to report;Homovanillic acid/5-hydroxyindoleacetic acid ratio;HMDBCSF01;NA;NA_Ratio_CSF01;NA;NA;CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;6-pyruvoyltetrahydropterin synthase deficiency;261640;https://omim.org/entry/261640;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261640;PTS;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;6-pyruvoyltetrahydropterin synthase deficiency;261640;https://omim.org/entry/261640;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261640;PTS;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;6-pyruvoyltetrahydropterin synthase deficiency;261640;https://omim.org/entry/261640;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261640;PTS;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Pyruvoyl tetrahydropterin;HMDB01195;http://www.hmdb.ca/metabolites/HMDB01195;237.2153;Yes;"Biopterin; D-Biopterin; Sepiapterin; Orinapterin; Primapterin";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;6-pyruvoyltetrahydropterin synthase deficiency;261640;https://omim.org/entry/261640;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261640;PTS;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Dihydroneopterin triphosphate;HMDB00980;http://www.hmdb.ca/metabolites/HMDB00980;495.1703;No;NA;Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;6-pyruvoyltetrahydropterin synthase deficiency;261640;https://omim.org/entry/261640;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261640;PTS;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Homovanillic acid;HMDB00118;http://www.hmdb.ca/metabolites/HMDB00118;182.1733;Yes;"Isohomovanillic acid; Hydroxyphenyllactic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;6-pyruvoyltetrahydropterin synthase deficiency;261640;https://omim.org/entry/261640;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261640;PTS;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;5-Hydroxyindoleacetic acid;HMDB00763;http://www.hmdb.ca/metabolites/HMDB00763;191.1834;No;NA;CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;6-pyruvoyltetrahydropterin synthase deficiency;261640;https://omim.org/entry/261640;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261640;PTS;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Tetrahydrobiopterin;HMDB00027;http://www.hmdb.ca/metabolites/HMDB00027;241.2471;Yes;"Sapropterin; L-erythro-tetrahydrobiopterin";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;6-pyruvoyltetrahydropterin synthase deficiency;261640;https://omim.org/entry/261640;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261640;PTS;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Biopterin;HMDB00468;http://www.hmdb.ca/metabolites/HMDB00468;237.2153;Yes;"D-Biopterin; Sepiapterin; Orinapterin; Pyruvoyl tetrahydropterin; Primapterin";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;6-pyruvoyltetrahydropterin synthase deficiency;261640;https://omim.org/entry/261640;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261640;PTS;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Neopterin;HMDB00845;http://www.hmdb.ca/metabolites/HMDB00845;253.2147;Yes;"L-Threoneopterin; Umanopterin; Hydroxysepiapterin";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;6-pyruvoyltetrahydropterin synthase deficiency;261640;https://omim.org/entry/261640;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261640;PTS;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Biopterin;HMDB00468;http://www.hmdb.ca/metabolites/HMDB00468;237.2153;Yes;"D-Biopterin; Sepiapterin; Orinapterin; Pyruvoyl tetrahydropterin; Primapterin";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;6-pyruvoyltetrahydropterin synthase deficiency;261640;https://omim.org/entry/261640;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261640;PTS;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Neopterin;HMDB00845;http://www.hmdb.ca/metabolites/HMDB00845;253.2147;Yes;"L-Threoneopterin; Umanopterin; Hydroxysepiapterin";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Dihydropteridine reductase deficiency;261630;https://omim.org/entry/261630;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261630;QDPR;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Dihydropteridine reductase deficiency;261630;https://omim.org/entry/261630;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261630;QDPR;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Dihydropteridine reductase deficiency;261630;https://omim.org/entry/261630;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261630;QDPR;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Tetrahydrobiopterin;HMDB00027;http://www.hmdb.ca/metabolites/HMDB00027;241.2471;Yes;"Sapropterin; L-erythro-tetrahydrobiopterin";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Dihydropteridine reductase deficiency;261630;https://omim.org/entry/261630;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261630;QDPR;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Dihydrobiopterin;HMDB00038;http://www.hmdb.ca/metabolites/HMDB00038;239.2312;Yes;"4a-Carbinolamine tetrahydrobiopterin; 6-Lactoyltetrahydropterin; O2'-4a-cyclic-tetrahydrobiopterin; 1-hydroxy-2-Oxopropyl tetrahydropterin";Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Dihydropteridine reductase deficiency;261630;https://omim.org/entry/261630;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261630;QDPR;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Homovanillic acid;HMDB00118;http://www.hmdb.ca/metabolites/HMDB00118;182.1733;Yes;"Isohomovanillic acid; Hydroxyphenyllactic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Dihydropteridine reductase deficiency;261630;https://omim.org/entry/261630;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261630;QDPR;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;5-Hydroxyindoleacetic acid;HMDB00763;http://www.hmdb.ca/metabolites/HMDB00763;191.1834;No;NA;CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Dihydropteridine reductase deficiency;261630;https://omim.org/entry/261630;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261630;QDPR;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Biopterin;HMDB00468;http://www.hmdb.ca/metabolites/HMDB00468;237.2153;Yes;"D-Biopterin; Sepiapterin; Orinapterin; Pyruvoyl tetrahydropterin; Primapterin";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Dihydropteridine reductase deficiency;261630;https://omim.org/entry/261630;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261630;QDPR;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Neopterin;HMDB00845;http://www.hmdb.ca/metabolites/HMDB00845;253.2147;Yes;"L-Threoneopterin; Umanopterin; Hydroxysepiapterin";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Dihydropteridine reductase deficiency;261630;https://omim.org/entry/261630;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261630;QDPR;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Biopterin;HMDB00468;http://www.hmdb.ca/metabolites/HMDB00468;237.2153;Yes;"D-Biopterin; Sepiapterin; Orinapterin; Pyruvoyl tetrahydropterin; Primapterin";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Dihydropteridine reductase deficiency;261630;https://omim.org/entry/261630;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261630;QDPR;Enzyme;Estimated 1:1.000,000;No possible artefacts to report;Neopterin;HMDB00845;http://www.hmdb.ca/metabolites/HMDB00845;253.2147;Yes;"L-Threoneopterin; Umanopterin; Hydroxysepiapterin";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;DNAJC12 deficiency;617384;https://omim.org/entry/617384;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617384;DNAJC12;Enzyme;Estimated ~25 cases;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;DNAJC12 deficiency;617384;https://omim.org/entry/617384;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617384;DNAJC12;Enzyme;Estimated ~25 cases;No possible artefacts to report;Homovanillic acid;HMDB00118;http://www.hmdb.ca/metabolites/HMDB00118;182.1733;Yes;"Isohomovanillic acid; Hydroxyphenyllactic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;DNAJC12 deficiency;617384;https://omim.org/entry/617384;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617384;DNAJC12;Enzyme;Estimated ~25 cases;No possible artefacts to report;5-Hydroxyindoleacetic acid;HMDB00763;http://www.hmdb.ca/metabolites/HMDB00763;191.1834;No;NA;CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;DNAJC12 deficiency;617384;https://omim.org/entry/617384;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617384;DNAJC12;Enzyme;Estimated ~25 cases;No possible artefacts to report;Neopterin;HMDB00845;http://www.hmdb.ca/metabolites/HMDB00845;253.2147;Yes;"L-Threoneopterin; Umanopterin; Hydroxysepiapterin";CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;DNAJC12 deficiency;617384;https://omim.org/entry/617384;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617384;DNAJC12;Enzyme;Estimated ~25 cases;No possible artefacts to report;5-Methyltetrahydrofolic acid;HMDB01396;http://www.hmdb.ca/metabolites/HMDB01396;459.4558;No;NA;CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;GTP cyclohydrolase I deficiency;233910;https://omim.org/entry/233910;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:233910;GCH1;Enzyme;Estimated ~350 cases;No possible artefacts to report;Biopterin;HMDB00468;http://www.hmdb.ca/metabolites/HMDB00468;237.2153;Yes;"D-Biopterin; Sepiapterin; Orinapterin; Pyruvoyl tetrahydropterin; Primapterin";CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;GTP cyclohydrolase I deficiency;233910;https://omim.org/entry/233910;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:233910;GCH1;Enzyme;Estimated ~350 cases;No possible artefacts to report;Neopterin;HMDB00845;http://www.hmdb.ca/metabolites/HMDB00845;253.2147;Yes;"L-Threoneopterin; Umanopterin; Hydroxysepiapterin";CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;GTP cyclohydrolase I deficiency;233910;https://omim.org/entry/233910;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:233910;GCH1;Enzyme;Estimated ~350 cases;No possible artefacts to report;Dihydroneopterin triphosphate;HMDB00980;http://www.hmdb.ca/metabolites/HMDB00980;495.1703;No;NA;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;GTP cyclohydrolase I deficiency;233910;https://omim.org/entry/233910;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:233910;GCH1;Enzyme;Estimated ~350 cases;No possible artefacts to report;Guanosine triphosphate;HMDB01273;http://www.hmdb.ca/metabolites/HMDB01273;523.1804;Yes;8-Oxo-dGTP;Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;GTP cyclohydrolase I deficiency;233910;https://omim.org/entry/233910;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:233910;GCH1;Enzyme;Estimated ~350 cases;No possible artefacts to report;Homovanillic acid;HMDB00118;http://www.hmdb.ca/metabolites/HMDB00118;182.1733;Yes;"Isohomovanillic acid; Hydroxyphenyllactic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;GTP cyclohydrolase I deficiency;233910;https://omim.org/entry/233910;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:233910;GCH1;Enzyme;Estimated ~350 cases;No possible artefacts to report;5-Hydroxyindoleacetic acid;HMDB00763;http://www.hmdb.ca/metabolites/HMDB00763;191.1834;No;NA;CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;GTP cyclohydrolase I deficiency;233910;https://omim.org/entry/233910;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:233910;GCH1;Enzyme;Estimated ~350 cases;No possible artefacts to report;Tetrahydrobiopterin;HMDB00027;http://www.hmdb.ca/metabolites/HMDB00027;241.2471;Yes;"Sapropterin; L-erythro-tetrahydrobiopterin";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;GTP cyclohydrolase I deficiency;233910;https://omim.org/entry/233910;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:233910;GCH1;Enzyme;Estimated ~350 cases;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;GTP cyclohydrolase I deficiency;233910;https://omim.org/entry/233910;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:233910;GCH1;Enzyme;Estimated ~350 cases;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;GTP cyclohydrolase I deficiency;233910;https://omim.org/entry/233910;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:233910;GCH1;Enzyme;Estimated ~350 cases;No possible artefacts to report;Biopterin;HMDB00468;http://www.hmdb.ca/metabolites/HMDB00468;237.2153;Yes;"D-Biopterin; Sepiapterin; Orinapterin; Pyruvoyl tetrahydropterin; Primapterin";Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;GTP cyclohydrolase I deficiency;233910;https://omim.org/entry/233910;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:233910;GCH1;Enzyme;Estimated ~350 cases;No possible artefacts to report;Neopterin;HMDB00845;http://www.hmdb.ca/metabolites/HMDB00845;253.2147;Yes;"L-Threoneopterin; Umanopterin; Hydroxysepiapterin";Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;PKU-DiagRatio-Phe/Tyr;HMDB0AA01;http://www.hmdb.ca/metabolites/HMDB0AA01;NA_Ratio_0AA01;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;L-Tyrosine;HMDB00158;http://www.hmdb.ca/metabolites/HMDB00158;181.1885;Yes;"Beta-Tyrosine; o-Tyrosine; L-Threo-3-Phenylserine";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;Homovanillic acid;HMDB00118;http://www.hmdb.ca/metabolites/HMDB00118;182.1733;Yes;"Isohomovanillic acid; Hydroxyphenyllactic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;5-Hydroxyindoleacetic acid;HMDB00763;http://www.hmdb.ca/metabolites/HMDB00763;191.1834;No;NA;CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;L-Tyrosine;HMDB00158;http://www.hmdb.ca/metabolites/HMDB00158;181.1885;Yes;"Beta-Tyrosine; o-Tyrosine; L-Threo-3-Phenylserine";Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;Phenylpyruvic acid;HMDB00205;http://www.hmdb.ca/metabolites/HMDB00205;164.158;Yes;Enol-phenylpyruvate;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;Phenylacetic acid;HMDB00209;http://www.hmdb.ca/metabolites/HMDB00209;136.1479;Yes;4-Hydroxyphenylacetaldehyde;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;p-Hydroxyphenylacetic acid;HMDB00020;http://www.hmdb.ca/metabolites/HMDB00020;152.1473;Yes;"3-Hydroxyphenylacetic acid; 3,4-Dihydroxyphenylacetaldehyde; 4-Hydroxy-3-methylbenzoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;Phenyllactic acid;HMDB00779;http://www.hmdb.ca/metabolites/HMDB00779;166.1739;Yes;"L- and D-Phenyllactic acid; 4-Methyoxyphenylacetic acid; Desaminotyrosine; 3-Phenoxypropionic acid; Homovanillin; 4-Hydroxyphenyl-2-propionic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;Hydroxyphenyllactic acid;HMDB00755;http://www.hmdb.ca/metabolites/HMDB00755;182.1733;Yes;"Homovanillic acid; Isohomovanillic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;N-Acetyl-L-phenylalanine;HMDB00512;http://www.hmdb.ca/metabolites/HMDB00512;207.2258;Yes;"Phenylpropionylglycine; 3-Phenylpropionylglycine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;Biopterin;HMDB00468;http://www.hmdb.ca/metabolites/HMDB00468;237.2153;Yes;"D-Biopterin; Sepiapterin; Orinapterin; Pyruvoyl tetrahydropterin; Primapterin";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Phenylketonuria;261600;https://omim.org/entry/261600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:261600;PAH;Enzyme;Estimated 1:10,000;No possible artefacts to report;Neopterin;HMDB00845;http://www.hmdb.ca/metabolites/HMDB00845;253.2147;Yes;"L-Threoneopterin; Umanopterin; Hydroxysepiapterin";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Pterin-4a-carbinolamine dehydratase deficiency;264070;https://omim.org/entry/264070;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:264070;PCBD1;Enzyme;Estimated ~23 cases;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Pterin-4a-carbinolamine dehydratase deficiency;264070;https://omim.org/entry/264070;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:264070;PCBD1;Enzyme;Estimated ~23 cases;No possible artefacts to report;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Pterin-4a-carbinolamine dehydratase deficiency;264070;https://omim.org/entry/264070;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:264070;PCBD1;Enzyme;Estimated ~23 cases;No possible artefacts to report;Dihydrobiopterin;HMDB00038;http://www.hmdb.ca/metabolites/HMDB00038;239.2312;Yes;"4a-Carbinolamine tetrahydrobiopterin; 6-Lactoyltetrahydropterin; O2'-4a-cyclic-tetrahydrobiopterin; 1-hydroxy-2-Oxopropyl tetrahydropterin";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Pterin-4a-carbinolamine dehydratase deficiency;264070;https://omim.org/entry/264070;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:264070;PCBD1;Enzyme;Estimated ~23 cases;No possible artefacts to report;4a-Carbinolamine tetrahydrobiopterin;HMDB02215;http://www.hmdb.ca/metabolites/HMDB02215;239.2312;Yes;"Dihydrobiopterin; 6-Lactoyltetrahydropterin; O2'-4a-cyclic-tetrahydrobiopterin; 1-hydroxy-2-Oxopropyl tetrahydropterin";Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Pterin-4a-carbinolamine dehydratase deficiency;264070;https://omim.org/entry/264070;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:264070;PCBD1;Enzyme;Estimated ~23 cases;No possible artefacts to report;Tetrahydrobiopterin;HMDB00027;http://www.hmdb.ca/metabolites/HMDB00027;241.2471;Yes;"Sapropterin; L-erythro-tetrahydrobiopterin";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Pterin-4a-carbinolamine dehydratase deficiency;264070;https://omim.org/entry/264070;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:264070;PCBD1;Enzyme;Estimated ~23 cases;No possible artefacts to report;Primapterin;HMDB02263;http://www.hmdb.ca/metabolites/HMDB02263;237.2153;Yes;"Biopterin; D-Biopterin; Sepiapterin; Orinapterin; Pyruvoyl tetrahydropterin";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Pterin-4a-carbinolamine dehydratase deficiency;264070;https://omim.org/entry/264070;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:264070;PCBD1;Enzyme;Estimated ~23 cases;No possible artefacts to report;Biopterin;HMDB00468;http://www.hmdb.ca/metabolites/HMDB00468;237.2153;Yes;"D-Biopterin; Sepiapterin; Orinapterin; Pyruvoyl tetrahydropterin; Primapterin";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Pterin-4a-carbinolamine dehydratase deficiency;264070;https://omim.org/entry/264070;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:264070;PCBD1;Enzyme;Estimated ~23 cases;No possible artefacts to report;Neopterin;HMDB00845;http://www.hmdb.ca/metabolites/HMDB00845;253.2147;Yes;"L-Threoneopterin; Umanopterin; Hydroxysepiapterin";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Sepiapterine reductase deficiency;612716;https://omim.org/entry/612716;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612716;SPR;Enzyme;Estimated ~50 cases;No possible artefacts to report;Sepiapterin;HMDB00238;http://www.hmdb.ca/metabolites/HMDB00238;237.2153;Yes;"Biopterin; D-Biopterin; Orinapterin; Pyruvoyl tetrahydropterin; Primapterin";CSF;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Sepiapterine reductase deficiency;612716;https://omim.org/entry/612716;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612716;SPR;Enzyme;Estimated ~50 cases;No possible artefacts to report;Homovanillic acid;HMDB00118;http://www.hmdb.ca/metabolites/HMDB00118;182.1733;Yes;"Isohomovanillic acid; Hydroxyphenyllactic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Sepiapterine reductase deficiency;612716;https://omim.org/entry/612716;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612716;SPR;Enzyme;Estimated ~50 cases;No possible artefacts to report;5-Hydroxyindoleacetic acid;HMDB00763;http://www.hmdb.ca/metabolites/HMDB00763;191.1834;No;NA;CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Sepiapterine reductase deficiency;612716;https://omim.org/entry/612716;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612716;SPR;Enzyme;Estimated ~50 cases;No possible artefacts to report;Biopterin;HMDB00468;http://www.hmdb.ca/metabolites/HMDB00468;237.2153;Yes;"D-Biopterin; Sepiapterin; Orinapterin; Pyruvoyl tetrahydropterin; Primapterin";CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Sepiapterine reductase deficiency;612716;https://omim.org/entry/612716;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612716;SPR;Enzyme;Estimated ~50 cases;No possible artefacts to report;Dihydrobiopterin;HMDB00038;http://www.hmdb.ca/metabolites/HMDB00038;239.2312;Yes;"4a-Carbinolamine tetrahydrobiopterin; 6-Lactoyltetrahydropterin; O2'-4a-cyclic-tetrahydrobiopterin; 1-hydroxy-2-Oxopropyl tetrahydropterin";CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;11;Disorders of phenylalanine and tetrahydrobiopterin metabolism;Sepiapterine reductase deficiency;612716;https://omim.org/entry/612716;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:612716;SPR;Enzyme;Estimated ~50 cases;No possible artefacts to report;Biopterin;HMDB00468;http://www.hmdb.ca/metabolites/HMDB00468;237.2153;Yes;"D-Biopterin; Sepiapterin; Orinapterin; Pyruvoyl tetrahydropterin; Primapterin";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Homogentisic acid oxidase deficiency;203500;https://omim.org/entry/203500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203500;HGD;Enzyme;Estimated 1:111.000-1:1.000,000;No possible artefacts to report;Homogentisic acid;HMDB00130;http://www.hmdb.ca/metabolites/HMDB00130;168.1467;Yes;"Vanillic acid; Isovanillic acid; 3-Hydroxymandelic acid; p-Hydroxymandelic acid; 3,4-Dihydroxybenzeneacetic acid; 3,4-Dihydroxymandelaldehyde; 5-Methoxysalicylic acid";Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Homogentisic acid oxidase deficiency;203500;https://omim.org/entry/203500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203500;HGD;Enzyme;Estimated 1:111.000-1:1.000,000;No possible artefacts to report;Homogentisic acid;HMDB00130;http://www.hmdb.ca/metabolites/HMDB00130;168.1467;Yes;"Vanillic acid; Isovanillic acid; 3-Hydroxymandelic acid; p-Hydroxymandelic acid; 3,4-Dihydroxybenzeneacetic acid; 3,4-Dihydroxymandelaldehyde; 5-Methoxysalicylic acid";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Homogentisic acid oxidase deficiency;203500;https://omim.org/entry/203500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203500;HGD;Enzyme;Estimated 1:111.000-1:1.000,000;No possible artefacts to report;Homogentisic acid;HMDB00130;http://www.hmdb.ca/metabolites/HMDB00130;168.1467;Yes;"Vanillic acid; Isovanillic acid; 3-Hydroxymandelic acid; p-Hydroxymandelic acid; 3,4-Dihydroxybenzeneacetic acid; 3,4-Dihydroxymandelaldehyde; 5-Methoxysalicylic acid";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Homogentisic acid oxidase deficiency;203500;https://omim.org/entry/203500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203500;HGD;Enzyme;Estimated 1:111.000-1:1.000,000;No possible artefacts to report;Maleylacetoacetic acid;HMDB02052;http://www.hmdb.ca/metabolites/HMDB02052;200.1455;Yes;4-Fumarylacetoacetic acid;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type I;276700;https://omim.org/entry/276700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276700;FAH;Enzyme;Estimated 1:100,000;No possible artefacts to report;L-Tyrosine;HMDB00158;http://www.hmdb.ca/metabolites/HMDB00158;181.1885;Yes;"Beta-Tyrosine; o-Tyrosine; L-Threo-3-Phenylserine";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type I;276700;https://omim.org/entry/276700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276700;FAH;Enzyme;Estimated 1:100,000;No possible artefacts to report;4-Fumarylacetoacetic acid;HMDB01268;http://www.hmdb.ca/metabolites/HMDB01268;200.1455;Yes;Maleylacetoacetic acid;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type I;276700;https://omim.org/entry/276700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276700;FAH;Enzyme;Estimated 1:100,000;No possible artefacts to report;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type I;276700;https://omim.org/entry/276700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276700;FAH;Enzyme;Estimated 1:100,000;No possible artefacts to report;Fumaric acid;HMDB00134;http://www.hmdb.ca/metabolites/HMDB00134;116.0722;Yes;Maleic acid;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type I;276700;https://omim.org/entry/276700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276700;FAH;Enzyme;Estimated 1:100,000;No possible artefacts to report;Succinylacetone;HMDB00635;http://www.hmdb.ca/metabolites/HMDB00635;158.1519;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type I;276700;https://omim.org/entry/276700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276700;FAH;Enzyme;Estimated 1:100,000;No possible artefacts to report;5-Aminolevulinic acid;HMDB01149;http://www.hmdb.ca/metabolites/HMDB01149;131.1299;Yes;"4-Hydroxyproline; 4-Hydroxy-L-Proline; 4-Hydroxy-2-pyrrolidinecarboxylic acid; Trans-3-hydroxy-L-Proline; cis-4-Hydroxy-D-Proline; N-Acetyl-L-Alanine; Propionylglycine; 5-Amino-2-oxopentanoic acid; L-Glutamic gamma-semialdehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type I;276700;https://omim.org/entry/276700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276700;FAH;Enzyme;Estimated 1:100,000;No possible artefacts to report;p-Hydroxyphenylacetic acid;HMDB00020;http://www.hmdb.ca/metabolites/HMDB00020;152.1473;Yes;"3-Hydroxyphenylacetic acid; 3,4-Dihydroxyphenylacetaldehyde; 4-Hydroxy-3-methylbenzoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type I;276700;https://omim.org/entry/276700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276700;FAH;Enzyme;Estimated 1:100,000;No possible artefacts to report;4-Hydroxyphenylpyruvic acid;HMDB00707;http://www.hmdb.ca/metabolites/HMDB00707;180.1574;Yes;"3-Hydroxyphenylpyruvic acid; 2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid; ";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type I;276700;https://omim.org/entry/276700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276700;FAH;Enzyme;Estimated 1:100,000;No possible artefacts to report;Hydroxyphenyllactic acid;HMDB00755;http://www.hmdb.ca/metabolites/HMDB00755;182.1733;Yes;"Homovanillic acid; Isohomovanillic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type I;276700;https://omim.org/entry/276700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276700;FAH;Enzyme;Estimated 1:100,000;No possible artefacts to report;N-Acetyl-L-tyrosine;HMDB00866;http://www.hmdb.ca/metabolites/HMDB00866;223.2252;Yes;Salsolinol 1-carboxylate;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type II;276600;https://omim.org/entry/276600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276600;TAT;Enzyme;Estimated 1:250,000;No possible artefacts to report;L-Tyrosine;HMDB00158;http://www.hmdb.ca/metabolites/HMDB00158;181.1885;Yes;"Beta-Tyrosine; o-Tyrosine; L-Threo-3-Phenylserine";Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type II;276600;https://omim.org/entry/276600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276600;TAT;Enzyme;Estimated ~150 cases;No possible artefacts to report;4-Hydroxyphenylpyruvic acid;HMDB00707;http://www.hmdb.ca/metabolites/HMDB00707;180.1574;Yes;"3-Hydroxyphenylpyruvic acid; 2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid; ";Product;3;Decrease;-1.5;Important influence;3;-13.5;13.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type II;276600;https://omim.org/entry/276600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276600;TAT;Enzyme;Estimated 1:250,000;No possible artefacts to report;L-Tyrosine;HMDB00158;http://www.hmdb.ca/metabolites/HMDB00158;181.1885;Yes;"Beta-Tyrosine; o-Tyrosine; L-Threo-3-Phenylserine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type II;276600;https://omim.org/entry/276600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276600;TAT;Enzyme;Estimated 1:250,000;No possible artefacts to report;p-Hydroxyphenylacetic acid;HMDB00020;http://www.hmdb.ca/metabolites/HMDB00020;152.1473;Yes;"3-Hydroxyphenylacetic acid; 3,4-Dihydroxyphenylacetaldehyde; 4-Hydroxy-3-methylbenzoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type II;276600;https://omim.org/entry/276600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276600;TAT;Enzyme;Estimated 1:250,000;No possible artefacts to report;4-Hydroxyphenylpyruvic acid;HMDB00707;http://www.hmdb.ca/metabolites/HMDB00707;180.1574;Yes;"3-Hydroxyphenylpyruvic acid; 2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid; ";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type II;276600;https://omim.org/entry/276600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276600;TAT;Enzyme;Estimated 1:250,000;No possible artefacts to report;Hydroxyphenyllactic acid;HMDB00755;http://www.hmdb.ca/metabolites/HMDB00755;182.1733;Yes;"Homovanillic acid; Isohomovanillic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type II;276600;https://omim.org/entry/276600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276600;TAT;Enzyme;Estimated 1:250,000;No possible artefacts to report;N-Acetyl-L-tyrosine;HMDB00866;http://www.hmdb.ca/metabolites/HMDB00866;223.2252;Yes;Salsolinol 1-carboxylate;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type III;276710;https://omim.org/entry/276710;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276710;HPD;Enzyme;Estimated ~20 cases;No possible artefacts to report;Homogentisic acid;HMDB00130;http://www.hmdb.ca/metabolites/HMDB00130;168.1467;Yes;"Vanillic acid; Isovanillic acid; 3-Hydroxymandelic acid; p-Hydroxymandelic acid; 3,4-Dihydroxybenzeneacetic acid; 3,4-Dihydroxymandelaldehyde; 5-Methoxysalicylic acid";Product;3;Decrease;-1.5;Important influence;3;-13.5;13.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type III;276710;https://omim.org/entry/276710;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276710;HPD;Enzyme;Estimated ~20 cases;No possible artefacts to report;L-Tyrosine;HMDB00158;http://www.hmdb.ca/metabolites/HMDB00158;181.1885;Yes;"Beta-Tyrosine; o-Tyrosine; L-Threo-3-Phenylserine";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type III;276710;https://omim.org/entry/276710;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276710;HPD;Enzyme;Estimated ~20 cases;No possible artefacts to report;4-Hydroxyphenylpyruvic acid;HMDB00707;http://www.hmdb.ca/metabolites/HMDB00707;180.1574;Yes;"3-Hydroxyphenylpyruvic acid; 2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid; ";Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type III;276710;https://omim.org/entry/276710;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276710;HPD;Enzyme;Estimated ~20 cases;No possible artefacts to report;p-Hydroxyphenylacetic acid;HMDB00020;http://www.hmdb.ca/metabolites/HMDB00020;152.1473;Yes;"3-Hydroxyphenylacetic acid; 3,4-Dihydroxyphenylacetaldehyde; 4-Hydroxy-3-methylbenzoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type III;276710;https://omim.org/entry/276710;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276710;HPD;Enzyme;Estimated ~20 cases;No possible artefacts to report;4-Hydroxyphenylpyruvic acid;HMDB00707;http://www.hmdb.ca/metabolites/HMDB00707;180.1574;Yes;"3-Hydroxyphenylpyruvic acid; 2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid; ";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;12;Disorders of tyrosine metabolism;Tyrosinaemia type III;276710;https://omim.org/entry/276710;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:276710;HPD;Enzyme;Estimated ~20 cases;No possible artefacts to report;Hydroxyphenyllactic acid;HMDB00755;http://www.hmdb.ca/metabolites/HMDB00755;182.1733;Yes;"Homovanillic acid; Isohomovanillic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Adenosine kinase deficiency;614300;https://omim.org/entry/614300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614300;ADK;Enzyme;Estimated ~6 cases;No possible artefacts to report;S-Adenosylmethionine;HMDB01185;http://www.hmdb.ca/metabolites/HMDB01185;399.445;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Adenosine kinase deficiency;614300;https://omim.org/entry/614300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614300;ADK;Enzyme;Estimated ~6 cases;No possible artefacts to report;Adenosine;HMDB00050;http://www.hmdb.ca/metabolites/HMDB00050;267.2413;Yes;Deoxyguanosine;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Adenosine kinase deficiency;614300;https://omim.org/entry/614300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614300;ADK;Enzyme;Estimated ~6 cases;No possible artefacts to report;S-Adenosylhomocysteine;HMDB00939;http://www.hmdb.ca/metabolites/HMDB00939;384.411;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Adenosine kinase deficiency;614300;https://omim.org/entry/614300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614300;ADK;Enzyme;Estimated ~6 cases;No possible artefacts to report;Adenosine;HMDB00050;http://www.hmdb.ca/metabolites/HMDB00050;267.2413;Yes;Deoxyguanosine;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Adenosine kinase deficiency;614300;https://omim.org/entry/614300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614300;ADK;Enzyme;Estimated ~6 cases;No possible artefacts to report;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Adenosine kinase deficiency;614300;https://omim.org/entry/614300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614300;ADK;Enzyme;Estimated ~6 cases;No possible artefacts to report;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Adenosine kinase deficiency;614300;https://omim.org/entry/614300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614300;ADK;Enzyme;Estimated ~6 cases;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;1.5;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;Cysthathionine;HMDB00099;http://www.hmdb.ca/metabolites/HMDB00099;222.262;Yes;"Allocystathionine; Cysteinyl-Threonine; Threoninyl-Cysteine";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;L-Cystine;HMDB00192;http://www.hmdb.ca/metabolites/HMDB00192;240.3;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;L-Homocystine;HMDB00676;http://www.hmdb.ca/metabolites/HMDB00676;268.354;Yes;DL-Homocystine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;S-Adenosylhomocysteine;HMDB00939;http://www.hmdb.ca/metabolites/HMDB00939;384.411;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;S-Adenosylmethionine;HMDB01185;http://www.hmdb.ca/metabolites/HMDB01185;399.445;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Cystathionine Bta-synthase deficiency;236200;https://omim.org/entry/236200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236200;CBS;Enzyme;Estimated 1:20,000-1:344.000;No possible artefacts to report;L-Homocystine;HMDB00676;http://www.hmdb.ca/metabolites/HMDB00676;268.354;Yes;DL-Homocystine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Ethylmalonic encephalopathy;602473;https://omim.org/entry/602473;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:602473;ETHE1;Enzyme;Estimated ~40 cases;No possible artefacts to report;Isobutyryl-L-carnitine;HMDB00736;http://www.hmdb.ca/metabolites/HMDB00736;231.292;Yes;Butyrylcarnitine;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Ethylmalonic encephalopathy;602473;https://omim.org/entry/602473;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:602473;ETHE1;Enzyme;Estimated ~40 cases;No possible artefacts to report;Ethylmalonic acid;HMDB00622;http://www.hmdb.ca/metabolites/HMDB00622;132.1146;Yes;"Monoethyl malonic acid; Dimethylmalonic acid; Glutaric acid; Methylsuccinic acid; 2-Acetolactate";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Ethylmalonic encephalopathy;602473;https://omim.org/entry/602473;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:602473;ETHE1;Enzyme;Estimated ~40 cases;No possible artefacts to report;Isobutyryl-L-carnitine;HMDB00736;http://www.hmdb.ca/metabolites/HMDB00736;231.292;Yes;Butyrylcarnitine;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Ethylmalonic encephalopathy;602473;https://omim.org/entry/602473;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:602473;ETHE1;Enzyme;Estimated ~40 cases;No possible artefacts to report;Thiosulfate;HMDB00257;http://www.hmdb.ca/metabolites/HMDB00257;112.128;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Ethylmalonic encephalopathy;602473;https://omim.org/entry/602473;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:602473;ETHE1;Enzyme;Estimated ~40 cases;No possible artefacts to report;Isovalerylglycine;HMDB00678;http://www.hmdb.ca/metabolites/HMDB00678;159.183;Yes;"2-Methylbutyrylglycine; 3-Dehydrocarnitine; Valerylglycine; N-Acetylvaline; 5-Acetamidovalerate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Ethylmalonic encephalopathy;602473;https://omim.org/entry/602473;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:602473;ETHE1;Enzyme;Estimated ~40 cases;No possible artefacts to report;2-Methylbutyrylglycine;HMDB00339;http://www.hmdb.ca/metabolites/HMDB00339;159.183;Yes;"3-Dehydrocarnitine; Isovalerylglycine; Valerylglycine; N-Acetylvaline; 5-Acetamidovalerate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Ethylmalonic encephalopathy;602473;https://omim.org/entry/602473;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:602473;ETHE1;Enzyme;Estimated ~40 cases;No possible artefacts to report;Methylsuccinic acid;HMDB01844;http://www.hmdb.ca/metabolites/HMDB01844;132.1146;Yes;"Monoethyl malonic acid; Dimethylmalonic acid; Ethylmalonic acid; Glutaric acid; 2-Acetolactate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Glycine N-methyltransferase deficiency;606664;https://omim.org/entry/606664;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606664;GNMT;Enzyme;Estimated ~3 cases;No possible artefacts to report;S-Adenosylmethionine;HMDB01185;http://www.hmdb.ca/metabolites/HMDB01185;399.445;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Glycine N-methyltransferase deficiency;606664;https://omim.org/entry/606664;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606664;GNMT;Enzyme;Estimated ~3 cases;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Methionine adenosyltransferase I/III deficiency;250850;https://omim.org/entry/250850;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250850;MAT1A;Enzyme;Estimated >60 cases;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;2.5;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Methionine adenosyltransferase I/III deficiency;250850;https://omim.org/entry/250850;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250850;MAT1A;Enzyme;Estimated >60 cases;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;2.5;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Methionine adenosyltransferase I/III deficiency;250850;https://omim.org/entry/250850;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250850;MAT1A;Enzyme;Estimated >60 cases;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;2.5;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Methionine adenosyltransferase I/III deficiency;250850;https://omim.org/entry/250850;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250850;MAT1A;Enzyme;Estimated >60 cases;No possible artefacts to report;S-Adenosylmethionine;HMDB01185;http://www.hmdb.ca/metabolites/HMDB01185;399.445;No;NA;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Methionine adenosyltransferase I/III deficiency;250850;https://omim.org/entry/250850;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250850;MAT1A;Enzyme;Estimated >60 cases;No possible artefacts to report;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Methionine adenosyltransferase I/III deficiency;250850;https://omim.org/entry/250850;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250850;MAT1A;Enzyme;Estimated >60 cases;No possible artefacts to report;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;S-Adenosylhomocysteine hydrolase deficiency;613752;https://omim.org/entry/613752;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613752;AHCY;Enzyme;Estimated ~4 cases;No possible artefacts to report;S-Adenosylmethionine;HMDB01185;http://www.hmdb.ca/metabolites/HMDB01185;399.445;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;S-Adenosylhomocysteine hydrolase deficiency;613752;https://omim.org/entry/613752;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613752;AHCY;Enzyme;Estimated ~4 cases;No possible artefacts to report;S-Adenosylhomocysteine;HMDB00939;http://www.hmdb.ca/metabolites/HMDB00939;384.411;No;NA;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;S-Adenosylhomocysteine hydrolase deficiency;613752;https://omim.org/entry/613752;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613752;AHCY;Enzyme;Estimated ~4 cases;No possible artefacts to report;Adenosine;HMDB00050;http://www.hmdb.ca/metabolites/HMDB00050;267.2413;Yes;Deoxyguanosine;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;S-Adenosylhomocysteine hydrolase deficiency;613752;https://omim.org/entry/613752;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613752;AHCY;Enzyme;Estimated ~4 cases;No possible artefacts to report;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;S-Adenosylhomocysteine hydrolase deficiency;613752;https://omim.org/entry/613752;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613752;AHCY;Enzyme;Estimated ~4 cases;No possible artefacts to report;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;S-Adenosylhomocysteine hydrolase deficiency;613752;https://omim.org/entry/613752;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613752;AHCY;Enzyme;Estimated ~4 cases;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;S-Adenosylhomocysteine hydrolase deficiency;613752;https://omim.org/entry/613752;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613752;AHCY;Enzyme;Estimated ~4 cases;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;S-Adenosylhomocysteine hydrolase deficiency;613752;https://omim.org/entry/613752;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613752;AHCY;Enzyme;Estimated ~4 cases;No possible artefacts to report;S-Adenosylhomocysteine;HMDB00939;http://www.hmdb.ca/metabolites/HMDB00939;384.411;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;S-Adenosylhomocysteine hydrolase deficiency;613752;https://omim.org/entry/613752;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613752;AHCY;Enzyme;Estimated ~4 cases;No possible artefacts to report;Guanidinoacetic acid;HMDB00128;http://www.hmdb.ca/metabolites/HMDB00128;117.1066;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;S-Adenosylhomocysteine hydrolase deficiency;613752;https://omim.org/entry/613752;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613752;AHCY;Enzyme;Estimated ~4 cases;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;S-Adenosylhomocysteine hydrolase deficiency;613752;https://omim.org/entry/613752;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613752;AHCY;Enzyme;Estimated ~4 cases;No possible artefacts to report;S-Adenosylhomocysteine;HMDB00939;http://www.hmdb.ca/metabolites/HMDB00939;384.411;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Sulphite oxidase deficiency;272300;https://omim.org/entry/272300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:272300;SUOX;Enzyme;Estimated ~25 cases;No possible artefacts to report;L-Cystine;HMDB00192;http://www.hmdb.ca/metabolites/HMDB00192;240.3;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Sulphite oxidase deficiency;272300;https://omim.org/entry/272300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:272300;SUOX;Enzyme;Estimated ~25 cases;No possible artefacts to report;Cysteine-S-sulfate;HMDB00731;http://www.hmdb.ca/metabolites/HMDB00731;201.221;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Sulphite oxidase deficiency;272300;https://omim.org/entry/272300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:272300;SUOX;Enzyme;Estimated ~25 cases;No possible artefacts to report;Cysteine-S-sulfate;HMDB00731;http://www.hmdb.ca/metabolites/HMDB00731;201.221;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Sulphite oxidase deficiency;272300;https://omim.org/entry/272300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:272300;SUOX;Enzyme;Estimated ~25 cases;No possible artefacts to report;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Sulphite oxidase deficiency;272300;https://omim.org/entry/272300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:272300;SUOX;Enzyme;Estimated ~25 cases;No possible artefacts to report;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Sulphite oxidase deficiency;272300;https://omim.org/entry/272300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:272300;SUOX;Enzyme;Estimated ~25 cases;No possible artefacts to report;L-Cystine;HMDB00192;http://www.hmdb.ca/metabolites/HMDB00192;240.3;No;NA;Urine;1;Decrease;-1.5;Important influence;3;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Sulphite oxidase deficiency;272300;https://omim.org/entry/272300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:272300;SUOX;Enzyme;Estimated ~25 cases;No possible artefacts to report;Taurine;HMDB00251;http://www.hmdb.ca/metabolites/HMDB00251;125.147;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Sulphite oxidase deficiency;272300;https://omim.org/entry/272300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:272300;SUOX;Enzyme;Estimated ~25 cases;No possible artefacts to report;Alpha-aminoadipic acid delta-semialdehyde;HMDB01263;http://www.hmdb.ca/metabolites/HMDB01263;145.1564;Yes;"Isobutyrylglycine; N-butyrylglycine; 4-Acetamidobutanoic acid; 5-Amino-3-oxohexanoate; 2-Amino-6-oxohexanoate; 2-Keto-6-aminocaproate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Sulphite oxidase deficiency;272300;https://omim.org/entry/272300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:272300;SUOX;Enzyme;Estimated ~25 cases;No possible artefacts to report;Thiosulfate;HMDB00257;http://www.hmdb.ca/metabolites/HMDB00257;112.128;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;13;Disorders of sulfur amino acid and sulfide metabolism;Sulphite oxidase deficiency;272300;https://omim.org/entry/272300;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:272300;SUOX;Enzyme;Estimated ~25 cases;No possible artefacts to report;Taurine;HMDB00251;http://www.hmdb.ca/metabolites/HMDB00251;125.147;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;2-Methyl-3-hydroxybutyric aciduria;300438;https://omim.org/entry/300438;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300438;HSD17B10;Enzyme;Estimated ~18 cases;No possible artefacts to report;2-Methyl-3-hydroxybutyric acid;HMDB00354;http://www.hmdb.ca/metabolites/HMDB00354;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 3-Hydroxyisovaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;2-Methyl-3-hydroxybutyric aciduria;300438;https://omim.org/entry/300438;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300438;HSD17B10;Enzyme;Estimated ~18 cases;No possible artefacts to report;2-Ethylhydracrylic acid;HMDB00396;http://www.hmdb.ca/metabolites/HMDB00396;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 3-Hydroxyisovaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; Erythronilic acid;";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;2-Methyl-3-hydroxybutyric aciduria;300438;https://omim.org/entry/300438;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300438;HSD17B10;Enzyme;Estimated ~18 cases;No possible artefacts to report;Tiglylglycine;HMDB00959;http://www.hmdb.ca/metabolites/HMDB00959;157.1671;Yes;3-Methylcrotonylglycine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;3-Methylcrotonylglycinuria;210200;https://omim.org/entry/210200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:210200;"MCCC1; MCCC2";Enzyme;Estimated 1:30,000-1:50,000;No possible artefacts to report;3-Methylcrotonylglycine;HMDB00459;http://www.hmdb.ca/metabolites/HMDB00459;157.1671;Yes;Tiglylglycine;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;3-Methylcrotonylglycinuria;210200;https://omim.org/entry/210200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:210200;"MCCC1; MCCC2";Enzyme;Estimated 1:30,000-1:50,000;No possible artefacts to report;3-Hydroxyisovaleric acid;HMDB00754;http://www.hmdb.ca/metabolites/HMDB00754;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;3-Methylcrotonylglycinuria;210200;https://omim.org/entry/210200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:210200;"MCCC1; MCCC2";Enzyme;Estimated 1:30,000-1:50,000;No possible artefacts to report;3-Hydroxyisovalerylcarnitine;HMDB0061189;http://www.hmdb.ca/metabolites/HMDB0061189;262.3227;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;3-Methylcrotonylglycinuria;210200;https://omim.org/entry/210200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:210200;"MCCC1; MCCC2";Enzyme;Estimated 1:30,000-1:50,000;No possible artefacts to report;3-Methylcrotonylglycine;HMDB00459;http://www.hmdb.ca/metabolites/HMDB00459;157.1671;Yes;Tiglylglycine;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;3-Methylcrotonylglycinuria;210200;https://omim.org/entry/210200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:210200;"MCCC1; MCCC2";Enzyme;Estimated 1:30,000-1:50,000;No possible artefacts to report;3-Hydroxyisovaleric acid;HMDB00754;http://www.hmdb.ca/metabolites/HMDB00754;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;3-Methylcrotonylglycinuria;210200;https://omim.org/entry/210200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:210200;"MCCC1; MCCC2";Enzyme;Estimated 1:30,000-1:50,000;No possible artefacts to report;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;3-Methylglutaconic aciduria;250950;https://omim.org/entry/250950;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250950;"AUH; OPA3; SERAC1; DNAJC19; HTRA2; CLPB; TIMM50; MGCA1";Enzyme;Estimated 1:1.000,000;Consider pregnancy induced 3-methylglutaconic aciduria;3-Methylglutaconic acid;HMDB00522;http://www.hmdb.ca/metabolites/HMDB00522;144.1253;Yes;"2-Methylglutaconic acid; 3-Hexenedioic acid; trans-2-hexenedioic acid; 3-Hydroxyadipic acid 3,6-lactone";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;3-Methylglutaconic aciduria;250950;https://omim.org/entry/250950;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250950;"AUH; OPA3; SERAC1; DNAJC19; HTRA2; CLPB; TIMM50; MGCA1";Enzyme;Estimated 1:1.000,000;Consider pregnancy induced 3-methylglutaconic aciduria;3-Methylglutaconic acid;HMDB00522;http://www.hmdb.ca/metabolites/HMDB00522;144.1253;Yes;"2-Methylglutaconic acid; 3-Hexenedioic acid; trans-2-hexenedioic acid; 3-Hydroxyadipic acid 3,6-lactone";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;3-Methylglutaconic aciduria;250950;https://omim.org/entry/250950;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250950;"AUH; OPA3; SERAC1; DNAJC19; HTRA2; CLPB; TIMM50; MGCA1";Enzyme;Estimated 1:1.000,000;Consider pregnancy induced 3-methylglutaconic aciduria;3-Hydroxyisovaleric acid;HMDB00754;http://www.hmdb.ca/metabolites/HMDB00754;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;3-Methylglutaconic aciduria;250950;https://omim.org/entry/250950;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250950;"AUH; OPA3; SERAC1; DNAJC19; HTRA2; CLPB; TIMM50; MGCA1";Enzyme;Estimated 1:1.000,000;Consider pregnancy induced 3-methylglutaconic aciduria;Methylglutaric acid;HMDB00752;http://www.hmdb.ca/metabolites/HMDB00752;146.1412;Yes;"Adipic acid; 2-Methylglutaric acid; Monomethylglutaric acid; 2,2-Dimethylsuccinic acid; Solerol; 2-Aceto-2-hydroxybutanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;HMG-CoA lyase deficiency;246450;https://omim.org/entry/246450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:246450;HMGCL;Enzyme;Estimated 1:100,000;No possible artefacts to report;3-Hydroxyisovalerylcarnitine;HMDB0061189;http://www.hmdb.ca/metabolites/HMDB0061189;262.3227;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;HMG-CoA lyase deficiency;246450;https://omim.org/entry/246450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:246450;HMGCL;Enzyme;Estimated 1:100,000;No possible artefacts to report;3-Methylglutarylcarnitine;HMDB00552;http://www.hmdb.ca/metabolites/HMDB00552;289.3248;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;HMG-CoA lyase deficiency;246450;https://omim.org/entry/246450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:246450;HMGCL;Enzyme;Estimated 1:100,000;No possible artefacts to report;3-Methylglutaconic acid;HMDB00522;http://www.hmdb.ca/metabolites/HMDB00522;144.1253;Yes;"2-Methylglutaconic acid; 3-Hexenedioic acid; trans-2-hexenedioic acid; 3-Hydroxyadipic acid 3,6-lactone";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;HMG-CoA lyase deficiency;246450;https://omim.org/entry/246450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:246450;HMGCL;Enzyme;Estimated 1:100,000;No possible artefacts to report;3-Hydroxymethylglutaric acid;HMDB00355;http://www.hmdb.ca/metabolites/HMDB00355;162.1406;Yes;"2-Hydroxyadipic acid; 3-Hydroxyadipic acid; 2-Hydroxy-2-ethylsuccinic acid";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;HMG-CoA lyase deficiency;246450;https://omim.org/entry/246450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:246450;HMGCL;Enzyme;Estimated 1:100,000;No possible artefacts to report;Hexanoylcarnitine;HMDB00705;http://www.hmdb.ca/metabolites/HMDB00705;259.3419;Yes;L-Hexanoylcarnitine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;HMG-CoA lyase deficiency;246450;https://omim.org/entry/246450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:246450;HMGCL;Enzyme;Estimated 1:100,000;No possible artefacts to report;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;HMG-CoA lyase deficiency;246450;https://omim.org/entry/246450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:246450;HMGCL;Enzyme;Estimated 1:100,000;No possible artefacts to report;3-Hydroxyisovaleric acid;HMDB00754;http://www.hmdb.ca/metabolites/HMDB00754;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;HMG-CoA lyase deficiency;246450;https://omim.org/entry/246450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:246450;HMGCL;Enzyme;Estimated 1:100,000;No possible artefacts to report;Methylglutaric acid;HMDB00752;http://www.hmdb.ca/metabolites/HMDB00752;146.1412;Yes;"Adipic acid; 2-Methylglutaric acid; Monomethylglutaric acid; 2,2-Dimethylsuccinic acid; Solerol; 2-Aceto-2-hydroxybutanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;HMG-CoA lyase deficiency;246450;https://omim.org/entry/246450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:246450;HMGCL;Enzyme;Estimated 1:100,000;No possible artefacts to report;3-Methylcrotonylglycine;HMDB00459;http://www.hmdb.ca/metabolites/HMDB00459;157.1671;Yes;Tiglylglycine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Isovaleric aciduria;243500;https://omim.org/entry/243500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:243500;IVD;Enzyme;Estimated 1:100,000;Might be an artefact caused by the use of antibiotics;Isovalerylcarnitine;HMDB00688;http://www.hmdb.ca/metabolites/HMDB00688;245.3153;Yes;"2-Methylbutyroylcarnitine; Valerylcarnitine";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Isovaleric aciduria;243500;https://omim.org/entry/243500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:243500;IVD;Enzyme;Estimated 1:100,000;Might be an artefact caused by the use of antibiotics;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Isovaleric aciduria;243500;https://omim.org/entry/243500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:243500;IVD;Enzyme;Estimated 1:100,000;Might be an artefact caused by the use of antibiotics;Isovalerylglycine;HMDB00678;http://www.hmdb.ca/metabolites/HMDB00678;159.183;Yes;"2-Methylbutyrylglycine; 3-Dehydrocarnitine; Valerylglycine; N-Acetylvaline; 5-Acetamidovalerate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Isovaleric aciduria;243500;https://omim.org/entry/243500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:243500;IVD;Enzyme;Estimated 1:100,000;Might be an artefact caused by the use of antibiotics;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Isovaleric aciduria;243500;https://omim.org/entry/243500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:243500;IVD;Enzyme;Estimated 1:100,000;Might be an artefact caused by the use of antibiotics;Isovaleric acid;HMDB00718;http://www.hmdb.ca/metabolites/HMDB00718;102.1317;Yes;"Ethylmethylacetic acid; Pivalic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Isovaleric aciduria;243500;https://omim.org/entry/243500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:243500;IVD;Enzyme;Estimated 1:100,000;Might be an artefact caused by the use of antibiotics;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Isovaleric aciduria;243500;https://omim.org/entry/243500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:243500;IVD;Enzyme;Estimated 1:100,000;Might be an artefact caused by the use of antibiotics;4-Hydroxyisovaleric acid;HMDB02011;http://www.hmdb.ca/metabolites/HMDB02011;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 3-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Isovaleric aciduria;243500;https://omim.org/entry/243500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:243500;IVD;Enzyme;Estimated 1:100,000;Might be an artefact caused by the use of antibiotics;cis-2-Methylaconitate;HMDB06357;http://www.hmdb.ca/metabolites/HMDB06357;188.1348;Yes;(Z)-But-1-ene-1,2,4-tricarboxylate;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;L-Leucine;HMDB00687;http://www.hmdb.ca/metabolites/HMDB00687;131.1729;Yes;"L-Isoleucine; L-Alloisoleucine; L-Norleucine; Beta-Leucine; D-Leucine; 3-Aminocaproic acid";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;L-Isoleucine;HMDB00172;http://www.hmdb.ca/metabolites/HMDB00172;131.1729;Yes;"L-Leucine; L-Alloisoleucine; L-Norleucine; Beta-Leucine; D-Leucine; 3-Aminocaproic acid";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;L-Valine;HMDB00883;http://www.hmdb.ca/metabolites/HMDB00883;117.1463;Yes;"Betaine; N-Methyl-aminoisobutyric acid; Aminopentanoic acid; Norvaline";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;L-Leucine;HMDB00687;http://www.hmdb.ca/metabolites/HMDB00687;131.1729;Yes;"L-Isoleucine; L-Alloisoleucine; L-Norleucine; Beta-Leucine; D-Leucine; 3-Aminocaproic acid";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;L-Alloisoleucine;HMDB00557;http://www.hmdb.ca/metabolites/HMDB00557;131.1729;Yes;"L-Isoleucine; L-Leucine; L-Norleucine; Beta-Leucine; D-Leucine; 3-Aminocaproic acid";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;L-Isoleucine;HMDB00172;http://www.hmdb.ca/metabolites/HMDB00172;131.1729;Yes;"L-Leucine; L-Alloisoleucine; L-Norleucine; Beta-Leucine; D-Leucine; 3-Aminocaproic acid";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;Alpha-ketoisovaleric acid;HMDB00019;http://www.hmdb.ca/metabolites/HMDB00019;116.1152;Yes;"2-Methylacetoacetic acid; Methylacetoacetic acid; Luvlinic acid; 2-Oxovaleric acid; Glutarate semialdehyde";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;L-Valine;HMDB00883;http://www.hmdb.ca/metabolites/HMDB00883;117.1463;Yes;"Betaine; N-Methyl-aminoisobutyric acid; Aminopentanoic acid; Norvaline";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;Ketoleucine;HMDB00695;http://www.hmdb.ca/metabolites/HMDB00695;130.1418;Yes;"2-Methyl-3-Ketovaleric acid; 3-Methyl-2-oxovaleric acid; 2-Ketohexanoic acid; Mevalonolactone; 3-Oxohexanoic acid; Adipate semialdehyde; Pantolactone";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;2-Hydroxy-3-methylbutyric acid;HMDB00407;http://www.hmdb.ca/metabolites/HMDB00407;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 3-Hydroxyisovaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;3-Methyl-2-oxovaleric acid;HMDB00491;http://www.hmdb.ca/metabolites/HMDB00491;130.1418;Yes;"2-Methyl-3-Ketovaleric acid; Ketoleucine; 2-Ketohexanoic acid; Mevalonolactone; 3-Oxohexanoic acid; Adipate semialdehyde; Pantolactone";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;Hydroxyisocaproic acid;HMDB00746;http://www.hmdb.ca/metabolites/HMDB00746;132.1577;Yes;"2-Hydroxy-3-Methylpentanoic acid; 3-Hydroxyhexanoic acid; 5-Hydroxyhexanoic acid; 6-Hydroxyhexanoic acid; D-Leucic acid; Leucinic acid; 2-Hydroxycaproic acid; 2-Methyl-3-hydroxyvaleric acid; Butoxyacetic acid; Threo-3-Hydroxy-2methylbutyric acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Maple syrup urine disease;248600;https://omim.org/entry/248600;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248600;"BCKDHA; BDKDHB; DBT; DLD";Enzyme;Estimated 1:150,000;No possible artefacts to report;2-Hydroxy-3-methylpentanoic acid;HMDB00317;http://www.hmdb.ca/metabolites/HMDB00317;132.1577;Yes;"3-Hydroxyhexanoic acid; 5-Hydroxyhexanoic acid; 6-Hydroxyhexanoic acid; D-Leucic acid; Leucinic acid; Hydroxyisocaproic acid; 2-Hydroxycaproic acid; 2-Methyl-3-hydroxyvaleric acid; Butoxyacetic acid; Threo-3-Hydroxy-2methylbutyric acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;PAMMA-DiagRatio-C3/C2;HMDB0AC08;NA;NA_Ratio_0AC08;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;Methylmalonic acid;HMDB00202;http://www.hmdb.ca/metabolites/HMDB00202;118.088;Yes;"Succinic acid; Erythrono-1,4-lactone; Threonolactone";CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;Methylmalonic acid;HMDB00202;http://www.hmdb.ca/metabolites/HMDB00202;118.088;Yes;"Succinic acid; Erythrono-1,4-lactone; Threonolactone";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;2-Methylcitric acid;HMDB00379;http://www.hmdb.ca/metabolites/HMDB00379;206.1501;Yes;"Homocitric acid; Methylisocitric acid; 3-(Carboxymethyl)-3-hydroxypentanedioic acid";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;Propionylcarnitine;HMDB00824;http://www.hmdb.ca/metabolites/HMDB00824;217.2622;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;Methylmalonylcarnitine;HMDB13133;http://www.hmdb.ca/metabolites/HMDB13133;261.2717;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;Methylmalonic acid;HMDB00202;http://www.hmdb.ca/metabolites/HMDB00202;118.088;Yes;"Succinic acid; Erythrono-1,4-lactone; Threonolactone";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;2-Methylcitric acid;HMDB00379;http://www.hmdb.ca/metabolites/HMDB00379;206.1501;Yes;"Homocitric acid; Methylisocitric acid; 3-(Carboxymethyl)-3-hydroxypentanedioic acid";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;Heptadecanoyl carnitine;HMDB06210;http://www.hmdb.ca/metabolites/HMDB06210;413.6343;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Methylmalonic aciduria - Isolated;251000;https://omim.org/entry/251000;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:251000;"MUT; MMAA; MMAB; MMADHC; MCEE";Enzyme;Estimated 1:48.000-1:61.000;No possible artefacts to report;Propionylglycine;HMDB00783;http://www.hmdb.ca/metabolites/HMDB00783;131.1299;Yes;"4-Hydroxyproline; 4-Hydroxy-L-Proline; 4-Hydroxy-2-pyrrolidinecarboxylic acid; Trans-3-hydroxy-L-Proline; cis-4-Hydroxy-D-Proline; N-Acetyl-L-Alanine; 5-Aminolevulinic acid; 5-Amino-2-oxopentanoic acid; L-Glutamic gamma-semialdehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;PAMMA-DiagRatio-C3/C2;HMDB0AC08;NA;NA_Ratio_0AC08;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;Propionic acid;HMDB00237;http://www.hmdb.ca/metabolites/HMDB00237;74.0785;Yes;Lactaldehyde;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;2-Methylcitric acid;HMDB00379;http://www.hmdb.ca/metabolites/HMDB00379;206.1501;Yes;"Homocitric acid; Methylisocitric acid; 3-(Carboxymethyl)-3-hydroxypentanedioic acid";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;Propionylcarnitine;HMDB00824;http://www.hmdb.ca/metabolites/HMDB00824;217.2622;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;2-Methylcitric acid;HMDB00379;http://www.hmdb.ca/metabolites/HMDB00379;206.1501;Yes;"Homocitric acid; Methylisocitric acid; 3-(Carboxymethyl)-3-hydroxypentanedioic acid";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;Propionylcarnitine;HMDB00824;http://www.hmdb.ca/metabolites/HMDB00824;217.2622;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;Heptadecanoyl carnitine;HMDB06210;http://www.hmdb.ca/metabolites/HMDB06210;413.6343;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;3-Hydroxypropionic acid;HMDB00700;http://www.hmdb.ca/metabolites/HMDB00700;90.0779;Yes;"L- and D-Lactic acid; Glyceraldehyde; Dihydroxyacetone; Methoxyacetic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;14;Disorders of branched-chain amino acid metabolism;Propionic aciduria;606054;https://omim.org/entry/606054;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606054;"PCCA; PCCB";Enzyme;Estimated 1:100,000;No possible artefacts to report;Propionylglycine;HMDB00783;http://www.hmdb.ca/metabolites/HMDB00783;131.1299;Yes;"4-Hydroxyproline; 4-Hydroxy-L-Proline; 4-Hydroxy-2-pyrrolidinecarboxylic acid; Trans-3-hydroxy-L-Proline; cis-4-Hydroxy-D-Proline; N-Acetyl-L-Alanine; 5-Aminolevulinic acid; 5-Amino-2-oxopentanoic acid; L-Glutamic gamma-semialdehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Alpha-aminoadipic semialdehyde dehydrogenase deficiency;266100;https://omim.org/entry/266100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266100;ALDH7A1;Enzyme;Estimated 1:20,000-1:783.000;Consider dietary deficiency;Alpha-aminoadipic acid delta-semialdehyde;HMDB01263;http://www.hmdb.ca/metabolites/HMDB01263;145.1564;Yes;"Isobutyrylglycine; N-butyrylglycine; 4-Acetamidobutanoic acid; 5-Amino-3-oxohexanoate; 2-Amino-6-oxohexanoate; 2-Keto-6-aminocaproate";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;2.0;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Alpha-aminoadipic semialdehyde dehydrogenase deficiency;266100;https://omim.org/entry/266100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266100;ALDH7A1;Enzyme;Estimated 1:20,000-1:783.000;Consider dietary deficiency;Alpha-aminoadipic acid delta-semialdehyde;HMDB01263;http://www.hmdb.ca/metabolites/HMDB01263;145.1564;Yes;"Isobutyrylglycine; N-butyrylglycine; 4-Acetamidobutanoic acid; 5-Amino-3-oxohexanoate; 2-Amino-6-oxohexanoate; 2-Keto-6-aminocaproate";CSF;2;Increase;1;Critical;5;10;10;Indispensable;2.0;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Alpha-aminoadipic semialdehyde dehydrogenase deficiency;266100;https://omim.org/entry/266100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266100;ALDH7A1;Enzyme;Estimated 1:20,000-1:783.000;Consider dietary deficiency;1-Piperideine-6-carboxylate;HMDB01084;http://www.hmdb.ca/metabolites/HMDB01084;126.136;Yes;1-Piperideine-2-carboxylic acid;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;2.0;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Alpha-aminoadipic semialdehyde dehydrogenase deficiency;266100;https://omim.org/entry/266100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266100;ALDH7A1;Enzyme;Estimated 1:20,000-1:783.000;Consider dietary deficiency;1-Piperideine-6-carboxylate;HMDB01084;http://www.hmdb.ca/metabolites/HMDB01084;126.136;Yes;1-Piperideine-2-carboxylic acid;CSF;2;Increase;1;Critical;5;10;10;Indispensable;2.0;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Alpha-aminoadipic semialdehyde dehydrogenase deficiency;266100;https://omim.org/entry/266100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266100;ALDH7A1;Enzyme;Estimated 1:20,000-1:783.000;Consider dietary deficiency;Alpha-aminoadipic acid delta-semialdehyde;HMDB01263;http://www.hmdb.ca/metabolites/HMDB01263;145.1564;Yes;"Isobutyrylglycine; N-butyrylglycine; 4-Acetamidobutanoic acid; 5-Amino-3-oxohexanoate; 2-Amino-6-oxohexanoate; 2-Keto-6-aminocaproate";Urine;1;Increase;1;Critical;5;5;5;Indispensable;2.0;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Alpha-aminoadipic semialdehyde dehydrogenase deficiency;266100;https://omim.org/entry/266100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266100;ALDH7A1;Enzyme;Estimated 1:20,000-1:783.000;Consider dietary deficiency;1-Piperideine-6-carboxylate;HMDB01084;http://www.hmdb.ca/metabolites/HMDB01084;126.136;Yes;1-Piperideine-2-carboxylic acid;Urine;1;Increase;1;Critical;5;5;5;Indispensable;2.0;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Alpha-aminoadipic semialdehyde dehydrogenase deficiency;266100;https://omim.org/entry/266100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266100;ALDH7A1;Enzyme;Estimated 1:20,000-1:783.000;Consider dietary deficiency;Pipecolic acid;HMDB00070;http://www.hmdb.ca/metabolites/HMDB00070;129.157;Yes;"L- and D-Pipecolic acid; N4-Acetylaminobutanal";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Alpha-aminoadipic semialdehyde dehydrogenase deficiency;266100;https://omim.org/entry/266100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266100;ALDH7A1;Enzyme;Estimated 1:20,000-1:783.000;Consider dietary deficiency;Pipecolic acid;HMDB00070;http://www.hmdb.ca/metabolites/HMDB00070;129.157;Yes;"L- and D-Pipecolic acid; N4-Acetylaminobutanal";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Alpha-aminoadipic semialdehyde dehydrogenase deficiency;266100;https://omim.org/entry/266100;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:266100;ALDH7A1;Enzyme;Estimated 1:20,000-1:783.000;Consider dietary deficiency;Pipecolic acid;HMDB00070;http://www.hmdb.ca/metabolites/HMDB00070;129.157;Yes;"L- and D-Pipecolic acid; N4-Acetylaminobutanal";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Glutaric aciduria type I;231670;https://omim.org/entry/231670;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231670;GCDH;Enzyme;Estimated 1:100,000;No possible artefacts to report;Glutarylcarnitine;HMDB13130;http://www.hmdb.ca/metabolites/HMDB13130;275.301;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;2.0;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Glutaric aciduria type I;231670;https://omim.org/entry/231670;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231670;GCDH;Enzyme;Estimated 1:100,000;No possible artefacts to report;Glutaric acid;HMDB00661;http://www.hmdb.ca/metabolites/HMDB00661;132.1146;Yes;"Monoethyl malonic acid; Dimethylmalonic acid; Ethylmalonic acid; Methylsuccinic acid; 2-Acetolactate";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Glutaric aciduria type I;231670;https://omim.org/entry/231670;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231670;GCDH;Enzyme;Estimated 1:100,000;No possible artefacts to report;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Glutaric aciduria type I;231670;https://omim.org/entry/231670;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231670;GCDH;Enzyme;Estimated 1:100,000;No possible artefacts to report;3-Hydroxyglutaric acid;HMDB00428;http://www.hmdb.ca/metabolites/HMDB00428;148.114;Yes;"L-2-Hydroxyglutaric acid; D-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Glutaric aciduria type I;231670;https://omim.org/entry/231670;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231670;GCDH;Enzyme;Estimated 1:100,000;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Glutaric aciduria type I;231670;https://omim.org/entry/231670;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231670;GCDH;Enzyme;Estimated 1:100,000;No possible artefacts to report;Glutaconic acid;HMDB00620;http://www.hmdb.ca/metabolites/HMDB00620;130.0987;Yes;"Citraconic acid; Mesaconic acid; Itaconic acid; Gamma-delta-dioxovaleric acid; 2-Hydroxyglutaric acid lactone; 2,5-Dioxopentanoate; 2-Pentendioate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;15;Disorders of lysine metabolism;Glutaric aciduria type I;231670;https://omim.org/entry/231670;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231670;GCDH;Enzyme;Estimated 1:100,000;No possible artefacts to report;Glutaric acid;HMDB00661;http://www.hmdb.ca/metabolites/HMDB00661;132.1146;Yes;"Monoethyl malonic acid; Dimethylmalonic acid; Ethylmalonic acid; Methylsuccinic acid; 2-Acetolactate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Adult;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Adult;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Adult;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Adult;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Adult;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Adult;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Adult;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;L-Glutamic acid;HMDB00148;http://www.hmdb.ca/metabolites/HMDB00148;147.1293;Yes;"D-Glutamic acid; DL-Glutamate; N-Methyl-D-aspartic acid; N-Acetylserine; L-4-Hydroxyglutamate semialdehyde";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Adult;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Adult;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;3-Amino-2-piperidone;HMDB00323;http://www.hmdb.ca/metabolites/HMDB00323;114.1457;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Adult;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Neonate;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;1-Pyrroline-5-carboxylic acid;HMDB01301;http://www.hmdb.ca/metabolites/HMDB01301;113.1146;Yes;1-Pyrroline-2-carboxylic acid;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Neonate;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;L-Proline;HMDB00162;http://www.hmdb.ca/metabolites/HMDB00162;115.1305;Yes;"D-Proline; Acetamidopropanal";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Neonate;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Neonate;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;L-Proline;HMDB00162;http://www.hmdb.ca/metabolites/HMDB00162;115.1305;Yes;"D-Proline; Acetamidopropanal";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Neonate;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Neonate;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Neonate;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Neonate;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Neonate;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine aminotransferase deficiency - Neonate;258870;https://omim.org/entry/258870;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:258870;OAT;Enzyme;Estimated 1:50,000;No possible artefacts to report;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine decarboxylase gain-of-function;165640;https://omim.org/entry/165640;NA;ODC1;Enzyme;Estimated ~5 cases;No possible artefacts to report;Putrescine;HMDB01414;http://www.hmdb.ca/metabolites/HMDB01414;88.1515;Yes;1,4-Butanediammonium;Product;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine decarboxylase gain-of-function;165640;https://omim.org/entry/165640;NA;ODC1;Enzyme;Estimated ~5 cases;No possible artefacts to report;Putrescine;HMDB01414;http://www.hmdb.ca/metabolites/HMDB01414;88.1515;Yes;1,4-Butanediammonium;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Ornithine decarboxylase gain-of-function;165640;https://omim.org/entry/165640;NA;ODC1;Enzyme;Estimated ~5 cases;No possible artefacts to report;N-acetylputrescine;HMDB02064;http://www.hmdb.ca/metabolites/HMDB02064;130.1882;Yes;N-Acetylputrescinium;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Proline dehydrogenase deficiency;239500;https://omim.org/entry/239500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239500;PRODH;Enzyme;Estimated ~30 cases;Consider 22Q11 deletion syndrome;L-Proline;HMDB00162;http://www.hmdb.ca/metabolites/HMDB00162;115.1305;Yes;"D-Proline; Acetamidopropanal";Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Proline dehydrogenase deficiency;239500;https://omim.org/entry/239500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239500;PRODH;Enzyme;Estimated ~30 cases;Consider 22Q11 deletion syndrome;L-Proline;HMDB00162;http://www.hmdb.ca/metabolites/HMDB00162;115.1305;Yes;"D-Proline; Acetamidopropanal";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Proline dehydrogenase deficiency;239500;https://omim.org/entry/239500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239500;PRODH;Enzyme;Estimated ~30 cases;Consider 22Q11 deletion syndrome;L-Proline;HMDB00162;http://www.hmdb.ca/metabolites/HMDB00162;115.1305;Yes;"D-Proline; Acetamidopropanal";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Proline dehydrogenase deficiency;239500;https://omim.org/entry/239500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239500;PRODH;Enzyme;Estimated ~30 cases;Consider 22Q11 deletion syndrome;1-Pyrroline-5-carboxylic acid;HMDB01301;http://www.hmdb.ca/metabolites/HMDB01301;113.1146;Yes;1-Pyrroline-2-carboxylic acid;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Proline dehydrogenase deficiency;239500;https://omim.org/entry/239500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239500;PRODH;Enzyme;Estimated ~30 cases;Consider 22Q11 deletion syndrome;Pipecolic acid;HMDB00070;http://www.hmdb.ca/metabolites/HMDB00070;129.157;Yes;"L- and D-Pipecolic acid; N4-Acetylaminobutanal";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Proline dehydrogenase deficiency;239500;https://omim.org/entry/239500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239500;PRODH;Enzyme;Estimated ~30 cases;Consider 22Q11 deletion syndrome;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Proline dehydrogenase deficiency;239500;https://omim.org/entry/239500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239500;PRODH;Enzyme;Estimated ~30 cases;Consider 22Q11 deletion syndrome;4-Hydroxyproline;HMDB00725;http://www.hmdb.ca/metabolites/HMDB00725;131.1299;Yes;"4-Hydroxy-L-Proline; 4-Hydroxy-2-pyrrolidinecarboxylic acid; Trans-3-hydroxy-L-Proline; cis-4-Hydroxy-D-Proline; N-Acetyl-L-Alanine; Propionylglycine; 5-Aminolevulinic acid; 5-Amino-2-oxopentanoic acid; L-Glutamic gamma-semialdehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Pyrroline-5-carboxylate dehydrogenase deficiency;239510;https://omim.org/entry/239510;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239510;ALDH4A1;Enzyme;Estimated ~4 cases;Consider 22Q11 deletion syndrome;L-Proline;HMDB00162;http://www.hmdb.ca/metabolites/HMDB00162;115.1305;Yes;"D-Proline; Acetamidopropanal";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Pyrroline-5-carboxylate dehydrogenase deficiency;239510;https://omim.org/entry/239510;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239510;ALDH4A1;Enzyme;Estimated ~4 cases;Consider 22Q11 deletion syndrome;1-Pyrroline-5-carboxylic acid;HMDB01301;http://www.hmdb.ca/metabolites/HMDB01301;113.1146;Yes;1-Pyrroline-2-carboxylic acid;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Pyrroline-5-carboxylate dehydrogenase deficiency;239510;https://omim.org/entry/239510;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239510;ALDH4A1;Enzyme;Estimated ~4 cases;Consider 22Q11 deletion syndrome;L-Proline;HMDB00162;http://www.hmdb.ca/metabolites/HMDB00162;115.1305;Yes;"D-Proline; Acetamidopropanal";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Pyrroline-5-carboxylate dehydrogenase deficiency;239510;https://omim.org/entry/239510;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239510;ALDH4A1;Enzyme;Estimated ~4 cases;Consider 22Q11 deletion syndrome;L-Glutamic acid;HMDB00148;http://www.hmdb.ca/metabolites/HMDB00148;147.1293;Yes;"D-Glutamic acid; DL-Glutamate; N-Methyl-D-aspartic acid; N-Acetylserine; L-4-Hydroxyglutamate semialdehyde";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Pyrroline-5-carboxylate dehydrogenase deficiency;239510;https://omim.org/entry/239510;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239510;ALDH4A1;Enzyme;Estimated ~4 cases;Consider 22Q11 deletion syndrome;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Pyrroline-5-carboxylate dehydrogenase deficiency;239510;https://omim.org/entry/239510;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239510;ALDH4A1;Enzyme;Estimated ~4 cases;Consider 22Q11 deletion syndrome;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Pyrroline-5-carboxylate dehydrogenase deficiency;239510;https://omim.org/entry/239510;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:239510;ALDH4A1;Enzyme;Estimated ~4 cases;Consider 22Q11 deletion syndrome;4-Hydroxyproline;HMDB00725;http://www.hmdb.ca/metabolites/HMDB00725;131.1299;Yes;"4-Hydroxy-L-Proline; 4-Hydroxy-2-pyrrolidinecarboxylic acid; Trans-3-hydroxy-L-Proline; cis-4-Hydroxy-D-Proline; N-Acetyl-L-Alanine; Propionylglycine; 5-Aminolevulinic acid; 5-Amino-2-oxopentanoic acid; L-Glutamic gamma-semialdehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Pyrroline-5-carboxylate synthetase deficiency;138250;https://omim.org/entry/138250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:138250;ALDH18A1;Enzyme;Estimated ~14 cases;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Pyrroline-5-carboxylate synthetase deficiency;138250;https://omim.org/entry/138250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:138250;ALDH18A1;Enzyme;Estimated ~14 cases;No possible artefacts to report;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Pyrroline-5-carboxylate synthetase deficiency;138250;https://omim.org/entry/138250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:138250;ALDH18A1;Enzyme;Estimated ~14 cases;No possible artefacts to report;L-Proline;HMDB00162;http://www.hmdb.ca/metabolites/HMDB00162;115.1305;Yes;"D-Proline; Acetamidopropanal";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Pyrroline-5-carboxylate synthetase deficiency;138250;https://omim.org/entry/138250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:138250;ALDH18A1;Enzyme;Estimated ~14 cases;No possible artefacts to report;Citrulline;HMDB00904;http://www.hmdb.ca/metabolites/HMDB00904;175.1857;Yes;Argininic acid;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Spermine synthase deficiency;309583;https://omim.org/entry/309583;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:309583;SMS;Enzyme;Estimated ~30 cases;No possible artefacts to report;SMS-DiagRatio-Spermidine/Spermine;HMDB0PA01;NA;NA_Ratio_0PA01;NA;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Spermine synthase deficiency;309583;https://omim.org/entry/309583;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:309583;SMS;Enzyme;Estimated ~30 cases;No possible artefacts to report;Spermine;HMDB01256;http://www.hmdb.ca/metabolites/HMDB01256;202.3402;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Spermine synthase deficiency;309583;https://omim.org/entry/309583;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:309583;SMS;Enzyme;Estimated ~30 cases;No possible artefacts to report;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Spermine synthase deficiency;309583;https://omim.org/entry/309583;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:309583;SMS;Enzyme;Estimated ~30 cases;No possible artefacts to report;Spermidine;HMDB01257;http://www.hmdb.ca/metabolites/HMDB01275;145.2459;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Spermine synthase deficiency;309583;https://omim.org/entry/309583;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:309583;SMS;Enzyme;Estimated ~30 cases;No possible artefacts to report;Isoputreanine;HMDB06009;http://www.hmdb.ca/metabolites/HMDB06009;160.2141;Yes;N(6)-Methyllysine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;16;Disorders of proline and ornithine metabolism;Spermine synthase deficiency;309583;https://omim.org/entry/309583;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:309583;SMS;Enzyme;Estimated ~30 cases;No possible artefacts to report;N8-Acetylspermidine;HMDB02189;http://www.hmdb.ca/metabolites/HMDB02189;187.2825;Yes;N1-Acetylspermidine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Dihydrouracil;HMDB00076;http://www.hmdb.ca/metabolites/HMDB00076;114.1026;Yes;N-Methylhydantoin;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Dihydrothymine;HMDB00079;http://www.hmdb.ca/metabolites/HMDB00079;128.1292;No;NA;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Dihydrouracil;HMDB00076;http://www.hmdb.ca/metabolites/HMDB00076;114.1026;Yes;N-Methylhydantoin;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Dihydrouracil;HMDB00076;http://www.hmdb.ca/metabolites/HMDB00076;114.1026;Yes;N-Methylhydantoin;CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Dihydrothymine;HMDB00079;http://www.hmdb.ca/metabolites/HMDB00079;128.1292;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Dihydrothymine;HMDB00079;http://www.hmdb.ca/metabolites/HMDB00079;128.1292;No;NA;CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Uracil;HMDB00300;http://www.hmdb.ca/metabolites/HMDB00300;112.0868;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Thymine;HMDB00262;http://www.hmdb.ca/metabolites/HMDB00262;126.1133;Yes;"Imidazoleacetic acid; Imidazol-4-ylacetate";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Ureidopropionic acid;HMDB00026;http://www.hmdb.ca/metabolites/HMDB00026;132.1179;Yes;"L- and D-Asparagaine; Glycyl-glycine; N-carbamoylsarcosine";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Uracil;HMDB00300;http://www.hmdb.ca/metabolites/HMDB00300;112.0868;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Dihydrouracil;HMDB00076;http://www.hmdb.ca/metabolites/HMDB00076;114.1026;Yes;N-Methylhydantoin;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Thymine;HMDB00262;http://www.hmdb.ca/metabolites/HMDB00262;126.1133;Yes;"Imidazoleacetic acid; Imidazol-4-ylacetate";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Dihydrothymine;HMDB00079;http://www.hmdb.ca/metabolites/HMDB00079;128.1292;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Tyramine;HMDB00306;http://www.hmdb.ca/metabolites/HMDB00306;137.179;Yes;"2-Hydroxyphenethylamine; Dimethylaniline-N-oxide; m-Tyramine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidinase deficiency;222748;https://omim.org/entry/222748;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:222748;DPYS;Enzyme;Estimated ~15 cases;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidine dehydrogenase deficiency;274270;https://omim.org/entry/274270;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:274270;DPYD;Enzyme;Estimated ~25 cases;No possible artefacts to report;Uracil;HMDB00300;http://www.hmdb.ca/metabolites/HMDB00300;112.0868;No;NA;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidine dehydrogenase deficiency;274270;https://omim.org/entry/274270;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:274270;DPYD;Enzyme;Estimated ~25 cases;No possible artefacts to report;Thymine;HMDB00262;http://www.hmdb.ca/metabolites/HMDB00262;126.1133;Yes;"Imidazoleacetic acid; Imidazol-4-ylacetate";Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidine dehydrogenase deficiency;274270;https://omim.org/entry/274270;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:274270;DPYD;Enzyme;Estimated ~25 cases;No possible artefacts to report;Uracil;HMDB00300;http://www.hmdb.ca/metabolites/HMDB00300;112.0868;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidine dehydrogenase deficiency;274270;https://omim.org/entry/274270;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:274270;DPYD;Enzyme;Estimated ~25 cases;No possible artefacts to report;Thymine;HMDB00262;http://www.hmdb.ca/metabolites/HMDB00262;126.1133;Yes;"Imidazoleacetic acid; Imidazol-4-ylacetate";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidine dehydrogenase deficiency;274270;https://omim.org/entry/274270;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:274270;DPYD;Enzyme;Estimated ~25 cases;No possible artefacts to report;Dihydrouracil;HMDB00076;http://www.hmdb.ca/metabolites/HMDB00076;114.1026;Yes;N-Methylhydantoin;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidine dehydrogenase deficiency;274270;https://omim.org/entry/274270;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:274270;DPYD;Enzyme;Estimated ~25 cases;No possible artefacts to report;Dihydrothymine;HMDB00079;http://www.hmdb.ca/metabolites/HMDB00079;128.1292;No;NA;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidine dehydrogenase deficiency;274270;https://omim.org/entry/274270;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:274270;DPYD;Enzyme;Estimated ~25 cases;No possible artefacts to report;Hydroxymethyluracil;HMDB00469;http://www.hmdb.ca/metabolites/HMDB00469;142.1137;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Dihydropyrimidine dehydrogenase deficiency;274270;https://omim.org/entry/274270;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:274270;DPYD;Enzyme;Estimated ~25 cases;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;GABA transaminase deficiency;613163;https://omim.org/entry/613163;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613163;ABAT;Enzyme;Estimated ~15 cases;No possible artefacts to report;Gamma-aminobutyric acid;HMDB00112;http://www.hmdb.ca/metabolites/HMDB00112;103.1198;Yes;"Dimethylglycine; N-Ethylglycine; Aminoisobutanoic acid; 3-Aminobutanoic acid; Aminoisobutyric acid; L- and D-alpha-aminobutyric acid";CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;GABA transaminase deficiency;613163;https://omim.org/entry/613163;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613163;ABAT;Enzyme;Estimated ~15 cases;No possible artefacts to report;Gamma-aminobutyric acid;HMDB00112;http://www.hmdb.ca/metabolites/HMDB00112;103.1198;Yes;"Dimethylglycine; N-Ethylglycine; Aminoisobutanoic acid; 3-Aminobutanoic acid; Aminoisobutyric acid; L- and D-alpha-aminobutyric acid";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;GABA transaminase deficiency;613163;https://omim.org/entry/613163;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613163;ABAT;Enzyme;Estimated ~15 cases;No possible artefacts to report;Beta-alanine;HMDB00056;http://www.hmdb.ca/metabolites/HMDB00056;89.0932;Yes;"L- and D-Alanine; Sarcosine";CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;GABA transaminase deficiency;613163;https://omim.org/entry/613163;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613163;ABAT;Enzyme;Estimated ~15 cases;No possible artefacts to report;Beta-alanine;HMDB00056;http://www.hmdb.ca/metabolites/HMDB00056;89.0932;Yes;"L- and D-Alanine; Sarcosine";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;GABA transaminase deficiency;613163;https://omim.org/entry/613163;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613163;ABAT;Enzyme;Estimated ~15 cases;No possible artefacts to report;2-Pyrrolidinone;HMDB02039;http://www.hmdb.ca/metabolites/HMDB02039;85.1045;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;4-Hydroxybutyric acid;HMDB00710;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 3-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";CSF;2;Increase;1;Critical;5;10;10;Indispensable;2.5;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;4-Hydroxybutyric acid;HMDB00710;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 3-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;2.5;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;4-Hydroxybutyric acid;HMDB00710;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 3-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Increase;1;Critical;5;5;5;Indispensable;2.5;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;Succinic acid semialdehyde;HMDB01259;http://www.hmdb.ca/metabolites/HMDB01259;102.0886;Yes;"Acetoacetic acid; 2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;Gamma-aminobutyric acid;HMDB00112;http://www.hmdb.ca/metabolites/HMDB00112;103.1198;Yes;"Dimethylglycine; N-Ethylglycine; Aminoisobutanoic acid; 3-Aminobutanoic acid; Aminoisobutyric acid; L- and D-alpha-aminobutyric acid";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;3-Hydroxypropionic acid;HMDB00700;http://www.hmdb.ca/metabolites/HMDB00700;90.0779;Yes;"L- and D-Lactic acid; Glyceraldehyde; Dihydroxyacetone; Methoxyacetic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;Succinic acid semialdehyde;HMDB01259;http://www.hmdb.ca/metabolites/HMDB01259;102.0886;Yes;"Acetoacetic acid; 2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;Gamma-aminobutyric acid;HMDB00112;http://www.hmdb.ca/metabolites/HMDB00112;103.1198;Yes;"Dimethylglycine; N-Ethylglycine; Aminoisobutanoic acid; 3-Aminobutanoic acid; Aminoisobutyric acid; L- and D-alpha-aminobutyric acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;3,4-Dihydroxybutyric acid;HMDB00337;http://www.hmdb.ca/metabolites/HMDB00337;120.1039;Yes;"2,4-Dihydroxybutanoic acid; 4-Deoxyerythronic acid; 4-Deoxythronic acid; 4-Deoxythreonic acid; Erythrose; Erythrulose";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;2,4-Dihydroxybutanoic acid;HMDB00360;http://www.hmdb.ca/metabolites/HMDB00360;120.1039;Yes;"3,4-Dihydroxybutyric acid; 4-Deoxyerythronic acid; 4-Deoxythronic acid; 4-Deoxythreonic acid; Erythrose; Erythrulose";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;Solerol;HMDB02173;http://www.hmdb.ca/metabolites/HMDB02173;146.1412;Yes;"Adipic acid; Methylglutaric acid; 2-Methylglutaric acid; Monomethylglutaric acid; 2,2-Dimethylsuccinic acid; 2-Aceto-2-hydroxybutanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Succinic semialdehyde dehydrogenase deficiency;271980;https://omim.org/entry/271980;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:271980;ALDH5A1;Enzyme;Estimated ~450 cases;No possible artefacts to report;Adipic acid;HMDB00448;http://www.hmdb.ca/metabolites/HMDB00448;146.1412;Yes;"Methylglutaric acid; 2-Methylglutaric acid; Monomethylglutaric acid; 2,2-Dimethylsuccinic acid; Solerol; 2-Aceto-2-hydroxybutanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Ureidopropionase deficiency;613161;https://omim.org/entry/613161;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613161;UPB1;Enzyme;Estimated ~10 cases;No possible artefacts to report;Ureidopropionic acid;HMDB00026;http://www.hmdb.ca/metabolites/HMDB00026;132.1179;Yes;"L- and D-Asparagaine; Glycyl-glycine; N-carbamoylsarcosine";Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Ureidopropionase deficiency;613161;https://omim.org/entry/613161;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613161;UPB1;Enzyme;Estimated ~10 cases;No possible artefacts to report;Ureidoisobutyric acid;HMDB02031;http://www.hmdb.ca/metabolites/HMDB02031;146.1445;Yes;"L- and D-Glutamine; Alanylglycine; Alanyl-Glycine";Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Ureidopropionase deficiency;613161;https://omim.org/entry/613161;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613161;UPB1;Enzyme;Estimated ~10 cases;No possible artefacts to report;Beta-alanine;HMDB00056;http://www.hmdb.ca/metabolites/HMDB00056;89.0932;Yes;"L- and D-Alanine; Sarcosine";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Ureidopropionase deficiency;613161;https://omim.org/entry/613161;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613161;UPB1;Enzyme;Estimated ~10 cases;No possible artefacts to report;Aminoisobutanoic acid;HMDB03911;http://www.hmdb.ca/metabolites/HMDB03911;103.1198;Yes;"Gamma-aminobutyric acid; Dimethylglycine; N-Ethylglycine; 3-Aminobutanoic acid; Aminoisobutyric acid; L- and D-alpha-aminobutyric acid";Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Ureidopropionase deficiency;613161;https://omim.org/entry/613161;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613161;UPB1;Enzyme;Estimated ~10 cases;No possible artefacts to report;Ureidopropionic acid;HMDB00026;http://www.hmdb.ca/metabolites/HMDB00026;132.1179;Yes;"L- and D-Asparagaine; Glycyl-glycine; N-carbamoylsarcosine";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Ureidopropionase deficiency;613161;https://omim.org/entry/613161;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613161;UPB1;Enzyme;Estimated ~10 cases;No possible artefacts to report;Ureidoisobutyric acid;HMDB02031;http://www.hmdb.ca/metabolites/HMDB02031;146.1445;Yes;"L- and D-Glutamine; Alanylglycine; Alanyl-Glycine";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Ureidopropionase deficiency;613161;https://omim.org/entry/613161;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613161;UPB1;Enzyme;Estimated ~10 cases;No possible artefacts to report;Dihydrouracil;HMDB00076;http://www.hmdb.ca/metabolites/HMDB00076;114.1026;Yes;N-Methylhydantoin;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Ureidopropionase deficiency;613161;https://omim.org/entry/613161;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613161;UPB1;Enzyme;Estimated ~10 cases;No possible artefacts to report;Dihydrothymine;HMDB00079;http://www.hmdb.ca/metabolites/HMDB00079;128.1292;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Ureidopropionase deficiency;613161;https://omim.org/entry/613161;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613161;UPB1;Enzyme;Estimated ~10 cases;No possible artefacts to report;Dihydrouracil;HMDB00076;http://www.hmdb.ca/metabolites/HMDB00076;114.1026;Yes;N-Methylhydantoin;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;17;Disorders of Bta- and Gamma-amino acids;Ureidopropionase deficiency;613161;https://omim.org/entry/613161;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:613161;UPB1;Enzyme;Estimated ~10 cases;No possible artefacts to report;Dihydrothymine;HMDB00079;http://www.hmdb.ca/metabolites/HMDB00079;128.1292;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;21;Disorders of glutamine metabolism;Glutamine synthetase deficiency;610015;https://omim.org/entry/610015;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610015;GLUL;Enzyme;Estimated ~3 cases;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Product;3;Decrease;-1.5;Critical;5;-22.5;22.5;Indispensable;-2.0;Yes
A;Disorders of nitrogen-containing compounds;21;Disorders of glutamine metabolism;Glutamine synthetase deficiency;610015;https://omim.org/entry/610015;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610015;GLUL;Enzyme;Estimated ~3 cases;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";CSF;2;Decrease;-1.5;Critical;5;-15;15;Indispensable;-2.0;Yes
A;Disorders of nitrogen-containing compounds;21;Disorders of glutamine metabolism;Glutamine synthetase deficiency;610015;https://omim.org/entry/610015;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610015;GLUL;Enzyme;Estimated ~3 cases;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Decrease;-1.5;Critical;5;-15;15;Indispensable;-2.0;Yes
A;Disorders of nitrogen-containing compounds;21;Disorders of glutamine metabolism;Glutamine synthetase deficiency;610015;https://omim.org/entry/610015;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610015;GLUL;Enzyme;Estimated ~3 cases;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Urine;1;Decrease;-1.5;Critical;5;-7.5;7.5;Indispensable;-2.0;Yes
A;Disorders of nitrogen-containing compounds;21;Disorders of glutamine metabolism;Glutamine synthetase deficiency;610015;https://omim.org/entry/610015;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610015;GLUL;Enzyme;Estimated ~3 cases;No possible artefacts to report;L-Glutamic acid;HMDB00148;http://www.hmdb.ca/metabolites/HMDB00148;147.1293;Yes;"D-Glutamic acid; DL-Glutamate; N-Methyl-D-aspartic acid; N-Acetylserine; L-4-Hydroxyglutamate semialdehyde";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;22;Disorders of asparagine metabolism;Asparagine synthetase deficiency;615574;https://omim.org/entry/615574;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:615574;ASNS;Enzyme;Estimated ~13 cases;No possible artefacts to report;L-Asparagine;HMDB00168;http://www.hmdb.ca/metabolites/HMDB00168;132.1179;Yes;"D-Asparagaine; Ureidopropionic acid; Glycyl-glycine; N-carbamoylsarcosine";Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;22;Disorders of asparagine metabolism;Asparagine synthetase deficiency;615574;https://omim.org/entry/615574;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:615574;ASNS;Enzyme;Estimated ~13 cases;No possible artefacts to report;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoglycerate dehydrogenase deficiency;601815;https://omim.org/entry/601815;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:601815;PHGDH;Enzyme;Estimated ~15 cases;No possible artefacts to report;L-Serine;HMDB00187;http://www.hmdb.ca/metabolites/HMDB00187;105.0926;Yes;D-Serine;CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoglycerate dehydrogenase deficiency;601815;https://omim.org/entry/601815;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:601815;PHGDH;Enzyme;Estimated ~15 cases;No possible artefacts to report;L-Serine;HMDB00187;http://www.hmdb.ca/metabolites/HMDB00187;105.0926;Yes;D-Serine;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoglycerate dehydrogenase deficiency;601815;https://omim.org/entry/601815;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:601815;PHGDH;Enzyme;Estimated ~15 cases;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoglycerate dehydrogenase deficiency;601815;https://omim.org/entry/601815;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:601815;PHGDH;Enzyme;Estimated ~15 cases;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoglycerate dehydrogenase deficiency;601815;https://omim.org/entry/601815;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:601815;PHGDH;Enzyme;Estimated ~15 cases;No possible artefacts to report;Phosphohydroxypyruvic acid;HMDB01024;http://www.hmdb.ca/metabolites/HMDB01024;184.0414;No;NA;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoglycerate dehydrogenase deficiency;601815;https://omim.org/entry/601815;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:601815;PHGDH;Enzyme;Estimated ~15 cases;No possible artefacts to report;3-Phosphoglyceric acid;HMDB00807;http://www.hmdb.ca/metabolites/HMDB00807;186.0572;Yes;"2-Phosphoglyceric acid; 2-Phospho-D-glyceric acid; (2R)-2-Hydroxy-3-(phosphonatooxy)propanoate";Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoserine aminotransferase deficiency;610992;https://omim.org/entry/610992;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610992;PSAT;Enzyme;Estimated ~2 cases;No possible artefacts to report;L-Serine;HMDB00187;http://www.hmdb.ca/metabolites/HMDB00187;105.0926;Yes;D-Serine;CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoserine aminotransferase deficiency;610992;https://omim.org/entry/610992;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610992;PSAT;Enzyme;Estimated ~2 cases;No possible artefacts to report;L-Serine;HMDB00187;http://www.hmdb.ca/metabolites/HMDB00187;105.0926;Yes;D-Serine;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoserine aminotransferase deficiency;610992;https://omim.org/entry/610992;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610992;PSAT;Enzyme;Estimated ~2 cases;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoserine aminotransferase deficiency;610992;https://omim.org/entry/610992;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610992;PSAT;Enzyme;Estimated ~2 cases;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoserine aminotransferase deficiency;610992;https://omim.org/entry/610992;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610992;PSAT;Enzyme;Estimated ~2 cases;No possible artefacts to report;3-Phosphoserine;HMDB00272;http://www.hmdb.ca/metabolites/HMDB00272;185.0725;Yes;DL-O-Phosphoserine;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoserine aminotransferase deficiency;610992;https://omim.org/entry/610992;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610992;PSAT;Enzyme;Estimated ~2 cases;No possible artefacts to report;Phosphohydroxypyruvic acid;HMDB01024;http://www.hmdb.ca/metabolites/HMDB01024;184.0414;No;NA;Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoserine phosphatase deficiency;614023;https://omim.org/entry/614023;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614023;PSPH;Enzyme;Estimated ~8 cases;No possible artefacts to report;L-Serine;HMDB00187;http://www.hmdb.ca/metabolites/HMDB00187;105.0926;Yes;D-Serine;Product;3;Decrease;-1.5;Important influence;3;-13.5;13.5;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoserine phosphatase deficiency;614023;https://omim.org/entry/614023;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614023;PSPH;Enzyme;Estimated ~8 cases;No possible artefacts to report;L-Serine;HMDB00187;http://www.hmdb.ca/metabolites/HMDB00187;105.0926;Yes;D-Serine;CSF;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoserine phosphatase deficiency;614023;https://omim.org/entry/614023;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614023;PSPH;Enzyme;Estimated ~8 cases;No possible artefacts to report;L-Serine;HMDB00187;http://www.hmdb.ca/metabolites/HMDB00187;105.0926;Yes;D-Serine;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoserine phosphatase deficiency;614023;https://omim.org/entry/614023;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614023;PSPH;Enzyme;Estimated ~8 cases;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;23;Disorders of serine metabolism;3-Phosphoserine phosphatase deficiency;614023;https://omim.org/entry/614023;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:614023;PSPH;Enzyme;Estimated ~8 cases;No possible artefacts to report;3-Phosphoserine;HMDB00272;http://www.hmdb.ca/metabolites/HMDB00272;185.0725;Yes;DL-O-Phosphoserine;Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
A;Disorders of nitrogen-containing compounds;24;Disorders of glycine metabolism;Non-ketotic hyperglycinaemia;605899;https://omim.org/entry/605899;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605899;"GLDC; AMT; GCSH";Enzyme;Estimated 1:55.000-1:63.000;Might be an artefact caused by use of depakine;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Only biomarker;5;Increase;1;Critical;5;25;25;Indispensable;1.5;Yes
A;Disorders of nitrogen-containing compounds;24;Disorders of glycine metabolism;Non-ketotic hyperglycinaemia;605899;https://omim.org/entry/605899;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605899;"GLDC; AMT; GCSH";Enzyme;Estimated 1:55.000-1:63.000;Might be an artefact caused by use of depakine;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Substrate;3;Increase;1;Critical;5;15;15;Indispensable;1.5;Yes
A;Disorders of nitrogen-containing compounds;24;Disorders of glycine metabolism;Non-ketotic hyperglycinaemia;605899;https://omim.org/entry/605899;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605899;"GLDC; AMT; GCSH";Enzyme;Estimated 1:55.000-1:63.000;Might be an artefact caused by use of depakine;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;CSF;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
A;Disorders of nitrogen-containing compounds;24;Disorders of glycine metabolism;Non-ketotic hyperglycinaemia;605899;https://omim.org/entry/605899;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605899;"GLDC; AMT; GCSH";Enzyme;Estimated 1:55.000-1:63.000;Might be an artefact caused by use of depakine;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
A;Disorders of nitrogen-containing compounds;24;Disorders of glycine metabolism;Non-ketotic hyperglycinaemia;605899;https://omim.org/entry/605899;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605899;"GLDC; AMT; GCSH";Enzyme;Estimated 1:55.000-1:63.000;Might be an artefact caused by use of depakine;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;1.5;Yes
B;Disorders of vitamins, cofactors, metals and minerals;26;Disorders of cobalamin metabolism;Methionine synthase deficiency;"250940; 236270";https://omim.org/entry/250940;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250940;"MTR; MTRR";Enzyme;Estimated ~78 cases;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;26;Disorders of cobalamin metabolism;Methionine synthase deficiency;"250940; 236270";https://omim.org/entry/250940;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250940;"MTR; MTRR";Enzyme;Estimated ~78 cases;No possible artefacts to report;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;26;Disorders of cobalamin metabolism;Methionine synthase deficiency;"250940; 236270";https://omim.org/entry/250940;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250940;"MTR; MTRR";Enzyme;Estimated ~78 cases;No possible artefacts to report;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;26;Disorders of cobalamin metabolism;Methionine synthase deficiency;"250940; 236270";https://omim.org/entry/250940;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:250940;"MTR; MTRR";Enzyme;Estimated ~78 cases;No possible artefacts to report;Methylmalonic acid;HMDB00202;http://www.hmdb.ca/metabolites/HMDB00202;118.088;Yes;"Succinic acid; Erythrono-1,4-lactone; Threonolactone";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;26;Disorders of cobalamin metabolism;Methylmalonic aciduria and homocystinuria;"277400; 277410; 277380";https://omim.org/entry/277400;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:277400;"MMACHC; MMADHC; LMDB1";Enzyme;Estimated 1:67.000;No possible artefacts to report;Methylmalonic acid;HMDB00202;http://www.hmdb.ca/metabolites/HMDB00202;118.088;Yes;"Succinic acid; Erythrono-1,4-lactone; Threonolactone";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;26;Disorders of cobalamin metabolism;Methylmalonic aciduria and homocystinuria;"277400; 277410; 277380";https://omim.org/entry/277400;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:277400;"MMACHC; MMADHC; LMDB1";Enzyme;Estimated 1:67.000;No possible artefacts to report;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;26;Disorders of cobalamin metabolism;Methylmalonic aciduria and homocystinuria;"277400; 277410; 277380";https://omim.org/entry/277400;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:277400;"MMACHC; MMADHC; LMDB1";Enzyme;Estimated 1:67.000;No possible artefacts to report;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;26;Disorders of cobalamin metabolism;Methylmalonic aciduria and homocystinuria;"277400; 277410; 277380";https://omim.org/entry/277400;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:277400;"MMACHC; MMADHC; LMDB1";Enzyme;Estimated 1:67.000;No possible artefacts to report;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;26;Disorders of cobalamin metabolism;Methylmalonic aciduria and homocystinuria;"277400; 277410; 277380";https://omim.org/entry/277400;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:277400;"MMACHC; MMADHC; LMDB1";Enzyme;Estimated 1:67.000;No possible artefacts to report;Methylmalonic acid;HMDB00202;http://www.hmdb.ca/metabolites/HMDB00202;118.088;Yes;"Succinic acid; Erythrono-1,4-lactone; Threonolactone";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;27;Disorders of folate metabolism;MTHFR deficiency;236250;https://omim.org/entry/236250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236250;MTHFR;Enzyme;Estimated ~170 cases;No possible artefacts to report;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;27;Disorders of folate metabolism;MTHFR deficiency;236250;https://omim.org/entry/236250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236250;MTHFR;Enzyme;Estimated ~170 cases;No possible artefacts to report;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;27;Disorders of folate metabolism;MTHFR deficiency;236250;https://omim.org/entry/236250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236250;MTHFR;Enzyme;Estimated ~170 cases;No possible artefacts to report;L-Homocystine;HMDB00676;http://www.hmdb.ca/metabolites/HMDB00676;268.354;Yes;DL-Homocystine;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;27;Disorders of folate metabolism;MTHFR deficiency;236250;https://omim.org/entry/236250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236250;MTHFR;Enzyme;Estimated ~170 cases;No possible artefacts to report;5-Methyltetrahydrofolic acid;HMDB01396;http://www.hmdb.ca/metabolites/HMDB01396;459.4558;No;NA;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;27;Disorders of folate metabolism;MTHFR deficiency;236250;https://omim.org/entry/236250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236250;MTHFR;Enzyme;Estimated ~170 cases;No possible artefacts to report;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;27;Disorders of folate metabolism;MTHFR deficiency;236250;https://omim.org/entry/236250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236250;MTHFR;Enzyme;Estimated ~170 cases;No possible artefacts to report;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;27;Disorders of folate metabolism;MTHFR deficiency;236250;https://omim.org/entry/236250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236250;MTHFR;Enzyme;Estimated ~170 cases;No possible artefacts to report;L-Homocystine;HMDB00676;http://www.hmdb.ca/metabolites/HMDB00676;268.354;Yes;DL-Homocystine;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;27;Disorders of folate metabolism;MTHFR deficiency;236250;https://omim.org/entry/236250;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236250;MTHFR;Enzyme;Estimated ~170 cases;No possible artefacts to report;5,10-Methylene-THF;HMDB01533;http://www.hmdb.ca/metabolites/HMDB01533;457.4399;Yes;5-Methyldihydrofolic acid;Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;3-Hydroxyisovaleric acid;HMDB00754;http://www.hmdb.ca/metabolites/HMDB00754;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";CSF;2;Increase;1;Critical;5;10;10;Indispensable;2.0;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;3-Hydroxyisovaleric acid;HMDB00754;http://www.hmdb.ca/metabolites/HMDB00754;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;2.0;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;3-Hydroxyisovalerylcarnitine;HMDB0061189;http://www.hmdb.ca/metabolites/HMDB0061189;262.3227;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;3-Hydroxyisovaleric acid;HMDB00754;http://www.hmdb.ca/metabolites/HMDB00754;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Urine;1;Increase;1;Critical;5;5;5;Indispensable;2.0;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;3-Hydroxypropionic acid;HMDB00700;http://www.hmdb.ca/metabolites/HMDB00700;90.0779;Yes;"L- and D-Lactic acid; Glyceraldehyde; Dihydroxyacetone; Methoxyacetic acid";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;2-Hydroxybutyric acid;HMDB00008;http://www.hmdb.ca/metabolites/HMDB00008;104.1045;Yes;"3-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;Citric acid;HMDB00094;http://www.hmdb.ca/metabolites/HMDB00094;192.1235;Yes;"Isocitric acid; D-threo-Isocitric acid; Diketogulonic acid; 2,3-Diketo-L-gulonate; D-Glucaro-1,4-lactone";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;Biocytin;HMDB03134;http://www.hmdb.ca/metabolites/HMDB03134;372.483;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;3-Hydroxypropionic acid;HMDB00700;http://www.hmdb.ca/metabolites/HMDB00700;90.0779;Yes;"L- and D-Lactic acid; Glyceraldehyde; Dihydroxyacetone; Methoxyacetic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;3-Methylcrotonylglycine;HMDB00459;http://www.hmdb.ca/metabolites/HMDB00459;157.1671;Yes;Tiglylglycine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;Biotinidase deficiency or holocarboxylase deficiency;253260;https://omim.org/entry/253260;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:253260;"BTD; HLCS";Enzyme;Estimated 1:61.000;No possible artefacts to report;2-Methylcitric acid;HMDB00379;http://www.hmdb.ca/metabolites/HMDB00379;206.1501;Yes;"Homocitric acid; Methylisocitric acid; 3-(Carboxymethyl)-3-hydroxypentanedioic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;SLC5A6 deficiency;NA;NA;NA;SLC5A6;Transporter;Estimated ~2 cases;No possible artefacts to report;Biotin amide;HMDB01458;http://www.hmdb.ca/metabolites/HMDB01458;243.326;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;SLC5A6 deficiency;NA;NA;NA;SLC5A6;Transporter;Estimated ~2 cases;No possible artefacts to report;3-Hydroxyisovaleric acid;HMDB00754;http://www.hmdb.ca/metabolites/HMDB00754;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;28;Disorders of biotin metabolism;SLC5A6 deficiency;NA;NA;NA;SLC5A6;Transporter;Estimated ~2 cases;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;L-Octanoylcarnitine;HMDB00791;http://www.hmdb.ca/metabolites/HMDB00791;287.3951;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;2.0;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Isobutyryl-L-carnitine;HMDB00736;http://www.hmdb.ca/metabolites/HMDB00736;231.292;Yes;Butyrylcarnitine;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Hexanoylcarnitine;HMDB00705;http://www.hmdb.ca/metabolites/HMDB00705;259.3419;Yes;L-Hexanoylcarnitine;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Decanoylcarnitine;HMDB00651;http://www.hmdb.ca/metabolites/HMDB00651;315.4482;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Isobutyric acid;HMDB01873;http://www.hmdb.ca/metabolites/HMDB01873;88.105;Yes;Butyric acid;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;3-Hydroxyglutaric acid;HMDB00428;http://www.hmdb.ca/metabolites/HMDB00428;148.114;Yes;"L-2-Hydroxyglutaric acid; D-2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Isovalerylglycine;HMDB00678;http://www.hmdb.ca/metabolites/HMDB00678;159.183;Yes;"2-Methylbutyrylglycine; 3-Dehydrocarnitine; Valerylglycine; N-Acetylvaline; 5-Acetamidovalerate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;2-Methylbutyrylglycine;HMDB00339;http://www.hmdb.ca/metabolites/HMDB00339;159.183;Yes;"3-Dehydrocarnitine; Isovalerylglycine; Valerylglycine; N-Acetylvaline; 5-Acetamidovalerate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Isovaleric acid;HMDB00718;http://www.hmdb.ca/metabolites/HMDB00718;102.1317;Yes;"Ethylmethylacetic acid; Pivalic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;4-Hydroxybutyric acid;HMDB00710;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 3-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;3-Hydroxyisovaleric acid;HMDB00754;http://www.hmdb.ca/metabolites/HMDB00754;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Glutaric acid;HMDB00661;http://www.hmdb.ca/metabolites/HMDB00661;132.1146;Yes;"Monoethyl malonic acid; Dimethylmalonic acid; Ethylmalonic acid; Methylsuccinic acid; 2-Acetolactate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Ethylmalonic acid;HMDB00622;http://www.hmdb.ca/metabolites/HMDB00622;132.1146;Yes;"Monoethyl malonic acid; Dimethylmalonic acid; Glutaric acid; Methylsuccinic acid; 2-Acetolactate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Isobutyrylglycine;HMDB00730;http://www.hmdb.ca/metabolites/HMDB00730;145.1564;Yes;"Alpha-aminoadipic acid delta-semialdehyde; N-butyrylglycine; 4-Acetamidobutanoic acid; 5-Amino-3-oxohexanoate; 2-Amino-6-oxohexanoate; 2-Keto-6-aminocaproate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Adipic acid;HMDB00448;http://www.hmdb.ca/metabolites/HMDB00448;146.1412;Yes;"Methylglutaric acid; 2-Methylglutaric acid; Monomethylglutaric acid; 2,2-Dimethylsuccinic acid; Solerol; 2-Aceto-2-hydroxybutanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Suberic acid;HMDB00893;http://www.hmdb.ca/metabolites/HMDB00893;174.1944;Yes;"Ethyladipic acid; 2,4-Dimethyladipic acid; 3-Methylpimelic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;30;Disorders of riboflavin metabolism;Glutaric aciduria type II;231680;https://omim.org/entry/231680;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231680;"ETFA; ETFB; ETF-QO; ETFDH";Enzyme;Estimated 1:200,000;Might be an artefact caused by use of MCT diet;Sebacic acid;HMDB00792;http://www.hmdb.ca/metabolites/HMDB00792;202.2475;Yes;"2-Ethylsuberic acid; Heptylmalonic acid; 3-Methylazelaic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;33;Disorders of pyridoxine metabolism;Hypophosphatasia;241500;https://omim.org/entry/241500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:241500;ALPL;Enzyme;Estimated 1:300,000;No possible artefacts to report;Pyridoxal-5-phosphate;HMDB01491;http://www.hmdb.ca/metabolites/HMDB01491;247.1419;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;33;Disorders of pyridoxine metabolism;Hypophosphatasia;241500;https://omim.org/entry/241500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:241500;ALPL;Enzyme;Estimated 1:300,000;No possible artefacts to report;O-Phosphoethanolamine;HMDB00224;http://www.hmdb.ca/metabolites/HMDB00224;141.063;Yes;"O-Phosphonatoethanaminium; Ethamp";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;33;Disorders of pyridoxine metabolism;Hypophosphatasia;241500;https://omim.org/entry/241500;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:241500;ALPL;Enzyme;Estimated 1:300,000;No possible artefacts to report;Pyridoxal-5-phosphate;HMDB01491;http://www.hmdb.ca/metabolites/HMDB01491;247.1419;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;33;Disorders of pyridoxine metabolism;Pyridoxamine 5-prime phosphate oxidase deficiency;610090;https://omim.org/entry/610090;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610090;PNPO;Enzyme;Estimated ~19 cases;No possible artefacts to report;Vanillactic acid;HMDB00913;http://www.hmdb.ca/metabolites/HMDB00913;212.1993;Yes;"3-Hydroxy-4-methoxyphenyllactic acid; 3,4-Dihydroxyphenyllactic acid methyl ester; 3-(3,4-Dihydroxyphenyl)-2-methoxypropionic acid";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;33;Disorders of pyridoxine metabolism;Pyridoxamine 5-prime phosphate oxidase deficiency;610090;https://omim.org/entry/610090;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610090;PNPO;Enzyme;Estimated ~19 cases;No possible artefacts to report;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;33;Disorders of pyridoxine metabolism;Pyridoxamine 5-prime phosphate oxidase deficiency;610090;https://omim.org/entry/610090;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610090;PNPO;Enzyme;Estimated ~19 cases;No possible artefacts to report;L-Alanine;HMDB00161;http://www.hmdb.ca/metabolites/HMDB00161;89.0932;Yes;"D-Alanine; Beta-alanine; Sarcosine";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;33;Disorders of pyridoxine metabolism;Pyridoxamine 5-prime phosphate oxidase deficiency;610090;https://omim.org/entry/610090;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610090;PNPO;Enzyme;Estimated ~19 cases;No possible artefacts to report;L-Threonine;HMDB00167;http://www.hmdb.ca/metabolites/HMDB00167;119.1192;Yes;"L-Homoserine; L-Allothreonine";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Molybdenum cofactor deficiency;252150;https://omim.org/entry/252150;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:252150;"MOCS1; MOCS2; GPHN";Enzyme;Estimated ~100 cases;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Molybdenum cofactor deficiency;252150;https://omim.org/entry/252150;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:252150;"MOCS1; MOCS2; GPHN";Enzyme;Estimated ~100 cases;No possible artefacts to report;Alpha-aminoadipic acid delta-semialdehyde;HMDB01263;http://www.hmdb.ca/metabolites/HMDB01263;145.1564;Yes;"Isobutyrylglycine; N-butyrylglycine; 4-Acetamidobutanoic acid; 5-Amino-3-oxohexanoate; 2-Amino-6-oxohexanoate; 2-Keto-6-aminocaproate";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Molybdenum cofactor deficiency;252150;https://omim.org/entry/252150;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:252150;"MOCS1; MOCS2; GPHN";Enzyme;Estimated ~100 cases;No possible artefacts to report;Xanthine;HMDB00292;http://www.hmdb.ca/metabolites/HMDB00292;152.1109;Yes;6,8-Dihydroxypurine;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Molybdenum cofactor deficiency;252150;https://omim.org/entry/252150;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:252150;"MOCS1; MOCS2; GPHN";Enzyme;Estimated ~100 cases;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Urine;1;Decrease;-1.5;Important influence;3;-4.5;4.5;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Molybdenum cofactor deficiency;252150;https://omim.org/entry/252150;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:252150;"MOCS1; MOCS2; GPHN";Enzyme;Estimated ~100 cases;No possible artefacts to report;Cysteine-S-sulfate;HMDB00731;http://www.hmdb.ca/metabolites/HMDB00731;201.221;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Molybdenum cofactor deficiency;252150;https://omim.org/entry/252150;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:252150;"MOCS1; MOCS2; GPHN";Enzyme;Estimated ~100 cases;No possible artefacts to report;L-Cystine;HMDB00192;http://www.hmdb.ca/metabolites/HMDB00192;240.3;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Molybdenum cofactor deficiency;252150;https://omim.org/entry/252150;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:252150;"MOCS1; MOCS2; GPHN";Enzyme;Estimated ~100 cases;No possible artefacts to report;Taurine;HMDB00251;http://www.hmdb.ca/metabolites/HMDB00251;125.147;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Molybdenum cofactor deficiency;252150;https://omim.org/entry/252150;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:252150;"MOCS1; MOCS2; GPHN";Enzyme;Estimated ~100 cases;No possible artefacts to report;Cysteine-S-sulfate;HMDB00731;http://www.hmdb.ca/metabolites/HMDB00731;201.221;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Molybdenum cofactor deficiency;252150;https://omim.org/entry/252150;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:252150;"MOCS1; MOCS2; GPHN";Enzyme;Estimated ~100 cases;No possible artefacts to report;Hypoxanthine;HMDB00157;http://www.hmdb.ca/metabolites/HMDB00157;136.1115;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Product;3;Decrease;-1.5;Important influence;3;-13.5;13.5;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;Xanthine;HMDB00292;http://www.hmdb.ca/metabolites/HMDB00292;152.1109;Yes;6,8-Dihydroxypurine;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;2.5;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;N-methylnicotinamide;HMDB03152;http://www.hmdb.ca/metabolites/HMDB03152;136.1512;Yes;2-Methylnicotinamide;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;Xanthine;HMDB00292;http://www.hmdb.ca/metabolites/HMDB00292;152.1109;Yes;6,8-Dihydroxypurine;Urine;1;Increase;1;Critical;5;5;5;Indispensable;2.5;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;Uric acid;HMDB00289;http://www.hmdb.ca/metabolites/HMDB00289;168.1103;No;NA;Urine;1;Decrease;-1.5;Important influence;3;-4.5;4.5;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;Hypoxanthine;HMDB00157;http://www.hmdb.ca/metabolites/HMDB00157;136.1115;No;NA;Substrate;3;Increase;1;Supportive;1;3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;N-methylnicotinamide;HMDB03152;http://www.hmdb.ca/metabolites/HMDB03152;136.1512;Yes;2-Methylnicotinamide;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;2-Pyrrolidinone;HMDB02039;http://www.hmdb.ca/metabolites/HMDB02039;85.1045;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;N1-methyl-4-pyridone-3-carboxamide;HMDB04194;http://www.hmdb.ca/metabolites/HMDB04194;152.1506;Yes;N1-Methyl-2-pyridone-5-carboxamide;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;Hydantoin-5-propionic acid;HMDB01212;http://www.hmdb.ca/metabolites/HMDB01212;172.1387;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;5-Hydroxyisourate;HMDB30097;http://www.hmdb.ca/metabolites/HMDB30097;184.1097;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;2-Pyrrolidinone;HMDB02039;http://www.hmdb.ca/metabolites/HMDB02039;85.1045;No;NA;Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;N1-methyl-4-pyridone-3-carboxamide;HMDB04194;http://www.hmdb.ca/metabolites/HMDB04194;152.1506;Yes;N1-Methyl-2-pyridone-5-carboxamide;Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;Hydantoin-5-propionic acid;HMDB01212;http://www.hmdb.ca/metabolites/HMDB01212;172.1387;No;NA;Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;5-Hydroxyisourate;HMDB30097;http://www.hmdb.ca/metabolites/HMDB30097;184.1097;No;NA;Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
B;Disorders of vitamins, cofactors, metals and minerals;39;Disorders of molybdenum metabolism;Xanthinuria type II;603592;https://omim.org/entry/603592;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:603592;MOCOS;Enzyme;Estimated ~6 cases;No possible artefacts to report;Hypoxanthine;HMDB00157;http://www.hmdb.ca/metabolites/HMDB00157;136.1115;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type I;230400;https://omim.org/entry/230400;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230400;GALT;Enzyme;Estimated 1:40,000-1:60,000;No possible artefacts to report;Galactose-1-phosphate;HMDB00645;http://www.hmdb.ca/metabolites/HMDB00645;260.1358;Yes;"Fructose-1-phosphate; D-Fructose-1-phosphate; Beta-2-Fructose-2-phosphate; Fructose-6-phosphate; Beta-D-Fructose-6-phosphate; D-Mannose-1-phosphate; Mannose-6-phosphate; Glucose-1-phosphate; Glucose-6-phosphate; Beta-D-Glucose-6-phosphate; D-Tagatose-1-phosphate; D-Tagatose-6-phosphate; Sorbose-1-phosphate; Inositol phosphate; Myo-inositol-1-phosphate; Myo-inositol-3-phosphate; Myo-inositol-4-phosphate; Dolichyl phosphate-D-mannose; ";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type I;230400;https://omim.org/entry/230400;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230400;GALT;Enzyme;Estimated 1:40,000-1:60,000;No possible artefacts to report;D-Galactose;HMDB00143;http://www.hmdb.ca/metabolites/HMDB00143;180.1559;Yes;"L-Galactose; Beta-D-Galactose; D-Glucose; Alpha-D-Glucose; Beta-D-Glucose; D-Mannose; D-Fructose; D-Tagatose; Allose; L-Sorbose; L-Gulose; Myoinositol; Scyllitol; 3-Deoxyarabinohexonic acid; ";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type I;230400;https://omim.org/entry/230400;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230400;GALT;Enzyme;Estimated 1:40,000-1:60,000;No possible artefacts to report;Galactitol;HMDB00107;http://www.hmdb.ca/metabolites/HMDB00107;182.1718;Yes;"Sorbitol; Mannitol; L-Iditol";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type I;230400;https://omim.org/entry/230400;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230400;GALT;Enzyme;Estimated 1:40,000-1:60,000;No possible artefacts to report;Glucose;HMDB00122;http://www.hmdb.ca/metabolites/HMDB00122;180.1559;Yes;"L- and D-Galactose; Beta-D-Galactose; Alpha-D-Glucose; Beta-D-Glucose; D-Mannose; D-Fructose; D-Tagatose; Allose; L-Sorbose; L-Gulose; Myoinositol; Scyllitol; 3-Deoxyarabinohexonic acid; ";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type I;230400;https://omim.org/entry/230400;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230400;GALT;Enzyme;Estimated 1:40,000-1:60,000;No possible artefacts to report;Galactonic acid;HMDB00565;http://www.hmdb.ca/metabolites/HMDB00565;196.1553;Yes;"Gluconic acid; Gulonic acid";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type II;230200;https://omim.org/entry/230200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230200;GALK1;Enzyme;Estimated 1:100,000;No possible artefacts to report;D-Galactose;HMDB00143;http://www.hmdb.ca/metabolites/HMDB00143;180.1559;Yes;"L-Galactose; Beta-D-Galactose; D-Glucose; Alpha-D-Glucose; Beta-D-Glucose; D-Mannose; D-Fructose; D-Tagatose; Allose; L-Sorbose; L-Gulose; Myoinositol; Scyllitol; 3-Deoxyarabinohexonic acid; ";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type II;230200;https://omim.org/entry/230200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230200;GALK1;Enzyme;Estimated 1:100,000;No possible artefacts to report;Galactose-1-phosphate;HMDB00645;http://www.hmdb.ca/metabolites/HMDB00645;260.1358;Yes;"Fructose-1-phosphate; D-Fructose-1-phosphate; Beta-2-Fructose-2-phosphate; Fructose-6-phosphate; Beta-D-Fructose-6-phosphate; D-Mannose-1-phosphate; Mannose-6-phosphate; Glucose-1-phosphate; Glucose-6-phosphate; Beta-D-Glucose-6-phosphate; D-Tagatose-1-phosphate; D-Tagatose-6-phosphate; Sorbose-1-phosphate; Inositol phosphate; Myo-inositol-1-phosphate; Myo-inositol-3-phosphate; Myo-inositol-4-phosphate; Dolichyl phosphate-D-mannose; ";Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type II;230200;https://omim.org/entry/230200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230200;GALK1;Enzyme;Estimated 1:100,000;No possible artefacts to report;Galactitol;HMDB00107;http://www.hmdb.ca/metabolites/HMDB00107;182.1718;Yes;"Sorbitol; Mannitol; L-Iditol";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type II;230200;https://omim.org/entry/230200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230200;GALK1;Enzyme;Estimated 1:100,000;No possible artefacts to report;Glucose;HMDB00122;http://www.hmdb.ca/metabolites/HMDB00122;180.1559;Yes;"L- and D-Galactose; Beta-D-Galactose; Alpha-D-Glucose; Beta-D-Glucose; D-Mannose; D-Fructose; D-Tagatose; Allose; L-Sorbose; L-Gulose; Myoinositol; Scyllitol; 3-Deoxyarabinohexonic acid; ";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type II;230200;https://omim.org/entry/230200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230200;GALK1;Enzyme;Estimated 1:100,000;No possible artefacts to report;Galactonic acid;HMDB00565;http://www.hmdb.ca/metabolites/HMDB00565;196.1553;Yes;"Gluconic acid; Gulonic acid";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type III;230350;https://omim.org/entry/230350;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230350;GALE;Enzyme;Estimated ~30 cases;No possible artefacts to report;D-Galactose;HMDB00143;http://www.hmdb.ca/metabolites/HMDB00143;180.1559;Yes;"L-Galactose; Beta-D-Galactose; D-Glucose; Alpha-D-Glucose; Beta-D-Glucose; D-Mannose; D-Fructose; D-Tagatose; Allose; L-Sorbose; L-Gulose; Myoinositol; Scyllitol; 3-Deoxyarabinohexonic acid; ";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type III;230350;https://omim.org/entry/230350;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230350;GALE;Enzyme;Estimated ~30 cases;No possible artefacts to report;Galactose-1-phosphate;HMDB00645;http://www.hmdb.ca/metabolites/HMDB00645;260.1358;Yes;"Fructose-1-phosphate; D-Fructose-1-phosphate; Beta-2-Fructose-2-phosphate; Fructose-6-phosphate; Beta-D-Fructose-6-phosphate; D-Mannose-1-phosphate; Mannose-6-phosphate; Glucose-1-phosphate; Glucose-6-phosphate; Beta-D-Glucose-6-phosphate; D-Tagatose-1-phosphate; D-Tagatose-6-phosphate; Sorbose-1-phosphate; Inositol phosphate; Myo-inositol-1-phosphate; Myo-inositol-3-phosphate; Myo-inositol-4-phosphate; Dolichyl phosphate-D-mannose; ";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type III;230350;https://omim.org/entry/230350;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230350;GALE;Enzyme;Estimated ~30 cases;No possible artefacts to report;Glucose;HMDB00122;http://www.hmdb.ca/metabolites/HMDB00122;180.1559;Yes;"L- and D-Galactose; Beta-D-Galactose; Alpha-D-Glucose; Beta-D-Glucose; D-Mannose; D-Fructose; D-Tagatose; Allose; L-Sorbose; L-Gulose; Myoinositol; Scyllitol; 3-Deoxyarabinohexonic acid; ";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type III;230350;https://omim.org/entry/230350;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230350;GALE;Enzyme;Estimated ~30 cases;No possible artefacts to report;Galactitol;HMDB00107;http://www.hmdb.ca/metabolites/HMDB00107;182.1718;Yes;"Sorbitol; Mannitol; L-Iditol";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
C;Disorders of carbohydrates;47;Disorders of galactose metabolism;Galactosaemia type III;230350;https://omim.org/entry/230350;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:230350;GALE;Enzyme;Estimated ~30 cases;No possible artefacts to report;Galactonic acid;HMDB00565;http://www.hmdb.ca/metabolites/HMDB00565;196.1553;Yes;"Gluconic acid; Gulonic acid";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Ribose-5-phosphate isomerase deficiency;608611;https://omim.org/entry/608611;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608611;RPIA;Enzyme;Estimated ~1 case;No possible artefacts to report;D-Xylulose;HMDB01644;http://www.hmdb.ca/metabolites/HMDB01644;150.1299;Yes;L-Threo-2-pentulose, L-Ribulose, D-Ribulose, L-Arabinose, D-Arabinose, beta-Arabinose, 2-Deoxyribonic acid, D-Xylose, D-Ribose;CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Ribose-5-phosphate isomerase deficiency;608611;https://omim.org/entry/608611;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608611;RPIA;Enzyme;Estimated ~1 case;No possible artefacts to report;L-Arabitol;HMDB01851;http://www.hmdb.ca/metabolites/HMDB01851;152.1458;Yes;"D-Arabitol; Ribitol";CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Ribose-5-phosphate isomerase deficiency;608611;https://omim.org/entry/608611;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608611;RPIA;Enzyme;Estimated ~1 case;No possible artefacts to report;Ribitol;HMDB00508;http://www.hmdb.ca/metabolites/HMDB00508;152.1458;Yes;L- and D-Arabitol;CSF;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Ribose-5-phosphate isomerase deficiency;608611;https://omim.org/entry/608611;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608611;RPIA;Enzyme;Estimated ~1 case;No possible artefacts to report;D-Xylulose;HMDB01644;http://www.hmdb.ca/metabolites/HMDB01644;150.1299;Yes;L-Threo-2-pentulose, L-Ribulose, D-Ribulose, L-Arabinose, D-Arabinose, beta-Arabinose, 2-Deoxyribonic acid, D-Xylose, D-Ribose;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Ribose-5-phosphate isomerase deficiency;608611;https://omim.org/entry/608611;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608611;RPIA;Enzyme;Estimated ~1 case;No possible artefacts to report;L-Arabitol;HMDB01851;http://www.hmdb.ca/metabolites/HMDB01851;152.1458;Yes;"D-Arabitol; Ribitol";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Ribose-5-phosphate isomerase deficiency;608611;https://omim.org/entry/608611;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:608611;RPIA;Enzyme;Estimated ~1 case;No possible artefacts to report;Ribitol;HMDB00508;http://www.hmdb.ca/metabolites/HMDB00508;152.1458;Yes;L- and D-Arabitol;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Sedoheptulose kinase deficiency;617213;https://omim.org/entry/617213;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617213;SHPK;Enzyme;Estimated ~2 cases;No possible artefacts to report;Sedoheptulose;HMDB03219;http://www.hmdb.ca/metabolites/HMDB03219;210.1819;Yes;"L-Galacto-2-heptulose; Mannoheptulose";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Sedoheptulose kinase deficiency;617213;https://omim.org/entry/617213;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617213;SHPK;Enzyme;Estimated ~2 cases;No possible artefacts to report;Sedoheptulose-7-phosphate;HMDB01068;http://www.hmdb.ca/metabolites/HMDB01068;290.1618;Yes;Sedoheptulose 1-phosphate;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Sedoheptulose kinase deficiency;617213;https://omim.org/entry/617213;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617213;SHPK;Enzyme;Estimated ~2 cases;No possible artefacts to report;Erythritol;HMDB02994;http://www.hmdb.ca/metabolites/HMDB02994;122.1198;Yes;D-Threitol;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;Erythritol;HMDB02994;http://www.hmdb.ca/metabolites/HMDB02994;122.1198;Yes;D-Threitol;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;L-Arabitol;HMDB01851;http://www.hmdb.ca/metabolites/HMDB01851;152.1458;Yes;"D-Arabitol; Ribitol";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;Ribitol;HMDB00508;http://www.hmdb.ca/metabolites/HMDB00508;152.1458;Yes;L- and D-Arabitol;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;Erythritol;HMDB02994;http://www.hmdb.ca/metabolites/HMDB02994;122.1198;Yes;D-Threitol;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;L-Arabitol;HMDB01851;http://www.hmdb.ca/metabolites/HMDB01851;152.1458;Yes;"D-Arabitol; Ribitol";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;Ribitol;HMDB00508;http://www.hmdb.ca/metabolites/HMDB00508;152.1458;Yes;L- and D-Arabitol;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;Sedoheptulose-7-phosphate;HMDB01068;http://www.hmdb.ca/metabolites/HMDB01068;290.1618;Yes;Sedoheptulose 1-phosphate;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;Sedoheptulose;HMDB03219;http://www.hmdb.ca/metabolites/HMDB03219;210.1819;Yes;"L-Galacto-2-heptulose; Mannoheptulose";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;Mannoheptulose;HMDB29935;http://www.hmdb.ca/metabolites/HMDB29935;210.1819;Yes;"L-Galacto-2-heptulose; Sedoheptulose";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;Perseitol;HMDB33750;http://www.hmdb.ca/metabolites/HMDB33750;212.1977;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;Ribulose-5-phosphate;HMDB00618;http://www.hmdb.ca/metabolites/HMDB00618;230.1098;Yes;"Ribose-1-phosphate; Ribose-5-phosphate; Xylulose-1-phosphate; Xylulose-5-phosphate; Beta-arabinose-1-phosphate; Arabinose-5-phosphate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;Ribose-5-phosphate;HMDB01548;http://www.hmdb.ca/metabolites/HMDB01548;230.1098;Yes;"Ribose-1-phosphate; Ribulose-5-phosphate; Xylulose-1-phosphate; Xylulose-5-phosphate; Beta-arabinose-1-phosphate; Arabinose-5-phosphate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transaldolase deficiency;606003;https://omim.org/entry/606003;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:606003;TALDO1;Enzyme;Estimated ~13 cases;No possible artefacts to report;Sedoheptulose-7-phosphate;HMDB01068;http://www.hmdb.ca/metabolites/HMDB01068;290.1618;Yes;Sedoheptulose 1-phosphate;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transketolase deficiency;617044;https://omim.org/entry/617044;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617044;TKT;Enzyme;Estimated ~5 cases;No possible artefacts to report;Erythritol;HMDB02994;http://www.hmdb.ca/metabolites/HMDB02994;122.1198;Yes;D-Threitol;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transketolase deficiency;617044;https://omim.org/entry/617044;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617044;TKT;Enzyme;Estimated ~5 cases;No possible artefacts to report;L-Arabitol;HMDB01851;http://www.hmdb.ca/metabolites/HMDB01851;152.1458;Yes;"D-Arabitol; Ribitol";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transketolase deficiency;617044;https://omim.org/entry/617044;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617044;TKT;Enzyme;Estimated ~5 cases;No possible artefacts to report;Ribitol;HMDB00508;http://www.hmdb.ca/metabolites/HMDB00508;152.1458;Yes;L- and D-Arabitol;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transketolase deficiency;617044;https://omim.org/entry/617044;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617044;TKT;Enzyme;Estimated ~5 cases;No possible artefacts to report;Erythritol;HMDB02994;http://www.hmdb.ca/metabolites/HMDB02994;122.1198;Yes;D-Threitol;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transketolase deficiency;617044;https://omim.org/entry/617044;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617044;TKT;Enzyme;Estimated ~5 cases;No possible artefacts to report;L-Arabitol;HMDB01851;http://www.hmdb.ca/metabolites/HMDB01851;152.1458;Yes;"D-Arabitol; Ribitol";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transketolase deficiency;617044;https://omim.org/entry/617044;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617044;TKT;Enzyme;Estimated ~5 cases;No possible artefacts to report;Ribitol;HMDB00508;http://www.hmdb.ca/metabolites/HMDB00508;152.1458;Yes;L- and D-Arabitol;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;49;Disorders of the pentose phosphate pathway and polyol metabolism;Transketolase deficiency;617044;https://omim.org/entry/617044;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:617044;TKT;Enzyme;Estimated ~5 cases;No possible artefacts to report;Ribose-5-phosphate;HMDB01548;http://www.hmdb.ca/metabolites/HMDB01548;230.1098;Yes;"Ribose-1-phosphate; Ribulose-5-phosphate; Xylulose-1-phosphate; Xylulose-5-phosphate; Beta-arabinose-1-phosphate; Arabinose-5-phosphate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
C;Disorders of carbohydrates;52;Disorders of gluconeogenesis;Fructose-1,6-biphosphatase deficiency;229700;https://omim.org/entry/229700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:229700;FBP1;Enzyme;Estimated 1:147.575;No possible artefacts to report;Glycerol;HMDB00131;http://www.hmdb.ca/metabolites/HMDB00131;92.0938;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.0;Yes
C;Disorders of carbohydrates;52;Disorders of gluconeogenesis;Fructose-1,6-biphosphatase deficiency;229700;https://omim.org/entry/229700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:229700;FBP1;Enzyme;Estimated 1:147.575;No possible artefacts to report;L-Alanine;HMDB00161;http://www.hmdb.ca/metabolites/HMDB00161;89.0932;Yes;"D-Alanine; Beta-alanine; Sarcosine";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
C;Disorders of carbohydrates;52;Disorders of gluconeogenesis;Fructose-1,6-biphosphatase deficiency;229700;https://omim.org/entry/229700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:229700;FBP1;Enzyme;Estimated 1:147.575;No possible artefacts to report;Glycerol;HMDB00131;http://www.hmdb.ca/metabolites/HMDB00131;92.0938;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;1.0;Yes
C;Disorders of carbohydrates;52;Disorders of gluconeogenesis;Fructose-1,6-biphosphatase deficiency;229700;https://omim.org/entry/229700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:229700;FBP1;Enzyme;Estimated 1:147.575;No possible artefacts to report;L-Alanine;HMDB00161;http://www.hmdb.ca/metabolites/HMDB00161;89.0932;Yes;"D-Alanine; Beta-alanine; Sarcosine";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;52;Disorders of gluconeogenesis;Fructose-1,6-biphosphatase deficiency;229700;https://omim.org/entry/229700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:229700;FBP1;Enzyme;Estimated 1:147.575;No possible artefacts to report;Glycerol-3-phosphate;HMDB00126;http://www.hmdb.ca/metabolites/HMDB00126;172.0737;Yes;Beta-Glycerophosphoric acid;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
C;Disorders of carbohydrates;52;Disorders of gluconeogenesis;Fructose-1,6-biphosphatase deficiency;229700;https://omim.org/entry/229700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:229700;FBP1;Enzyme;Estimated 1:147.575;No possible artefacts to report;Pyruvic acid;HMDB00243;http://www.hmdb.ca/metabolites/HMDB00243;88.0621;Yes;Malonic semialdehyde;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
C;Disorders of carbohydrates;52;Disorders of gluconeogenesis;Fructose-1,6-biphosphatase deficiency;229700;https://omim.org/entry/229700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:229700;FBP1;Enzyme;Estimated 1:147.575;No possible artefacts to report;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
C;Disorders of carbohydrates;52;Disorders of gluconeogenesis;Fructose-1,6-biphosphatase deficiency;229700;https://omim.org/entry/229700;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:229700;FBP1;Enzyme;Estimated 1:147.575;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;D-2-hydroxyglutaric aciduria;600721;https://omim.org/entry/600721;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:600721;"D2HGDH; IDH2";Enzyme;Estimated ~80 cases;No possible artefacts to report;D-2-hydroxyglutaric acid;HMDB00606;http://www.hmdb.ca/metabolites/HMDB00606;148.114;Yes;"L-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Substrate;3;Increase;1;Critical;5;15;15;Indispensable;1.5;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;D-2-hydroxyglutaric aciduria;600721;https://omim.org/entry/600721;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:600721;"D2HGDH; IDH2";Enzyme;Estimated ~80 cases;No possible artefacts to report;D-2-hydroxyglutaric acid;HMDB00606;http://www.hmdb.ca/metabolites/HMDB00606;148.114;Yes;"L-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";CSF;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;D-2-hydroxyglutaric aciduria;600721;https://omim.org/entry/600721;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:600721;"D2HGDH; IDH2";Enzyme;Estimated ~80 cases;No possible artefacts to report;D-2-hydroxyglutaric acid;HMDB00606;http://www.hmdb.ca/metabolites/HMDB00606;148.114;Yes;"L-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;D-2-hydroxyglutaric aciduria;600721;https://omim.org/entry/600721;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:600721;"D2HGDH; IDH2";Enzyme;Estimated ~80 cases;No possible artefacts to report;D-2-hydroxyglutaric acid;HMDB00606;http://www.hmdb.ca/metabolites/HMDB00606;148.114;Yes;"L-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Urine;1;Increase;1;Critical;5;5;5;Indispensable;1.5;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;D-2-hydroxyglutaric aciduria;600721;https://omim.org/entry/600721;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:600721;"D2HGDH; IDH2";Enzyme;Estimated ~80 cases;No possible artefacts to report;Succinic acid;HMDB00254;http://www.hmdb.ca/metabolites/HMDB00254;118.088;Yes;"Methylmalonic acid; Erythrono-1,4-lactone; Threonolactone";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;D-2-hydroxyglutaric aciduria;600721;https://omim.org/entry/600721;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:600721;"D2HGDH; IDH2";Enzyme;Estimated ~80 cases;No possible artefacts to report;Citric acid;HMDB00094;http://www.hmdb.ca/metabolites/HMDB00094;192.1235;Yes;"Isocitric acid; D-threo-Isocitric acid; Diketogulonic acid; 2,3-Diketo-L-gulonate; D-Glucaro-1,4-lactone";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;L-2-hydroxyglutaric aciduria;236792;https://omim.org/entry/236792;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236792;L2HGDH;Enzyme;Estimated ~140 cases;No possible artefacts to report;L-2-Hydroxyglutaric acid;HMDB00694;http://www.hmdb.ca/metabolites/HMDB00694;148.114;Yes;"D-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Substrate;3;Increase;1;Critical;5;15;15;Indispensable;3.0;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;L-2-hydroxyglutaric aciduria;236792;https://omim.org/entry/236792;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236792;L2HGDH;Enzyme;Estimated ~140 cases;No possible artefacts to report;L-2-Hydroxyglutaric acid;HMDB00694;http://www.hmdb.ca/metabolites/HMDB00694;148.114;Yes;"D-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;L-2-hydroxyglutaric aciduria;236792;https://omim.org/entry/236792;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236792;L2HGDH;Enzyme;Estimated ~140 cases;No possible artefacts to report;L-2-Hydroxyglutaric acid;HMDB00694;http://www.hmdb.ca/metabolites/HMDB00694;148.114;Yes;"D-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;L-2-hydroxyglutaric aciduria;236792;https://omim.org/entry/236792;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236792;L2HGDH;Enzyme;Estimated ~140 cases;No possible artefacts to report;L-2-Hydroxyglutaric acid;HMDB00694;http://www.hmdb.ca/metabolites/HMDB00694;148.114;Yes;"D-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;L-2-hydroxyglutaric aciduria;236792;https://omim.org/entry/236792;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236792;L2HGDH;Enzyme;Estimated ~140 cases;No possible artefacts to report;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";CSF;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
D;Mitochondrial disorders of energy metabolism;56;Disorders of metabolite repair;L-2-hydroxyglutaric aciduria;236792;https://omim.org/entry/236792;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:236792;L2HGDH;Enzyme;Estimated ~140 cases;No possible artefacts to report;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
D;Mitochondrial disorders of energy metabolism;57;Disorders of mitochondrial carriers;Combined D-2- and L-2-hydroxyglutaric aciduria;615182;https://omim.org/entry/615182;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:615182;SLC25A1;Transporter;Estimated ~16 cases;No possible artefacts to report;L-2-Hydroxyglutaric acid;HMDB00694;http://www.hmdb.ca/metabolites/HMDB00694;148.114;Yes;"D-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
D;Mitochondrial disorders of energy metabolism;57;Disorders of mitochondrial carriers;Combined D-2- and L-2-hydroxyglutaric aciduria;615182;https://omim.org/entry/615182;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:615182;SLC25A1;Transporter;Estimated ~16 cases;No possible artefacts to report;L-2-Hydroxyglutaric acid;HMDB00694;http://www.hmdb.ca/metabolites/HMDB00694;148.114;Yes;"D-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
D;Mitochondrial disorders of energy metabolism;57;Disorders of mitochondrial carriers;Combined D-2- and L-2-hydroxyglutaric aciduria;615182;https://omim.org/entry/615182;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:615182;SLC25A1;Transporter;Estimated ~16 cases;No possible artefacts to report;D-2-hydroxyglutaric acid;HMDB00606;http://www.hmdb.ca/metabolites/HMDB00606;148.114;Yes;"L-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
D;Mitochondrial disorders of energy metabolism;57;Disorders of mitochondrial carriers;Combined D-2- and L-2-hydroxyglutaric aciduria;615182;https://omim.org/entry/615182;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:615182;SLC25A1;Transporter;Estimated ~16 cases;No possible artefacts to report;D-2-hydroxyglutaric acid;HMDB00606;http://www.hmdb.ca/metabolites/HMDB00606;148.114;Yes;"L-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
D;Mitochondrial disorders of energy metabolism;57;Disorders of mitochondrial carriers;Combined D-2- and L-2-hydroxyglutaric aciduria;615182;https://omim.org/entry/615182;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:615182;SLC25A1;Transporter;Estimated ~16 cases;No possible artefacts to report;L-2-Hydroxyglutaric acid;HMDB00694;http://www.hmdb.ca/metabolites/HMDB00694;148.114;Yes;"D-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
D;Mitochondrial disorders of energy metabolism;57;Disorders of mitochondrial carriers;Combined D-2- and L-2-hydroxyglutaric aciduria;615182;https://omim.org/entry/615182;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:615182;SLC25A1;Transporter;Estimated ~16 cases;No possible artefacts to report;D-2-hydroxyglutaric acid;HMDB00606;http://www.hmdb.ca/metabolites/HMDB00606;148.114;Yes;"L-2-Hydroxyglutaric acid; 2-Hydroxyglutaric acid; 3-Hydroxyglutaric acid; Citramalic acid; Ribonolactone; D-Xylono-1,5-lactone";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
D;Mitochondrial disorders of energy metabolism;57;Disorders of mitochondrial carriers;Combined D-2- and L-2-hydroxyglutaric aciduria;615182;https://omim.org/entry/615182;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:615182;SLC25A1;Transporter;Estimated ~16 cases;No possible artefacts to report;Oxoglutaric acid;HMDB00208;http://www.hmdb.ca/metabolites/HMDB00208;146.0981;Yes;3-Oxoglutaric acid;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
D;Mitochondrial disorders of energy metabolism;77;Disorders of mitochondrial phospholipid metabolism;3-Methylglutaconic aciduria - Barth syndrome;302060;https://omim.org/entry/302060;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:302060;TAZ;Enzyme;Estimated 1:140,000-1:400,000;Consider pregnancy induced 3-methylglutaconic aciduria;3-Methylglutaconic acid;HMDB00522;http://www.hmdb.ca/metabolites/HMDB00522;144.1253;Yes;"2-Methylglutaconic acid; 3-Hexenedioic acid; trans-2-hexenedioic acid; 3-Hydroxyadipic acid 3,6-lactone";Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
D;Mitochondrial disorders of energy metabolism;77;Disorders of mitochondrial phospholipid metabolism;3-Methylglutaconic aciduria - Barth syndrome;302060;https://omim.org/entry/302060;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:302060;TAZ;Enzyme;Estimated 1:140,000-1:400,000;Consider pregnancy induced 3-methylglutaconic aciduria;2-Ethylhydracrylic acid;HMDB00396;http://www.hmdb.ca/metabolites/HMDB00396;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 3-Hydroxyisovaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Methyl-3-Hydroxybutyric acid; Erythronilic acid;";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
D;Mitochondrial disorders of energy metabolism;77;Disorders of mitochondrial phospholipid metabolism;3-Methylglutaconic aciduria - Barth syndrome;302060;https://omim.org/entry/302060;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:302060;TAZ;Enzyme;Estimated 1:140,000-1:400,000;Consider pregnancy induced 3-methylglutaconic aciduria;Methylglutaric acid;HMDB00752;http://www.hmdb.ca/metabolites/HMDB00752;146.1412;Yes;"Adipic acid; 2-Methylglutaric acid; Monomethylglutaric acid; 2,2-Dimethylsuccinic acid; Solerol; 2-Aceto-2-hydroxybutanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
D;Mitochondrial disorders of energy metabolism;NA;Mitochondrial failure;Mitochondrial failure;NA;NA;NA;NA;NA;NA;NA;L-Alanine;HMDB00161;http://www.hmdb.ca/metabolites/HMDB00161;89.0932;Yes;"D-Alanine; Beta-alanine; Sarcosine";Plasma;2;Increase;1;Important influence;3;2;6;Dispensable;;Yes
D;Mitochondrial disorders of energy metabolism;NA;Mitochondrial failure;Mitochondrial failure;NA;NA;NA;NA;NA;NA;NA;L-Proline;HMDB00162;http://www.hmdb.ca/metabolites/HMDB00162;115.1305;Yes;"D-Proline; Acetamidopropanal";Plasma;2;Increase;1;Important influence;3;2;6;Dispensable;;Yes
D;Mitochondrial disorders of energy metabolism;NA;Mitochondrial failure;Mitochondrial failure;NA;NA;NA;NA;NA;NA;NA;Mitochondrial-DiagRatio-Ala/(Phe+Tyr);HMDB0AA03;http://www.hmdb.ca/metabolites/HMDB0AA03;NA_Ratio_0AA03;No;NA;Plasma;2;Increase;1;Important influence;3;2;6;Dispensable;;Yes
D;Mitochondrial disorders of energy metabolism;NA;Mitochondrial failure;Mitochondrial failure;NA;NA;NA;NA;NA;NA;NA;Mitochondrial-DiagRatio-Ala/Lys;HMDB0AA02;http://www.hmdb.ca/metabolites/HMDB0AA02;NA_Ratio_0AA02;No;NA;Plasma;2;Increase;1;Important influence;3;2;6;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase I deficiency;255120;https://omim.org/entry/255120;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255120;CPT1A;Enzyme;Estimated ~50 cases;No possible artefacts to report;L-Palmitoylcarnitine;HMDB00222;http://www.hmdb.ca/metabolites/HMDB00222;399.6077;No;NA;Plasma;2;Decrease;-1.5;Critical;5;-15;15;Indispensable;-1.5;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase I deficiency;255120;https://omim.org/entry/255120;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255120;CPT1A;Enzyme;Estimated ~50 cases;No possible artefacts to report;Oleoylcarnitine;HMDB05065;http://www.hmdb.ca/metabolites/HMDB05065;425.654;Yes;"Vaccenyl carnitine; Elaidic carnitine; 11Z-Octadecenylcarnitine";Plasma;2;Decrease;-1.5;Critical;5;-15;15;Indispensable;-1.0;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase I deficiency;255120;https://omim.org/entry/255120;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255120;CPT1A;Enzyme;Estimated ~50 cases;No possible artefacts to report;Linoleoylcarnitine;HMDB06469;http://www.hmdb.ca/metabolites/HMDB06469;423.6291;Yes;Linoelaidyl carnitine;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase I deficiency;255120;https://omim.org/entry/255120;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255120;CPT1A;Enzyme;Estimated ~50 cases;No possible artefacts to report;Stearoylcarnitine;HMDB00848;http://www.hmdb.ca/metabolites/HMDB00848;427.6609;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase I deficiency;255120;https://omim.org/entry/255120;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255120;CPT1A;Enzyme;Estimated ~50 cases;No possible artefacts to report;CPT1-DiagRatio-C0/(C16+C18);HMDB0AC01;http://www.hmdb.ca/metabolites/HMDB0AC01;NA_Ratio_0AC01;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase I deficiency;255120;https://omim.org/entry/255120;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255120;CPT1A;Enzyme;Estimated ~50 cases;No possible artefacts to report;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase II deficiency or carnitine translocase deficiency;"255110; 212138";https://omim.org/entry/255110;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255110;"CPT2; SLC25A20";"Enzyme; Transporter";Estimated 1:750,000;No possible artefacts to report;L-Palmitoylcarnitine;HMDB00222;http://www.hmdb.ca/metabolites/HMDB00222;399.6077;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase II deficiency or carnitine translocase deficiency;"255110; 212138";https://omim.org/entry/255110;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255110;"CPT2; SLC25A20";"Enzyme; Transporter";Estimated 1:750,000;No possible artefacts to report;CPT2-DiagRatio-(C16+C18:1)/C2;HMDB0AC02;NA;NA_Ratio_0AC02;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase II deficiency or carnitine translocase deficiency;"255110; 212138";https://omim.org/entry/255110;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255110;"CPT2; SLC25A20";"Enzyme; Transporter";Estimated 1:750,000;No possible artefacts to report;Oleoylcarnitine;HMDB05065;http://www.hmdb.ca/metabolites/HMDB05065;425.654;Yes;"Vaccenyl carnitine; Elaidic carnitine; 11Z-Octadecenylcarnitine";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase II deficiency or carnitine translocase deficiency;"255110; 212138";https://omim.org/entry/255110;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255110;"CPT2; SLC25A20";"Enzyme; Transporter";Estimated 1:750,000;No possible artefacts to report;Linoleoylcarnitine;HMDB06469;http://www.hmdb.ca/metabolites/HMDB06469;423.6291;Yes;Linoelaidyl carnitine;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase II deficiency or carnitine translocase deficiency;"255110; 212138";https://omim.org/entry/255110;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255110;"CPT2; SLC25A20";"Enzyme; Transporter";Estimated 1:750,000;No possible artefacts to report;Stearoylcarnitine;HMDB00848;http://www.hmdb.ca/metabolites/HMDB00848;427.6609;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase II deficiency or carnitine translocase deficiency;"255110; 212138";https://omim.org/entry/255110;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255110;"CPT2; SLC25A20";"Enzyme; Transporter";Estimated 1:750,000;No possible artefacts to report;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine palmitoyltransferase II deficiency or carnitine translocase deficiency;"255110; 212138";https://omim.org/entry/255110;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:255110;"CPT2; SLC25A20";"Enzyme; Transporter";Estimated 1:750,000;No possible artefacts to report;L-Acetylcarnitine;HMDB00201;http://www.hmdb.ca/metabolites/HMDB00201;203.2356;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine transporter deficiency;212140;https://omim.org/entry/212140;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:212140;SLC22A5;Transporter;Estimated 1:20,000-1:70,000;No possible artefacts to report;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Plasma;2;Decrease;-1.5;Critical;5;-15;15;Indispensable;-1.5;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine transporter deficiency;212140;https://omim.org/entry/212140;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:212140;SLC22A5;Transporter;Estimated 1:20,000-1:70,000;No possible artefacts to report;L-Acetylcarnitine;HMDB00201;http://www.hmdb.ca/metabolites/HMDB00201;203.2356;No;NA;Plasma;2;Decrease;-1.5;Critical;5;-15;15;Indispensable;-1.5;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine transporter deficiency;212140;https://omim.org/entry/212140;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:212140;SLC22A5;Transporter;Estimated 1:20,000-1:70,000;No possible artefacts to report;Propionylcarnitine;HMDB00824;http://www.hmdb.ca/metabolites/HMDB00824;217.2622;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine transporter deficiency;212140;https://omim.org/entry/212140;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:212140;SLC22A5;Transporter;Estimated 1:20,000-1:70,000;No possible artefacts to report;OCTN2-DiagRatio-C3/Met;HMDBAAC01;http://www.hmdb.ca/metabolites/HMDBAAC01;NA_Ratio_AAC01;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Carnitine transporter deficiency;212140;https://omim.org/entry/212140;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:212140;SLC22A5;Transporter;Estimated 1:20,000-1:70,000;No possible artefacts to report;OCTN2-DiagRatio-Phe/(C3+C16);HMDBAAC02;http://www.hmdb.ca/metabolites/HMDBAAC02;NA_Ratio_AAC02;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Epsilon-trimethyllysine hydroxylase deficiency;300872;https://omim.org/entry/300872;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300872;TMLHE;Enzyme;Estimated ~30 cases;No possible artefacts to report;Gamma-butyrobetaine;HMDB06831;http://www.hmdb.ca/metabolites/HMDB06831;145.1995;No;NA;Plasma;2;Decrease;-1.5;Critical;5;-15;15;Indispensable;-1.5;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Epsilon-trimethyllysine hydroxylase deficiency;300872;https://omim.org/entry/300872;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300872;TMLHE;Enzyme;Estimated ~30 cases;No possible artefacts to report;TMLHE-DiagRatio-TML/GBB;HMDB0AC06;NA;NA_Ratio_0AC06;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Epsilon-trimethyllysine hydroxylase deficiency;300872;https://omim.org/entry/300872;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300872;TMLHE;Enzyme;Estimated ~30 cases;No possible artefacts to report;Trimethyllysine;HMDB01325;http://www.hmdb.ca/metabolites/HMDB01325;188.2673;No;NA;Substrate;3;Increase;1;Important influence;3;9;9;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Epsilon-trimethyllysine hydroxylase deficiency;300872;https://omim.org/entry/300872;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300872;TMLHE;Enzyme;Estimated ~30 cases;No possible artefacts to report;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Plasma;2;Decrease;-1.5;Important influence;3;-9;9;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Epsilon-trimethyllysine hydroxylase deficiency;300872;https://omim.org/entry/300872;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300872;TMLHE;Enzyme;Estimated ~30 cases;No possible artefacts to report;Trimethyllysine;HMDB01325;http://www.hmdb.ca/metabolites/HMDB01325;188.2673;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Epsilon-trimethyllysine hydroxylase deficiency;300872;https://omim.org/entry/300872;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300872;TMLHE;Enzyme;Estimated ~30 cases;No possible artefacts to report;Hydroxytrimethyllysine;HMDB01422;http://www.hmdb.ca/metabolites/HMDB01422;205.2746;No;NA;Product;3;Decrease;-1.5;Supportive;1;-4.5;4.5;Dispensable;;Yes
E;Disorders of lipids;82;Disorders of carnitine metabolism;Epsilon-trimethyllysine hydroxylase deficiency;300872;https://omim.org/entry/300872;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:300872;TMLHE;Enzyme;Estimated ~30 cases;No possible artefacts to report;L-Acetylcarnitine;HMDB00201;http://www.hmdb.ca/metabolites/HMDB00201;203.2356;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;3-Hydroxyacyl-CoA dehydrogenase deficiency;231530;https://omim.org/entry/231530;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231530;HADH;Enzyme;Estimated ~8 cases;No possible artefacts to report;SCHAD-DiagRatio-C4OH/C2;HMDB0AC05;http://www.hmdb.ca/metabolites/HMDB0AC05;NA_Ratio_0AC05;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;3-Hydroxyacyl-CoA dehydrogenase deficiency;231530;https://omim.org/entry/231530;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231530;HADH;Enzyme;Estimated ~8 cases;No possible artefacts to report;3-Hydroxysuberic acid;HMDB00325;http://www.hmdb.ca/metabolites/HMDB00325;190.1938;Yes;"Diethyl L-malate; 6-(2-Hydroxyethoxy)-6-oxohexanoic acid";Urine;1;Increase;1;Critical;5;5;5;Indispensable;2.0;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;3-Hydroxyacyl-CoA dehydrogenase deficiency;231530;https://omim.org/entry/231530;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231530;HADH;Enzyme;Estimated ~8 cases;No possible artefacts to report;Suberic acid;HMDB00893;http://www.hmdb.ca/metabolites/HMDB00893;174.1944;Yes;"Ethyladipic acid; 2,4-Dimethyladipic acid; 3-Methylpimelic acid";Urine;1;Increase;1;Critical;5;5;5;Indispensable;2.0;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;3-Hydroxyacyl-CoA dehydrogenase deficiency;231530;https://omim.org/entry/231530;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231530;HADH;Enzyme;Estimated ~8 cases;No possible artefacts to report;3-Hydroxytetradecanedioic acid;HMDB00394;http://www.hmdb.ca/metabolites/HMDB004394;274.3532;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;3-Hydroxyacyl-CoA dehydrogenase deficiency;231530;https://omim.org/entry/231530;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231530;HADH;Enzyme;Estimated ~8 cases;No possible artefacts to report;3-Hydroxydodecanedioic acid;HMDB00413;http://www.hmdb.ca/metabolites/HMDB00413;246.3001;Yes;Dibutyl malate;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;3-Hydroxyacyl-CoA dehydrogenase deficiency;231530;https://omim.org/entry/231530;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231530;HADH;Enzyme;Estimated ~8 cases;No possible artefacts to report;3-Hydroxysebacic acid;HMDB00350;http://www.hmdb.ca/metabolites/HMDB00350;218.249;Yes;5-Hydroxysebacate;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;3-Hydroxyacyl-CoA dehydrogenase deficiency;231530;https://omim.org/entry/231530;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231530;HADH;Enzyme;Estimated ~8 cases;No possible artefacts to report;3-Hydroxyadipic acid;HMDB00345;http://www.hmdb.ca/metabolites/HMDB00345;162.1406;Yes;"3-Hydroxymethylglutaric acid; 2-Hydroxyadipic acid; 2(R)-Hydroxyadipic acid; Levoglucosan; Diethyl dicarbonate; D-1,5-Anhydrofructose; 2-Hydroxy-2-ethylsuccinic acid; D-1-Deoxy-erythro-hexo-2,3-diulose";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;3-Hydroxyacyl-CoA dehydrogenase deficiency;231530;https://omim.org/entry/231530;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231530;HADH;Enzyme;Estimated ~8 cases;No possible artefacts to report;Hydroxybutyrylcarnitine;HMDB13127;http://www.hmdb.ca/metabolites/HMDB13127;247.2881;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;3-Hydroxyacyl-CoA dehydrogenase deficiency;231530;https://omim.org/entry/231530;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231530;HADH;Enzyme;Estimated ~8 cases;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;3-Hydroxyacyl-CoA dehydrogenase deficiency;231530;https://omim.org/entry/231530;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231530;HADH;Enzyme;Estimated ~8 cases;No possible artefacts to report;Sebacic acid;HMDB00792;http://www.hmdb.ca/metabolites/HMDB00792;202.2475;Yes;"2-Ethylsuberic acid; Heptylmalonic acid; 3-Methylazelaic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;3-Hydroxyacyl-CoA dehydrogenase deficiency;231530;https://omim.org/entry/231530;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:231530;HADH;Enzyme;Estimated ~8 cases;No possible artefacts to report;Adipic acid;HMDB00448;http://www.hmdb.ca/metabolites/HMDB00448;146.1412;Yes;"Methylglutaric acid; 2-Methylglutaric acid; Monomethylglutaric acid; 2,2-Dimethylsuccinic acid; Solerol; 2-Aceto-2-hydroxybutanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Long-chain hydroxyacyl-CoA dehydrogenase deficiency or Mitochondrial trifunctional protein deficiency;"609016; 609015";https://omim.org/entry/609016;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:609016;"HADHA; HADHB";Enzyme;Estimated 1:20,000-1:250,000;No possible artefacts to report;2-Hydroxyhexadecanoylcarnitine;HMDB13337;http://www.hmdb.ca/metabolites/HMDB13337;415.6071;Yes;3-Hydroxyhexadecanoylcarnitine;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Long-chain hydroxyacyl-CoA dehydrogenase deficiency or Mitochondrial trifunctional protein deficiency;"609016; 609015";https://omim.org/entry/609016;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:609016;"HADHA; HADHB";Enzyme;Estimated 1:20,000-1:250,000;No possible artefacts to report;3-Hydroxy-9-hexadecenoylcarnitine;HMDB13333;http://www.hmdb.ca/metabolites/HMDB13333;413.5912;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Long-chain hydroxyacyl-CoA dehydrogenase deficiency or Mitochondrial trifunctional protein deficiency;"609016; 609015";https://omim.org/entry/609016;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:609016;"HADHA; HADHB";Enzyme;Estimated 1:20,000-1:250,000;No possible artefacts to report;3-Hydroxy-11Z-octadecenoylcarnitine;HMDB13339;http://www.hmdb.ca/metabolites/HMDB13339;441.6444;Yes;3-Hydroxy-9Z-octadecenoylcarnitine;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Long-chain hydroxyacyl-CoA dehydrogenase deficiency or Mitochondrial trifunctional protein deficiency;"609016; 609015";https://omim.org/entry/609016;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:609016;"HADHA; HADHB";Enzyme;Estimated 1:20,000-1:250,000;No possible artefacts to report;12-Hydroxy-12-octadecanoylcarnitine;HMDB13154;http://www.hmdb.ca/metabolites/HMDB13154;443.6603;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Long-chain hydroxyacyl-CoA dehydrogenase deficiency or Mitochondrial trifunctional protein deficiency;"609016; 609015";https://omim.org/entry/609016;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:609016;"HADHA; HADHB";Enzyme;Estimated 1:20,000-1:250,000;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Long-chain hydroxyacyl-CoA dehydrogenase deficiency or Mitochondrial trifunctional protein deficiency;"609016; 609015";https://omim.org/entry/609016;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:609016;"HADHA; HADHB";Enzyme;Estimated 1:20,000-1:250,000;No possible artefacts to report;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Long-chain hydroxyacyl-CoA dehydrogenase deficiency or Mitochondrial trifunctional protein deficiency;"609016; 609015";https://omim.org/entry/609016;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:609016;"HADHA; HADHB";Enzyme;Estimated 1:20,000-1:250,000;No possible artefacts to report;3-Hydroxy-cis-5-tetradecenoylcarnitine;HMDB13330;http://www.hmdb.ca/metabolites/HMDB13330;385.5381;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Long-chain hydroxyacyl-CoA dehydrogenase deficiency or Mitochondrial trifunctional protein deficiency;"609016; 609015";https://omim.org/entry/609016;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:609016;"HADHA; HADHB";Enzyme;Estimated 1:20,000-1:250,000;No possible artefacts to report;3-Hydroxyadipic acid;HMDB00345;http://www.hmdb.ca/metabolites/HMDB00345;162.1406;Yes;"2-Hydroxyadipic acid; 3-Hydroxymethylglutaric acid; 2-Hydroxy-2-ethylsuccinic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Long-chain hydroxyacyl-CoA dehydrogenase deficiency or Mitochondrial trifunctional protein deficiency;"609016; 609015";https://omim.org/entry/609016;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:609016;"HADHA; HADHB";Enzyme;Estimated 1:20,000-1:250,000;No possible artefacts to report;3-Hydroxysuberic acid;HMDB00325;http://www.hmdb.ca/metabolites/HMDB00325;190.1938;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Long-chain hydroxyacyl-CoA dehydrogenase deficiency or Mitochondrial trifunctional protein deficiency;"609016; 609015";https://omim.org/entry/609016;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:609016;"HADHA; HADHB";Enzyme;Estimated 1:20,000-1:250,000;No possible artefacts to report;3-Hydroxysebacic acid;HMDB00350;http://www.hmdb.ca/metabolites/HMDB00350;218.2469;Yes;2-Hydroxydecanedioic acid;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Medium-chain acyl-CoA dehydrogenase deficiency;201450;https://omim.org/entry/201450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201450;ACADM;Enzyme;Estimated 1:14.600;No possible artefacts to report;L-Octanoylcarnitine;HMDB00791;http://www.hmdb.ca/metabolites/HMDB00791;287.3951;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Medium-chain acyl-CoA dehydrogenase deficiency;201450;https://omim.org/entry/201450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201450;ACADM;Enzyme;Estimated 1:14.600;No possible artefacts to report;MCAD-DiagRatio-C8/C10;HMDB0AC07;http://www.hmdb.ca/metabolites/HMDB0AC07;NA_Ratio_0AC07;Yes;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Medium-chain acyl-CoA dehydrogenase deficiency;201450;https://omim.org/entry/201450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201450;ACADM;Enzyme;Estimated 1:14.600;No possible artefacts to report;Hexanoylcarnitine;HMDB00705;http://www.hmdb.ca/metabolites/HMDB00705;259.3419;Yes;L-Hexanoylcarnitine;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Medium-chain acyl-CoA dehydrogenase deficiency;201450;https://omim.org/entry/201450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201450;ACADM;Enzyme;Estimated 1:14.600;No possible artefacts to report;MCAD-DiagRatio-C8/C2;HMDB0AC04;http://www.hmdb.ca/metabolites/HMDB0AC04;NA_Ratio_0AC04;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Medium-chain acyl-CoA dehydrogenase deficiency;201450;https://omim.org/entry/201450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201450;ACADM;Enzyme;Estimated 1:14.600;No possible artefacts to report;Hexanoylglycine;HMDB00701;http://www.hmdb.ca/metabolites/HMDB00701;173.2096;Yes;"Isovalerylalanine; Isovalerylsarcosine; N-Acetylleucine";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Medium-chain acyl-CoA dehydrogenase deficiency;201450;https://omim.org/entry/201450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201450;ACADM;Enzyme;Estimated 1:14.600;No possible artefacts to report;9-Decenoylcarnitine;HMDB13205;http://www.hmdb.ca/metabolites/HMDB13205;313.4323;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Medium-chain acyl-CoA dehydrogenase deficiency;201450;https://omim.org/entry/201450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201450;ACADM;Enzyme;Estimated 1:14.600;No possible artefacts to report;Adipic acid;HMDB00448;http://www.hmdb.ca/metabolites/HMDB00448;146.1412;Yes;"Methylglutaric acid; 2-Methylglutaric acid; Monomethylglutaric acid; 2,2-Dimethylsuccinic acid; Solerol; 2-Aceto-2-hydroxybutanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Medium-chain acyl-CoA dehydrogenase deficiency;201450;https://omim.org/entry/201450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201450;ACADM;Enzyme;Estimated 1:14.600;No possible artefacts to report;Suberic acid;HMDB00893;http://www.hmdb.ca/metabolites/HMDB00893;174.1944;Yes;"Ethyladipic acid; 2,4-Dimethyladipic acid; 3-Methylpimelic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Medium-chain acyl-CoA dehydrogenase deficiency;201450;https://omim.org/entry/201450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201450;ACADM;Enzyme;Estimated 1:14.600;No possible artefacts to report;Sebacic acid;HMDB00792;http://www.hmdb.ca/metabolites/HMDB00792;202.2475;Yes;"2-Ethylsuberic acid; Heptylmalonic acid; 3-Methylazelaic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Medium-chain acyl-CoA dehydrogenase deficiency;201450;https://omim.org/entry/201450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201450;ACADM;Enzyme;Estimated 1:14.600;No possible artefacts to report;Phenylpropionylglycine;HMDB00860;http://www.hmdb.ca/metabolites/HMDB00860;207.2258;Yes;"N-Acetyl-L-phenylalanine; 3-Phenylpropionylglycine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Medium-chain acyl-CoA dehydrogenase deficiency;201450;https://omim.org/entry/201450;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201450;ACADM;Enzyme;Estimated 1:14.600;No possible artefacts to report;Suberylglycine;HMDB00953;http://www.hmdb.ca/metabolites/HMDB00953;231.2457;Yes;Isovalerylglutamic acid;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Short-chain acyl-CoA dehydrogenase deficiency;201470;https://omim.org/entry/201470;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201470;ACADS;Enzyme;Estimated 1:50,000;No possible artefacts to report;Isobutyryl-L-carnitine;HMDB00736;http://www.hmdb.ca/metabolites/HMDB00736;231.292;Yes;Butyrylcarnitine;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Short-chain acyl-CoA dehydrogenase deficiency;201470;https://omim.org/entry/201470;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201470;ACADS;Enzyme;Estimated 1:50,000;No possible artefacts to report;Isobutyryl-L-carnitine;HMDB00736;http://www.hmdb.ca/metabolites/HMDB00736;231.292;Yes;Butyrylcarnitine;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Short-chain acyl-CoA dehydrogenase deficiency;201470;https://omim.org/entry/201470;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201470;ACADS;Enzyme;Estimated 1:50,000;No possible artefacts to report;Methylsuccinic acid;HMDB01844;http://www.hmdb.ca/metabolites/HMDB01844;132.1146;Yes;"Monoethyl malonic acid; Dimethylmalonic acid; Ethylmalonic acid; Glutaric acid; 2-Acetolactate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Short-chain acyl-CoA dehydrogenase deficiency;201470;https://omim.org/entry/201470;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201470;ACADS;Enzyme;Estimated 1:50,000;No possible artefacts to report;Ethylmalonic acid;HMDB00622;http://www.hmdb.ca/metabolites/HMDB00622;132.1146;Yes;"Monoethyl malonic acid; Dimethylmalonic acid; Glutaric acid; Methylsuccinic acid; 2-Acetolactate";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Short-chain acyl-CoA dehydrogenase deficiency;201470;https://omim.org/entry/201470;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201470;ACADS;Enzyme;Estimated 1:50,000;No possible artefacts to report;Adipic acid;HMDB00448;http://www.hmdb.ca/metabolites/HMDB00448;146.1412;Yes;"Methylglutaric acid; 2-Methylglutaric acid; Monomethylglutaric acid; 2,2-Dimethylsuccinic acid; Solerol; 2-Aceto-2-hydroxybutanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Short-chain acyl-CoA dehydrogenase deficiency;201470;https://omim.org/entry/201470;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201470;ACADS;Enzyme;Estimated 1:50,000;No possible artefacts to report;Hexanoylglycine;HMDB00701;http://www.hmdb.ca/metabolites/HMDB00701;173.2096;Yes;"Isovalerylalanine; Isovalerylsarcosine; N-Acetylleucine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;cis-5-Tetradecenoylcarnitine;HMDB02014;http://www.hmdb.ca/metabolites/HMDB02014;369.5387;Yes;trans-2-Tetradecenoylcarnitine;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;Tetradecanoylcarnitine;HMDB05066;http://www.hmdb.ca/metabolites/HMDB05066;371.5545;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;VLCAD-DiagRatio-C14:1/C2;HMDB0AC03;http://www.hmdb.ca/metabolites/HMDB0AC03;NA_Ratio_0AC03;No;NA;Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;L-Carnitine;HMDB00062;http://www.hmdb.ca/metabolites/HMDB00062;161.1989;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;3,5-Tetradecadiencarnitine;HMDB13331;http://www.hmdb.ca/metabolites/HMDB13331;367.5228;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;5-Tetradecenoic acid;HMDB00499;http://www.hmdb.ca/metabolites/HMDB00499;226.355;Yes;"5Z-Tetradecenoic acid; Myristoleic acid; trans-Tetra-dec-2-enoic acid";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;L-Palmitoylcarnitine;HMDB00222;http://www.hmdb.ca/metabolites/HMDB00222;399.6077;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;9-Hexadecenoylcarnitine;HMDB13207;http://www.hmdb.ca/metabolites/HMDB13207;397.5918;Yes;trans-Hexadec-2-enoyl carnitine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;Oleoylcarnitine;HMDB05065;http://www.hmdb.ca/metabolites/HMDB05065;425.654;Yes;"Vaccenyl carnitine; Elaidic carnitine; 11Z-Octadecenylcarnitine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;Linoleoylcarnitine;HMDB06469;http://www.hmdb.ca/metabolites/HMDB06469;423.6291;Yes;Linoelaidyl carnitine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;Adipic acid;HMDB00448;http://www.hmdb.ca/metabolites/HMDB00448;146.1412;Yes;"Methylglutaric acid; 2-Methylglutaric acid; Monomethylglutaric acid; 2,2-Dimethylsuccinic acid; Solerol; 2-Aceto-2-hydroxybutanoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;Suberic acid;HMDB00893;http://www.hmdb.ca/metabolites/HMDB00893;174.1944;Yes;"Ethyladipic acid; 2,4-Dimethyladipic acid; 3-Methylpimelic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;83;Disorders of fatty acid oxidation and transport;Very long-chain acyl-CoA dehydrogenase deficiency;201475;https://omim.org/entry/201475;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:201475;ACADVL;Enzyme;Estimated 1:50,000;No possible artefacts to report;Sebacic acid;HMDB00792;http://www.hmdb.ca/metabolites/HMDB00792;202.2475;Yes;"2-Ethylsuberic acid; Heptylmalonic acid; 3-Methylazelaic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;HMG-CoA synthase deficiency;605911;https://omim.org/entry/605911;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605911;HMGCS2;Enzyme;Estimated ~20 cases;No possible artefacts to report;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;HMG-CoA synthase deficiency;605911;https://omim.org/entry/605911;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605911;HMGCS2;Enzyme;Estimated ~20 cases;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;HMG-CoA synthase deficiency;605911;https://omim.org/entry/605911;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605911;HMGCS2;Enzyme;Estimated ~20 cases;No possible artefacts to report;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;HMG-CoA synthase deficiency;605911;https://omim.org/entry/605911;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605911;HMGCS2;Enzyme;Estimated ~20 cases;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Decrease;-1.5;Supportive;1;-1.5;1.5;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;HMG-CoA synthase deficiency;605911;https://omim.org/entry/605911;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:605911;HMGCS2;Enzyme;Estimated ~20 cases;No possible artefacts to report;3-Methylcrotonylglycine;HMDB00459;http://www.hmdb.ca/metabolites/HMDB00459;157.1671;Yes;Tiglylglycine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Mitochondrial acetoacetyl-CoA thiolase deficiency;203750;https://omim.org/entry/203750;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203750;ACAT1;Enzyme;Estimated 1:137.120-1:232.000;No possible artefacts to report;Tiglylcarnitine;HMDB02366;http://www.hmdb.ca/metabolites/HMDB02366;243.303;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Mitochondrial acetoacetyl-CoA thiolase deficiency;203750;https://omim.org/entry/203750;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203750;ACAT1;Enzyme;Estimated 1:137.120-1:232.000;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Mitochondrial acetoacetyl-CoA thiolase deficiency;203750;https://omim.org/entry/203750;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203750;ACAT1;Enzyme;Estimated 1:137.120-1:232.000;No possible artefacts to report;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Mitochondrial acetoacetyl-CoA thiolase deficiency;203750;https://omim.org/entry/203750;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203750;ACAT1;Enzyme;Estimated 1:137.120-1:232.000;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Mitochondrial acetoacetyl-CoA thiolase deficiency;203750;https://omim.org/entry/203750;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203750;ACAT1;Enzyme;Estimated 1:137.120-1:232.000;No possible artefacts to report;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Mitochondrial acetoacetyl-CoA thiolase deficiency;203750;https://omim.org/entry/203750;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203750;ACAT1;Enzyme;Estimated 1:137.120-1:232.000;No possible artefacts to report;2-Methylacetoacetic acid;HMDB03771;http://www.hmdb.ca/metabolites/HMDB03771;116.1152;Yes;"Alpha-ketoisovaleric acid; Methylacetoacetic acid; Luvlinic acid; 2-Oxovaleric acid; Glutarate semialdehyde";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Mitochondrial acetoacetyl-CoA thiolase deficiency;203750;https://omim.org/entry/203750;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203750;ACAT1;Enzyme;Estimated 1:137.120-1:232.000;No possible artefacts to report;3-Hydroxyisovalerylcarnitine;HMDB0061189;http://www.hmdb.ca/metabolites/HMDB0061189;262.3227;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Mitochondrial acetoacetyl-CoA thiolase deficiency;203750;https://omim.org/entry/203750;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203750;ACAT1;Enzyme;Estimated 1:137.120-1:232.000;No possible artefacts to report;2-Methyl-3-hydroxybutyric acid;HMDB00354;http://www.hmdb.ca/metabolites/HMDB00354;118.1311;Yes;"2-Hydroxyvaleric acid; 3-Hydroxyvaleric acid; 3-Hydroxyisovaleric acid; 4-Hydroxyisovaleric acid; 3-Hydroxy-2-Methylbutanoic acid; 2-Hydroxy-3-Methyl-butyric acid; 2-Hydroxy-2-methylbutyric acid; 2-Ethylhydracrylic acid; Erythronilic acid;";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Mitochondrial acetoacetyl-CoA thiolase deficiency;203750;https://omim.org/entry/203750;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:203750;ACAT1;Enzyme;Estimated 1:137.120-1:232.000;No possible artefacts to report;Tiglylglycine;HMDB00959;http://www.hmdb.ca/metabolites/HMDB00959;157.1671;Yes;3-Methylcrotonylglycine;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Monocarboxylate transporter I deficiency;616095;https://omim.org/entry/616095;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:616095;SLC16A1;Transporter;Estimated ~9 cases;No possible artefacts to report;Pyroglutamic acid;HMDB00267;http://www.hmdb.ca/metabolites/HMDB00267;129.114;Yes;"Pyrrolidonecarboxylic acid; Pyrroline hydroxycarboxylic acid; 1-Pyrroline-4-hydroxy-2-carboxylate; N-Acryloylglycine; 5-Oxoprolinate";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Monocarboxylate transporter I deficiency;616095;https://omim.org/entry/616095;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:616095;SLC16A1;Transporter;Estimated ~9 cases;No possible artefacts to report;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Monocarboxylate transporter I deficiency;616095;https://omim.org/entry/616095;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:616095;SLC16A1;Transporter;Estimated ~9 cases;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Monocarboxylate transporter I deficiency;616095;https://omim.org/entry/616095;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:616095;SLC16A1;Transporter;Estimated ~9 cases;No possible artefacts to report;Pyroglutamic acid;HMDB00267;http://www.hmdb.ca/metabolites/HMDB00267;129.114;Yes;"Pyrrolidonecarboxylic acid; Pyrroline hydroxycarboxylic acid; 1-Pyrroline-4-hydroxy-2-carboxylate; N-Acryloylglycine; 5-Oxoprolinate";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Monocarboxylate transporter I deficiency;616095;https://omim.org/entry/616095;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:616095;SLC16A1;Transporter;Estimated ~9 cases;No possible artefacts to report;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Monocarboxylate transporter I deficiency;616095;https://omim.org/entry/616095;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:616095;SLC16A1;Transporter;Estimated ~9 cases;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Succinyl-CoA:3-oxoacid-CoA transferase;245050;https://omim.org/entry/245050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:245050;OXCT1;Enzyme;Estimated ~33 cases;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Succinyl-CoA:3-oxoacid-CoA transferase;245050;https://omim.org/entry/245050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:245050;OXCT1;Enzyme;Estimated ~33 cases;No possible artefacts to report;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Succinyl-CoA:3-oxoacid-CoA transferase;245050;https://omim.org/entry/245050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:245050;OXCT1;Enzyme;Estimated ~33 cases;No possible artefacts to report;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;84;Disorders of ketone body metabolism;Succinyl-CoA:3-oxoacid-CoA transferase;245050;https://omim.org/entry/245050;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:245050;OXCT1;Enzyme;Estimated ~33 cases;No possible artefacts to report;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;87;Disorders of glycerol metabolism;Glycerol kinase deficiency;307030;https://omim.org/entry/307030;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:307030;GK;Enzyme;Estimated ~50 cases;No possible artefacts to report;Glycerol;HMDB00131;http://www.hmdb.ca/metabolites/HMDB00131;92.0938;No;NA;Only biomarker;5;Increase;1;Critical;5;25;25;Indispensable;3.0;Yes
E;Disorders of lipids;87;Disorders of glycerol metabolism;Glycerol kinase deficiency;307030;https://omim.org/entry/307030;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:307030;GK;Enzyme;Estimated ~50 cases;No possible artefacts to report;Glycerol;HMDB00131;http://www.hmdb.ca/metabolites/HMDB00131;92.0938;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
E;Disorders of lipids;87;Disorders of glycerol metabolism;Glycerol kinase deficiency;307030;https://omim.org/entry/307030;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:307030;GK;Enzyme;Estimated ~50 cases;No possible artefacts to report;Glycerol;HMDB00131;http://www.hmdb.ca/metabolites/HMDB00131;92.0938;No;NA;Urine;1;Increase;1;Critical;5;5;5;Indispensable;3.0;Yes
E;Disorders of lipids;95;Disorders of cholesterol biosynthesis;Mevalonate kinase deficiency;610377;https://omim.org/entry/610377;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610377;MVK;Enzyme;Estimated ~14 cases;No possible artefacts to report;Mevalonic acid;HMDB00227;http://www.hmdb.ca/metabolites/HMDB00227;148.1571;Yes;"2,3-Dihydroxy-3-methylvaleric acid; (2-Methoxyethoxy)propanoic aicd";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
E;Disorders of lipids;95;Disorders of cholesterol biosynthesis;Mevalonate kinase deficiency;610377;https://omim.org/entry/610377;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610377;MVK;Enzyme;Estimated ~14 cases;No possible artefacts to report;Mevalonic acid;HMDB00227;http://www.hmdb.ca/metabolites/HMDB00227;148.1571;Yes;"2,3-Dihydroxy-3-methylvaleric acid; (2-Methoxyethoxy)propanoic aicd";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
E;Disorders of lipids;95;Disorders of cholesterol biosynthesis;Mevalonate kinase deficiency;610377;https://omim.org/entry/610377;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:610377;MVK;Enzyme;Estimated ~14 cases;No possible artefacts to report;Mevalonolactone;HMDB06024;http://www.hmdb.ca/metabolites/HMDB06024;130.1418;Yes;"2-Methyl-3-Ketovaleric acid; 3-Methyl-2-oxovaleric acid; Ketoleucine; 2-Ketohexanoic acid; 3-Oxohexanoic acid; Adipate semialdehyde; Pantolactone";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
G;Storage disorders;103;Oligosaccharidoses;Bta-mannosidase deficiency;248510;https://omim.org/entry/248510;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248510;MANBA;Enzyme;Estimated ~20 cases;No possible artefacts to report;Beta-1,4-mannose-N-acetylglucosamine;HMDB06535;http://www.hmdb.ca/metabolites/HMDB06535;383.3484;Yes;"N-Acetyllactosamine; Poly-N-acetyllactosamine; Lacto-N-biose I";Only biomarker;5;Increase;1;Important influence;3;15;15;Dispensable;;Yes
G;Storage disorders;103;Oligosaccharidoses;Bta-mannosidase deficiency;248510;https://omim.org/entry/248510;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:248510;MANBA;Enzyme;Estimated ~20 cases;No possible artefacts to report;Beta-1,4-mannose-N-acetylglucosamine;HMDB06535;http://www.hmdb.ca/metabolites/HMDB06535;383.3484;Yes;"N-Acetyllactosamine; Poly-N-acetyllactosamine; Lacto-N-biose I";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
H;Disorders of peroxisomes and oxalate;113;Peroxisomal disorders not involving lipid metabolism;Hyperoxaluria type I;259900;https://omim.org/entry/259900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:259900;AGXT;Enzyme;Estimated 1:333.000-1:1.000,000;No possible artefacts to report;Glycolic acid;HMDB00115;http://www.hmdb.ca/metabolites/HMDB00115;76.0514;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
H;Disorders of peroxisomes and oxalate;113;Peroxisomal disorders not involving lipid metabolism;Hyperoxaluria type I;259900;https://omim.org/entry/259900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:259900;AGXT;Enzyme;Estimated 1:333.000-1:1.000,000;No possible artefacts to report;Oxalic acid;HMDB02329;http://www.hmdb.ca/metabolites/HMDB02329;90.0349;No;NA;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
H;Disorders of peroxisomes and oxalate;113;Peroxisomal disorders not involving lipid metabolism;Hyperoxaluria type I;259900;https://omim.org/entry/259900;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:259900;AGXT;Enzyme;Estimated 1:333.000-1:1.000,000;No possible artefacts to report;Glyoxylic acid;HMDB00119;http://www.hmdb.ca/metabolites/HMDB00119;74.0355;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
I;Congenital disorders of glycosylation;130;Disorder of deglycosylation;N-glycanase I deficiency;615273;https://omim.org/entry/615273;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:615273;NGLY1;Enzyme;Estimated ~60 cases;No possible artefacts to report;Aspartylglycosamine;HMDB00489;http://www.hmdb.ca/metabolites/HMDB00489;335.3104;No;NA;Only biomarker;5;Increase;1;Important influence;3;15;15;Dispensable;;Yes
I;Congenital disorders of glycosylation;130;Disorder of deglycosylation;N-glycanase I deficiency;615273;https://omim.org/entry/615273;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:615273;NGLY1;Enzyme;Estimated ~60 cases;No possible artefacts to report;Aspartylglycosamine;HMDB00489;http://www.hmdb.ca/metabolites/HMDB00489;335.3104;No;NA;DBS;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
NA;Disoders of peptides;NA;Disorders of peptide metabolism;Carnosinase deficiency;212200;https://omim.org/entry/212200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:212200;18q21.3;NA;Estimated ~8 cases;No possible artefacts to report;Homocarnosine;HMDB00745;http://www.hmdb.ca/metabolites/HMDB00745;240.259;Yes;Anserine, Balenine;Only biomarker;5;Increase;1;Critical;5;25;25;Indispensable;3.0;Yes
NA;Disoders of peptides;NA;Disorders of peptide metabolism;Carnosinase deficiency;212200;https://omim.org/entry/212200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:212200;18q21.3;NA;Estimated ~8 cases;No possible artefacts to report;Homocarnosine;HMDB00745;http://www.hmdb.ca/metabolites/HMDB00745;240.259;Yes;Anserine, Balenine;CSF;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
NA;Disoders of peptides;NA;Disorders of peptide metabolism;Carnosinase deficiency;212200;https://omim.org/entry/212200;http://compbio.charite.de/hpoweb/showterm?id=HP:0000118#disease=OMIM:212200;18q21.3;NA;Estimated ~8 cases;No possible artefacts to report;Homocarnosine;HMDB00745;http://www.hmdb.ca/metabolites/HMDB00745;240.259;Yes;Anserine, Balenine;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;3.0;Yes
NA;NA;NA;NA;Cytosolic malate dehydrogenase deficiency;NA;NA;NA;MDH1;Enzyme;Estimated ~2 cases;No possible artefacts to report;Glycerol-3-phosphate;HMDB00126;http://www.hmdb.ca/metabolites/HMDB00126;172.0737;Yes;Beta-Glycerophosphoric acid;Only biomarker;5;Increase;1;Supportive;1;5;5;Dispensable;;Yes
NA;NA;NA;NA;Cytosolic malate dehydrogenase deficiency;NA;NA;NA;MDH1;Enzyme;Estimated ~2 cases;No possible artefacts to report;Glycerol-3-phosphate;HMDB00126;http://www.hmdb.ca/metabolites/HMDB00126;172.0737;Yes;Beta-Glycerophosphoric acid;DBS;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Dietary cobalamin deficiency;NA;NA;NA;NA;NA;NA;NA;Methylmalonic acid;HMDB00202;http://www.hmdb.ca/metabolites/HMDB00202;118.088;Yes;"Succinic acid; Erythrono-1,4-lactone; Threonolactone";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Dietary cobalamin deficiency;NA;NA;NA;NA;NA;NA;NA;Methylmalonic acid;HMDB00202;http://www.hmdb.ca/metabolites/HMDB00202;118.088;Yes;"Succinic acid; Erythrono-1,4-lactone; Threonolactone";Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Dietary cobalamin deficiency;NA;NA;NA;NA;NA;NA;NA;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Dietary cobalamin deficiency;NA;NA;NA;NA;NA;NA;NA;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;3-Hydroxybutyric acid;HMDB00357;http://www.hmdb.ca/metabolites/HMDB00357;104.1045;Yes;"2-Hydroxybutyric acid; 4-Hydroxybutyric acid; 2-Methyl-3-Hydroxypropanoic acid";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;2.0;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;Acetoacetic acid;HMDB00060;http://www.hmdb.ca/metabolites/HMDB00060;102.0886;Yes;"2-Ketobutyric acid; 2-Methyl-3-Oxopropanoic acid; Succinic acid semialdehyde; Methylmalonic acid semialdehyde; 4-Hydroxycrotonic acid";Plasma;2;Increase;1;Important influence;3;6;6;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;L-Alanine;HMDB00161;http://www.hmdb.ca/metabolites/HMDB00161;89.0932;Yes;"D-Alanine; Beta-alanine; Sarcosine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;L-Valine;HMDB00883;http://www.hmdb.ca/metabolites/HMDB00883;117.1463;Yes;"Betaine; N-Methyl-aminoisobutyric acid; Aminopentanoic acid; Norvaline";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;L-Threonine;HMDB00167;http://www.hmdb.ca/metabolites/HMDB00167;119.1192;Yes;"L-Homoserine; L-Allothreonine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;L-Leucine;HMDB00687;http://www.hmdb.ca/metabolites/HMDB00687;131.1729;Yes;"L-Isoleucine; L-Alloisoleucine; L-Norleucine; Beta-Leucine; D-Leucine; 3-Aminocaproic acid";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;L-Isoleucine;HMDB00172;http://www.hmdb.ca/metabolites/HMDB00172;131.1729;Yes;"L-Leucine; L-Alloisoleucine; L-Norleucine; Beta-Leucine; D-Leucine; 3-Aminocaproic acid";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;L-Lysine;HMDB00182;http://www.hmdb.ca/metabolites/HMDB00182;146.1876;Yes;"D-Lysine; 3,6-Diaminohexanoate";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;L-Tryptophan;HMDB00929;http://www.hmdb.ca/metabolites/HMDB00929;204.2252;Yes;"D-Tryptophan; (+)-Tryptophan; 3-Hydroxymethylantipyrine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;Oleoylcarnitine;HMDB05065;http://www.hmdb.ca/metabolites/HMDB05065;425.654;Yes;"Vaccenyl carnitine; Elaidic carnitine; 11Z-Octadecenylcarnitine";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;Hydroxybutyrylcarnitine;HMDB13127;http://www.hmdb.ca/metabolites/HMDB13127;247.2881;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;trans-2-Dodecenoylcarnitine;HMDB13326;http://www.hmdb.ca/metabolites/HMDB13326;341.4855;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;Dodecanoylcarnitine;HMDB02250;http://www.hmdb.ca/metabolites/HMDB02250;343.5014;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;cis-5-Tetradecenoylcarnitine;HMDB02014;http://www.hmdb.ca/metabolites/HMDB02014;369.5387;Yes;trans-2-Tetradecenoylcarnitine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;Tetradecanoylcarnitine;HMDB05066;http://www.hmdb.ca/metabolites/HMDB05066;371.5545;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;9-Hexadecenoylcarnitine;HMDB13207;http://www.hmdb.ca/metabolites/HMDB13207;397.5918;Yes;trans-Hexadec-2-enoyl carnitine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;L-Palmitoylcarnitine;HMDB00222;http://www.hmdb.ca/metabolites/HMDB00222;399.6077;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Fasting;NA;NA;NA;NA;NA;NA;NA;Stearoylcarnitine;HMDB00848;http://www.hmdb.ca/metabolites/HMDB00848;427.6609;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Folic acid deficiency;NA;NA;NA;NA;NA;NA;NA;Formiminoglutamic acid;HMDB00854;http://www.hmdb.ca/metabolites/HMDB00854;174.1546;Yes;N-Acetylasparagine;Urine;1;Increase;1;Important influence;3;3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Folic acid deficiency;NA;NA;NA;NA;NA;NA;NA;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Folic acid deficiency;NA;NA;NA;NA;NA;NA;NA;5-Methyltetrahydrofolic acid;HMDB01396;http://www.hmdb.ca/metabolites/HMDB01396;459.4558;No;NA;CSF;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Folic acid deficiency;NA;NA;NA;NA;NA;NA;NA;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Folic acid deficiency;NA;NA;NA;NA;NA;NA;NA;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Folic acid deficiency;NA;NA;NA;NA;NA;NA;NA;Sarcosine;HMDB00271;http://www.hmdb.ca/metabolites/HMDB00271;89.0932;Yes;"L- and D-Alanine; Beta-alanine";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Folic acid deficiency;NA;NA;NA;NA;NA;NA;NA;Orotic acid;HMDB00226;http://www.hmdb.ca/metabolites/HMDB00226;156.0963;No;NA;Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Haemolysis;NA;NA;NA;NA;NA;NA;NA;L-Glutamic acid;HMDB00148;http://www.hmdb.ca/metabolites/HMDB00148;147.1293;Yes;"D-Glutamic acid; DL-Glutamate; N-Methyl-D-aspartic acid; N-Acetylserine; L-4-Hydroxyglutamate semialdehyde";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Haemolysis;NA;NA;NA;NA;NA;NA;NA;L-Arginine;HMDB00517;http://www.hmdb.ca/metabolites/HMDB00517;174.201;Yes;D-Arginine;Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Haemolysis;NA;NA;NA;NA;NA;NA;NA;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Haemolysis;NA;NA;NA;NA;NA;NA;NA;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Haemolysis;NA;NA;NA;NA;NA;NA;NA;Taurine;HMDB00251;http://www.hmdb.ca/metabolites/HMDB00251;125.147;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Haemolysis;NA;NA;NA;NA;NA;NA;NA;L-Aspartic acid;HMDB00191;http://www.hmdb.ca/metabolites/HMDB00191;133.1027;Yes;"D-Aspartic acid; Iminodiacetic acid";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Haemolysis;NA;NA;NA;NA;NA;NA;NA;Ornithine;HMDB00214;http://www.hmdb.ca/metabolites/HMDB00214;132.161;Yes;D-Ornithine;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Haemolysis;NA;NA;NA;NA;NA;NA;NA;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Haemolysis;NA;NA;NA;NA;NA;NA;NA;Glycine;HMDB00123;http://www.hmdb.ca/metabolites/HMDB00123;75.0666;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Haemolysis;NA;NA;NA;NA;NA;NA;NA;L-Palmitoylcarnitine;HMDB00222;http://www.hmdb.ca/metabolites/HMDB00222;399.6077;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Haemolysis;NA;NA;NA;NA;NA;NA;NA;Stearoylcarnitine;HMDB00848;http://www.hmdb.ca/metabolites/HMDB00848;427.6609;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Liver failure;NA;NA;NA;NA;NA;NA;NA;L-Methionine;HMDB00696;http://www.hmdb.ca/metabolites/HMDB00696;149.211;No;NA;Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Liver failure;NA;NA;NA;NA;NA;NA;NA;L-Tyrosine;HMDB00158;http://www.hmdb.ca/metabolites/HMDB00158;181.1885;Yes;"Beta-Tyrosine; o-Tyrosine; L-Threo-3-Phenylserine";Plasma;2;Increase;1;Critical;5;10;10;Indispensable;1.5;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Liver failure;NA;NA;NA;NA;NA;NA;NA;L-Phenylalanine;HMDB00159;http://www.hmdb.ca/metabolites/HMDB00159;165.1891;Yes;Norsalsolinol;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Liver failure;NA;NA;NA;NA;NA;NA;NA;p-Hydroxyphenylacetic acid;HMDB00020;http://www.hmdb.ca/metabolites/HMDB00020;152.1473;Yes;"3-Hydroxyphenylacetic acid; 3,4-Dihydroxyphenylacetaldehyde; 4-Hydroxy-3-methylbenzoic acid";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Liver failure;NA;NA;NA;NA;NA;NA;NA;4-Hydroxyphenylpyruvic acid;HMDB00707;http://www.hmdb.ca/metabolites/HMDB00707;180.1574;Yes;"3-Hydroxyphenylpyruvic acid; 2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid; ";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Liver failure;NA;NA;NA;NA;NA;NA;NA;Hydroxyphenyllactic acid;HMDB00755;http://www.hmdb.ca/metabolites/HMDB00755;182.1733;Yes;"Homovanillic acid; Isohomovanillic acid; 3-Hydroxyphenyllactate; 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid; 3-Methoxy-4-hydroxyphenylglycolaldehyde";Urine;1;Increase;1;Supportive;1;1;1;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Prolonged plasma storage;NA;NA;NA;NA;NA;NA;NA;L-Glutamine;HMDB00641;http://www.hmdb.ca/metabolites/HMDB00641;146.1445;Yes;"D-Glutamine; Ureidoisobutyric acid; Alanylglycine; Alanyl-Glycine";Plasma;2;Decrease;-1.5;Supportive;1;-3;3;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Prolonged plasma storage;NA;NA;NA;NA;NA;NA;NA;L-Glutamic acid;HMDB00148;http://www.hmdb.ca/metabolites/HMDB00148;147.1293;Yes;"D-Glutamic acid; DL-Glutamate; N-Methyl-D-aspartic acid; N-Acetylserine; L-4-Hydroxyglutamate semialdehyde";Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Renal failure;NA;NA;NA;NA;NA;NA;NA;Glutarylcarnitine;HMDB13130;http://www.hmdb.ca/metabolites/HMDB13130;275.301;No;NA;Plasma;2;Increase;1;Important influence;3;2;6;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Renal failure;NA;NA;NA;NA;NA;NA;NA;Creatinine;HMDB00562;http://www.hmdb.ca/metabolites/HMDB00562;113.1179;No;NA;Plasma;2;Increase;1;Important influence;3;2;6;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Renal failure;NA;NA;NA;NA;NA;NA;NA;3-Methylglutarylcarnitine;HMDB00552;http://www.hmdb.ca/metabolites/HMDB00552;289.3248;No;NA;Plasma;2;Increase;1;Important influence;3;2;6;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Renal failure;NA;NA;NA;NA;NA;NA;NA;Homocysteine thiolactone;HMDB02287;http://www.hmdb.ca/metabolites/HMDB02287;117.169;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Renal failure;NA;NA;NA;NA;NA;NA;NA;Homocysteine;HMDB00742;http://www.hmdb.ca/metabolites/HMDB00742;135.185;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Renal failure;NA;NA;NA;NA;NA;NA;NA;S-Adenosylhomocysteine;HMDB00939;http://www.hmdb.ca/metabolites/HMDB00939;384.411;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Renal failure;NA;NA;NA;NA;NA;NA;NA;S-Adenosylmethionine;HMDB01185;http://www.hmdb.ca/metabolites/HMDB01185;399.445;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
NA;Other common conditions and interferences;NA;Other common conditions and interferences;Renal failure;NA;NA;NA;NA;NA;NA;NA;Methylmalonylcarnitine;HMDB13133;http://www.hmdb.ca/metabolites/HMDB13133;261.2717;No;NA;Plasma;2;Increase;1;Supportive;1;2;2;Dispensable;;Yes
